Wane ne mahaifiyarka take da wannan halin?
kuma irin wannan ciwon zuciya zai zama magani na yau da kullum a cikin shekaru
da kuma ƙwayoyin cuta
kuma ya kamata ya duba yawan cholesterol a cikin jini
Ba ku da wata alfarwa a yanzu?
ba ku da wani abu mai tsanani a zuciyarku?
kuma kuna da matsala da yin amfani da iska
Za ka iya lissafa alamun da ke nuna cewa kana da wani cuta?
Kuma ka san yadda za a yi wa ƙafarka magana.
kuma ina da wani abu mai kyau
Ina da ƙugiya da ƙugiya
Ina baƙin ciki ƙwarai a yau,
Lokaci ne na ƙanƙara a gare ni.
da kuma baƙin ciki
kuma ina da kamar ina da wata babbar mota
Ina so ka nuna mini yadda kake ji.
Kuma ba su da dukan kayan aiki.
da kuma rashin lafiyarku.
Kuma kun san yadda nake tunani a kaina.
Kuma ka san cewa duk abin da na rubuta yana shafan ka.
da kuma zuciyarka ta yi baƙin ciki
Kuna cewa, "An halaka birninku".
wani a cikin jikinka yana da ciwon zuciya wanda ya shafi yawan cholesterol a cikin jini
Ko kuwa akwai wata alama a jikinku ko kuma wata matsala?
Shin akwai wasu a cikin iyalinku da suke fama da irin wannan rashin lafiya?
Shin akwai wata alama da kake da ita?
Ba za ku taɓa yin wani abu kamar numfashin nan da yake mutuwa ba?
Don haka, ku da kuke baƙin ciki yanzu, ku yi haƙuri.
Domin lokaci ne na sanyi.
Amma ko da yake muna shan wahala sosai saboda rashin lafiyar zuciyarmu,
Amma matsalar da muke fuskanta yanzu ita ce, mugun yanayi.
Na ji ina fama da matsalar numfashi
Na san mutane da yawa suna son ni.
Amma dole ne mu yi wa kowane irin jinin da aka yi mana rauni, magani mai kyau.
Ba ku yi ƙoƙarin yin abin da yake da kyau ba?
Na yi addu'a ga Ubangiji saboda baƙin cikin zuciyata,
kamar dai wani ne yake kula da zuciyarka.
A yanzu kuwa kuna kama da numfashi mai lalacewa.
ko kuwa suna cewa suna da irin wannan cuta?
ko kuwa kuna da wata cuta ta jini ko kuma wata cuta ta jini?
Shin, kuna da wata cuta mai tsanani kamar ciwon sukari?
Shin, ba ku da wani tunani mai kyau?
Ba ku da jini mai ƙazanta?
Shin, ba za ka iya yin tunani cewa ba ka da wata sanadin cutar?
Kun san alamun rashin lafiyar da yake yi?
Ba ku ga wannan hoton ba?
domin yau akwai yawan shan giya
Na yi bincike na ciwon sukari
Na ji yana da irin wannan halin da nake ciki.
yadda barci yake ƙonewa
Don me kuke ƙin jinin kowa?
Don haka, sai ku yi ta shan azaba, kuna shan azaba.
Idan jikinka ya ƙone, sai ka ji zafi,
Idan kana ganin kana da wata alama ko wata matsala da za a bincika
Jikin na yana kama da wuta a Kenya
Ina da ƙananan gashin jiki
Jiki na ya tashi kamar na Kenya
Ina da ciwon zuciya mai tsanani.
Ina fama da rashin ƙarfi sosai
zan aiko maka da hoto
Ina da baƙin ciki ƙwarai a zuciyata.
Ina da ƙaya, jikina kuma yana ƙaruwa.
Ina tsammanin wannan baƙon abu ne ba
Ina tsammanin wannan shine farkon bazara
kamar yadda waɗansu masu bautar gumaka suke zaune a birnin da ba ku taɓa zuwa ba?
duk sun fara ne da ƙwayoyin cuta da kuma saurin jiki a lokaci guda.
Yana fitowa daga tsakiyar zuciya
Yana da zafi kamar ciwon zuciya
Na yi farin ciki ƙwarai da gaske.
a tsakiyar zuciyata
a cikin zuciyarmu
Ina da baƙin ciki a zuciyata,
Na ji zafi sosai a zuciyata
Ina so ku gaya mini yadda nake ji.
kamar ciwon jini ko ciwon sukari
kamar dai a tsakiyar zuciya
Yanzu za ku iya ɗaukar takardar shaidar don wannan rashin lafiyar jiki
Yanzu Maryamu, ina da wannan halin tun lokacin da ka sha wahala.
yanzu ka ce kana da ciwon zuciya
A cikin wannan rana, ina jin zafi sosai.
Ko kuwa kuna da wata cuta da ba za ku iya ɗauka ba bayan kun mutu?
Ko kuwa wani ya amince da kai?
Haka kuma za a yi da ƙura da ƙura da ƙura da ƙura da ƙura da ƙura.
Ya kasance a tsakiyar zuciyata
Ka nuna min hoton a lokacin da kake jin zafi
Daga jikinka mai ƙonawa
Me ya sa ba za a iya nuna muku alamun cutar ba sa'ad da mace ta yi ciki?
Shin, ba a taɓa ganin ɗanka yana da irin waɗannan alamun ba?
Ka sanar da ni game da birninka mai wahala
jikinsa ya yi ta yin tawaye da dare
Na yi baƙin ciki sosai a jikin na bayan kwana biyu da aka gicciye ni.
Jiki na ya yi barci a daren Kenya
duba likitan da ke kula da kula da asibitin gaggawa
Don me kuke so ku san cewa kuna cikin wani irin rashin lafiya?
Har ila yau, zuciyata tana cike da baƙin ciki a jikina.
Ni kuwa na yi baƙin ciki ƙwarai, na yi baƙin ciki ƙwarai.
in kuwa ina da wannan baƙin ciki a zuciyata,
Me ya sa kuke baƙin ciki?
ko kuwa kunã da baƙin ciki?
Me ya sa kuke baƙin ciki?
NS
kamar zuciyarka ta yi daidai
Kun san cewa ina da ciwon sukari.
kuna cewa, "Abin baƙin ciki ne a wannan zamani".
Ana gudanar da bincike kan cutar korona (COVID-19) a Majalisar Tarayyar Turai/Taron Tarayyar Turai da Majalisar Burtaniya, 1 ga Janairu zuwa 15 ga Maris, 2020
Masu kamuwa da cutar korona da ke tattare da cutar (COVID-19) suna nuna rashin daidaito a cikin tarayyar Turai/Turai na Turai da kuma Majalisar Ingila da ke kula da cutar, kuma a wasu lokuta, COVID-19 yana gudana cikin sauri a duk faɗin duniya.
Idan muka lura da abin da ya faru a Italiya, dole ne jihohi, asibitoci da kungiyoyin kula da marasa lafiya su kara tsarawa saboda yawan mutanen da ke fama da cutar COVID-19 da ke da ciwon sukari a jiki, da kuma yawan cututtukan da ke faruwa a jiki.
A ranar 31 ga Disamba, 2019, wani rukuni na kwayoyin cuta da ba a san su ba ya bayyana a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Hukumar Kula da Cututtuka ta kasar Sin ta bayyana cewa cutar coronavirus ta biyu da aka gano a matsayin cutar huhu ta coronavirus 2 (SARS-CoV-2) ba za ta iya haifar da cutar ba.
Tun daga wannan lokacin, ana kiran cutar ta SARS-CoV cutar (COVI-19).
Wani bincike ya nuna cewa kusan kashi 80 cikin dari na mutane suna da cututtuka masu tsanani, kamar rashin lafiyar numfashi, da kuma rashin lafiya.
A cikin kashi 14% na masu kamuwa da cutar, COVID-19 yana haifar da kamuwa da cutar da kuma hana su rayuwa a asibiti kuma kashi 6% na marasa lafiya suna fama da cutar kuma dole ne likitocin su kula da su.
Mutuwar marasa lafiya a asibiti na COVID-19 zai kai kashi 4%.
A cikin wannan binciken, muna nazarin yanayin cutar COVID-19 da ke faruwa a kowace ƙasa na Majalisar Turai/EEA da kuma Majalisar Dinkin Duniya (UK) da ke cikin lardin Hubei, China.
Ina kuma duba yawan adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Birtaniya da kuma wadanda ke Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Masu kamuwa da COVID-19 a cikin EU/EEA da Birtaniya
Bayan China, COVID-19 ya mamaye wasu wurare kuma a yanzu ana samun ci gaba da cutar COVID-19 a sauran sassan duniya.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa COVID-19 cuta ce ta duniya.
A cikin rahoton Eurosurveillance na 5 ga Maris, 2020, Spiteri al. ya ba da rahoton cewa an sami adadin mutanen da suka kamu da COVID-19 a Turai bisa ga WHO.
A cikin EU/EEA, an fara samun kamuwa da cutar ta uku a Faransa a ranar 24 ga Janairu, 2020 a cikin masu dawowa daga birnin Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an samu kamuwa da COVID-19 a kasashe 30 na EU/EEA da kuma a Majalisar Dinkin Duniya, wanda a tsakanin 31 ga Disamba, 2019 da wannan lokacin an samu kamuwa da cutar 39,768 da mutuwar 1,727 da kuma mutuwar 1,441 a wasu ƙasashe na Italiya.
Kula da yawan adadin masu cutar COVID-19
A cewar Hukumar Kula da Cututtuka ta Turai (ECDC), adadin adadin masu kamuwa da COVID-19 a kowace ƙasa a duniya, wanda aka ba da rahoton daga masu amincewa kamar Shugabannin Hukumar Lafiya, Shugabannin Kasashen Cikin Gida da na Birane da kuma WHO ba za a bincika duk wani abu da ya faru ba da safe da karfe 8:00 na safe.
Wannan bayanin da aka yi amfani da shi don gwajin COVID-19 a cikin EU/EEA da kuma a Birtaniya, yana gwadawa da na Italiya.
Bisa ga binciken da aka yi na yawan masu kamuwa da cutar COVID-19, mun ƙidaya yawan adadin masu kamuwa da cutar COVID-19, wanda ya ƙidaya yawan kamuwa da cutar COVID-19 a kowace ƙasa ta EU/EEA da kuma ƙasar Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gano cewa, adadin adadin masu kamuwa da cutar da aka samu a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na yamma ya shafi ƙasar Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Matsayi na COVID-19 a cikin EU/EEA da Birtaniya.
Ƙaddamar da ƙididdigar yawan adadin masu kamuwa da COVID-19 a cikin EU/EEA a cikin kwanaki 14 da Birtaniya ya biyo bayan babban adadin na Hubei Province (China) (Hotuna 1).
A cikin EU/EEA da Birtaniya duka, adadin adadin masu kamuwa da COVID-19 ya fara karuwa ne a ranar 21 ga Fabrairu kuma ya ci gaba ne a ranar 28 ga Fabrairu, 2020 (Abubuwa da yawa).
Mafi yawan abin da ya sa wannan ya faru shi ne yawan adadin wadanda aka samu a Italiya, amma sauran kasashen EU/EEA da Birtaniya sun samu irin wannan ci gaban a cikin adadin COVID-19 (Abin da ya sa).
Hoton na 2 ya nuna yadda ake samun adadin kamuwa da cutar COVID-19, a cikin EU/EEA da Birtaniya a lokacin da aka samu a Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya bayyana cewa, a ranar 15 ga watan Maris da karfe 8:00 na yammacin yammacin rana, kasashe 15 na EU/EEA da wasu kasashe na Birtaniya sun ba da rahoton adadin wadanda za su kamu da cutar a Italiya a cikin kwanaki 3 kafin ko bayan kammala.
Rahotanni sun nuna cewa adadin mutanen da suka kamu da cutar COVID-19 da aka ruwaito ba su da iyaka ga EU/EEA da Birtaniya.
Matsayin da muke fuskanta na COVID-19 ya nuna cewa cutar tana da tasiri sosai wanda zai iya zama sanarwa a duk ƙasashe.
Wannan shi ne saboda ƙasashe suna cikin wani yanayi na rashin daidaito, canje-canje a cikin takardun da ke tattare da lafiyar ƙasa, da kuma bayyanar cututtuka daban-daban a cikin ƙasashe da kuma wasu hanyoyin da za a iya gano marasa lafiya da ke buƙatar sake duba lafiyarsu don COVID-19, da kuma sake dubawa.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun gano cewa kashi 10% na mutanen da ke fama da COVID-19 suna bukatar kula da lafiya kuma rahotanni sun ce asibitoci da kungiyoyin kula da marasa lafiya a yankunan sun ci gaba da kula da lafiyarsu.
Bayanai na asibitoci da/ko kungiyoyin masu kula da cutar COVID-19 suna cikin EU/EEA na kashi 6% da 1% na masu cutar, dabam dabam (da kuma bayanan da aka ba su).
Sai kuma a haɗa su duka a cikin wani wuri don a yi amfani da bayanan kula da yawan waɗanda suka kamu da cutar da kuma yawan waɗanda suka mutu.
Wani bincike a shekara ta 2010-2011 ya nuna cewa akwai canji a cikin yawan gado da kuma yawan wuraren da ake kula da marasa lafiya a Turai, daga 29.2 a Jamus zuwa 4.2 a Portugal ga mutane 100,000.
Ƙasashen da ke da arziki sun fi Italiya arziki (12.5 da yawa da kuma abinci mai gina jiki a kowace shekara a cikin mutane 100,000 a shekara ta 2010-11).
Shirya tsarin da zai shafi tsarin shiga, da kuma yadda kowace ƙasa ta EU/EEA da Birtaniya za su iya karɓar marasa lafiya na COVID-19 da ke bukatar asibiti da kuma bukatar kwanciya mai kyau dole ne su sami umarnin kula da mutum aƙalla 90% a cikin takardar binciken ECDC na shekara ta bakwai na gwajin COVID-19.
Saboda yawan marasa lafiya ya karu a wasu sassan EU/EEA da kuma Birtaniya, kuma asibitoci da kungiyoyin kula da marasa lafiya suna aiki a wuraren da aka ba da izini ga masu cutar, ana iya samun bayanan marasa lafiya da kuma gado mai kyau a kowane tashar birni don batun lasisi na 2 (NUTS-2).
Abubuwan da suka faru a Italiya da kuma halin da ake ciki a wasu ƙasashe na nuna cewa COVID-19 ya kasance cikin gaggawa a cikin EU/EEA da Birtaniya.
Kasashe, asibitoci da kungiyoyin kula da marasa lafiya dole ne su shirya kansu don samar da taimakon jama'a don samun SARS-CoV-2 da kuma karuwar adadin masu cutar COVID-19 da ke bukatar kulawa ta likita, da kuma kulawa ta musamman, kamar yadda ake samu a wuraren da cutar ta kamu da ita a Italiya.
Kamar yadda aka ruwaito a cikin binciken binciken cutar na ECDC, akwai wani tsari na ƙarshe da ba zai iya jurewa ba na hana yaduwar SARS-COV-2, da kuma wani tsari na gaba da zai iya zuwa daga magani zuwa raguwa, kamar yadda yawan marasa lafiya da ke ci gaba da karuwa ba zai iya ba da lokaci mai kyau ga masu ɗaukar hoto don ganewa, amsawa da kuma magance tsarin amsawa a ranar Jumma'a da kuma lokaci ba.
Ƙididdigar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Akwai fatan cewa za a iya samun ci gaba ko kuma ƙasashe su sami hanyoyin da za su iya inganta kansu wajen rage yaduwar SARS-CoV-2 da kuma rage gaggawa a fannin kiwon lafiya.
Idan hakan ta faru, zai zama kamar tsarin kula da lafiya a wasu ƙasashen EU/EEA zai sami matsala saboda yawan marasa lafiya da ke buƙatar kula da lafiya zai ƙaru a cikin kwanaki ko makonni masu zuwa.
Cutar korona ta 2019 (COVID-19), wadda ta samo asali ne daga cutar sankara ta SARS (SARS-CoV-2), ta kashe fiye da mutane 3,000 kuma ta yi kamuwa da fiye da 80,000 a China da kuma wasu ƙasashe a duniya, wanda ke da matukar damuwa ga al'umma.
Kamar yadda yake a cikin cutar, SARS-CoV, wadda ta haifar da SARS ga dubban mutane a 2003, SARS-CoV-2 na iya kamuwa da cutar daga tsuntsaye kuma yana haifar da alamun cutar ta hanyar irin wannan hanyar.
Amma, COVID-19 ya rage yawan kisa da cutar da SARS ke haifarwa kuma yana cutar da tsofaffi fiye da mata.
Domin a san yawan marasa lafiya da ke ci gaba da kamuwa da cutar, wannan takardar ta yi watsi da ba da lokaci da kuma ba da izini ga abin da ake ciki a cikin binciken.
Za mu kuma yi la'akari da nazarin kamuwa da cuta, gano cutar, nazarin cutar, bincike, magani, zato, da kuma hana cutar.
Ko da yake yawancin bayanai suna da amsoshi, muna tsammanin wannan labarin yana da kyau ko kuma yana da mahimmanci a fahimtar wannan yanayin.
Bikin bazara a ranar 25 ga Janairu 2020 zai zama abin tunawa ga al'ummar kasar Sin da suka yi addu'a da kuma kasancewa a gida a lokacin bazara da kuma lokacin da suka yi bikin saboda sabon kamuwa da cutar.
Wannan kwayar cutar tana kama da cutar coronavirus (CoV) wadda ta haifar da cutar sankarar zuciya (SARS) a shekara ta 2003; saboda haka Hukumar Lafiya ta Duniya ta kira ta SARS-CoV-2, kuma ana kiran cutar cutar CoV 19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma daga baya ta yada ta ko'ina cikin kasar kuma ta kai kasashe kusan 50 a duniya.
Tun daga ranar 2 ga Maris, 2020, cutar ta shafi mutane 80,000 da suka kamu da cutar COVID-19, kuma an kammala kamuwa da cutar 40,000 da aka warke kuma an kashe fiye da 3,000.
WHO ta ce COVID-19 "na cutar da mutane" kuma yana iya zama mafi muni.
Kamar yadda aka bayyana a PubMed (https://www.ncbi.nlm.nih.gov/pubmed), a cikin makonni biyu da suka gabata, an wallafa fiye da takardu 200 game da COVID-19 da kuma bayanin game da cutar, gwaji, gwaji, da kuma magani daga farkon rahoton da aka bayar a ranar 7 ga Janairu 2020 wanda ya nuna cewa cutar ta bambanta a cikin mutane da yawa.
Wannan binciken ya kafa tushen samar da cibiyar bincike a cikin sabon bincike da kuma sauri.
A matsayin mai kula da cutar, za mu iya magance COVID-19 da SARS da kuma sauran cututtuka, wato cutar sankarar hanta ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta hanyar ta ta hanyar ta hanyar ta ta ta ta ta hanyar ta ta ta hanyar ta hanyar ta hanyar ta ta ta ta ta ta ta hanyar ta ta ta ta ta ta hanyar ta hanyar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta
Muna kuma fatan za mu yi amfani da abin da muka koya game da maganin cutar da kuma yadda za mu magance cututtuka da kuma abubuwan da ke faruwa a yanzu.
CoV yana da nau'i na kwayoyin da ba su kashe mutum ba, wanda ke haifar da cutar ta hanyar kashi 15% a cikin mutane 4.
Amma, a cikin wannan nau'in, zamu iya kwatanta cewa CoVs sun ninka yawan kamuwa da mutum, kamar SARS-CoV da MERS-CoV, wanda aka fara da shi a China a 2003 da kuma Arabia a 2012, kuma daga baya ya kai ga wasu ƙasashe tare da yawan cutar da ake kamuwa da ita.
Hakanan, COVID-19 na yanzu shine cutar ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a Hoton, Hoton 1,1, an gano wani samfurin cututtukan zuciya da aka samu a Wuhan a ranar 31 ga Disamba, 2019 a Hukumar Lafiya ta kasar Sin.
Bayan karfe takwas da rabi, CoV ya fito.
A ranar 15 ga Janairu, 2020, an sami mutum na farko da ya mutu a Wuhan.
A wannan lokacin, cutar ta bazu a wasu birane da yankuna da kuma ƙasashe.
A ranar 20 ga Janairu, an sanar da cewa asibitoci sun yi wa marasa lafiya asibiti, amma ba su san yadda za a iya watsa cutar daga mutum zuwa mutum ba.
A ranar 23 ga Janairu, 2020, birnin Wuhan ya rufe kuma an dakatar da zirga-zirgar jiragen sama.
A ranar 24 ga watan Janairu, wani bincike na farko na asibiti ya nuna cewa, daga cikin mutane 41 da suka kamu da cutar, 21 sun yi hasarar cutar Wuhan, wadda aka ɗauka a matsayin cutar da ta fito daga wani dabba mai cutar.
Bayan 30 ga watan Janairu, WHO ta sanar da gaggawa a duniya.
A lokacin da ake rubuta wannan wasiƙar, cutar ta ƙare a kasar Sin da kuma kusan ƙasashe 50 a duniya (Hotuna (Hotuna 2).
Ko da yake cutar tana ci gaba da sauri, ƙarshen bege da kuma cutar ko kuma wanda zai iya zama sananne ne.
A ranar 11 ga Fabrairu, 2020, wani bincike da aka gudanar akan mutane 8,866 da kuma mutane 4,021 da suka kamu da cutar COVID-19 a cikin dakunan gwaje-gwaje daban-daban ya nuna sabon sakamako na cutar (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana shafar mutane na kowane zamani, yana shafar yawancin mutane a tsakanin shekaru 30 zuwa 65.
Kashi 47% na mutanen da suka kamu da cutar sun wuce shekaru 50, wadanda ba su kai shekara 20 ba sun cika shekaru 20, kuma 14 daga cikin wadanda suka kamu da cutar sun kai shekaru 10.
SARS-CoV-2 ya fi rinjayar maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu a cikin iska da kuma wurare masu nisa a Hubei da kuma a cikin yamma.
COVID-19 ya ɗauki kimanin kwanaki 5 (2 zuwa 9) daga lokacin da aka fara gwajin.
Lokaci na bayyanar ita ce kimanin kwanaki 4.8 (3.0 zuwa 7.2)
Lokaci na ƙarshe daga farkon zuwa ƙarshe shine kimanin kwanaki 9.5 (4.8 zuwa 13).
Adadin farko na ci gaba (R0) ya kasance 3.77 (95% CI:3.51-4.05), kuma R0 da aka gwada ya kasance 2.23-4.82.
Yawan masu kamuwa da cutar zai yi tsanani kafin 23 ga Janairu, 2020, wanda ya shafi lokacin tashi na jirgin sama kafin bikin bazara a kasar Sin.
Mutuwar da aka sani a cikin marasa lafiya da cutar ta kasance kusan 1.44% 59% CI:1.10-1.86%), kuma yawan mutuwar da aka gano a cikin marasa lafiya duka ya kasance kusan 3.06% (95% CI: 2.02-4.59%).
Akwai dalilai uku da suka fi haifar da kamuwa da COVID-19 kamar rashin lafiya (ƙuruciya), shekaru (≥ 60), da kuma rashin lafiyar zuciya.
CoVs suna kama da nau'in kwayoyin cuta da kuma ƙwayoyin cuta masu rarraba da ke da RNA guda ɗaya.
Ana iya rarraba shi da cewa rukuni huɗu, kamar alpha, beta, gamma, delta, da cov alpha da beta suna da haɗari ga mutum.
Bayan lura (S) glycoprotein yana haɗuwa da ƙwayoyin angiotensin mai karɓar jini kuma yana dawo da nau'i na 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, daban-daban, da kuma haɗin kai a kwakwalwa.
An saki kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan haihuwar kwayar, kwayar RNA ta kwayar halitta da kuma kula da kwayoyin glycoproteins da nucleocapsid suna sarrafa ƙananan kwayoyin da ke karɓar kwayar cutar, wanda ke shiga cikin jini kuma yana fitar da kwayar.
An fara samun cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon beta-CoV wanda ya fi yawan kwayoyin halitta 99.98% a cikin gidajen 10 da aka ɗauka a farkon lokacin da cutar ta fara, kasuwar Huanan Seafood a Wuhan.
SARS-CoV-2 ya yi kama da SARS-CoV na MERS-CoV ta hanyar halittarsa.
Ta hanyar gano ƙananan electrons, SARS-CoV-2 ya kamu da cutar ta hanyar ɓoyewa a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar cuyar.
An gano ACE2 a cikin mutum a matsayin mai hana karɓar SARS-CoV-2 kamar SARS-CoV.
Amma, sunadarai na S na SARS-CoV-2 suna da haɗari da ACE2 na mutum fiye da na SARS-CoV? wanda ya haɗa da SARS-CoV-2 wanda cutar ta fi muni da SARS-CoV.
SARS-CoV-2 na iya haifar da ƙananan furotin da aka ƙayyade ta hanyar orf3b da kuma wasu furotin da aka ƙayyade ta hanyar orf8.
SARS-CoV-2 na iya zama mai amfani a cikin ƙwayar cutar kuma yana haifar da wani abu da ake kira IFNβ; amma, orf8 ba shi da wani abu da zai iya aiki ko kuma ya nuna alama.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun bayyana cewa, wani nau'i na EM-crypto-create mai wannan matsayi zai iya zama na mutum ACE2 a 2.9 A tare da haɗuwa da mai aikawa da amino mai tsawo BOAT1.
An gano cewa wannan haɗin, wanda ya buɗe da kuma rufe kwayoyin halitta, ya haɗa da wani abu mai ban sha'awa kuma haɗin ACE2-B0AT1 zai iya haɗa da sunadarai S guda biyu, wanda ke ba da damar gano CoV da kuma kamuwa da cuta.
BOAT1 na iya zama magani ko magani don gwajin magani don kashe cutar SARS-CoV-2.
Haikali na Ɗaya da Tsakiya
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga tsuntsaye kuma an watsa su zuwa mutum ta hanyar dabbobi kamar dabbobi da dabbobi, da sauransu.
Ta hanyar gano nau'in SARS-CoV-2 da sauran nau'in CoV, tsuntsaye sun kasance farkon nau'in SARS-CoV-2 a matsayin sabon kwayar cutar wanda ya kasance 96% kama da nau'in SARS CoV wanda ya samo asali a cikin tsuntsaye masu suna SL-CoVZX45 da SL-CoVZX21.
Amma, gidan wasan kwaikwayo ya taimaka wa wani kwayar cutar ta shiga wani gini don kada mutum ya san shi, kuma dole ne wani ya sake bincika kayan aikin da ya ɗauka.
Ji et al., sun yi la'akari da cewa macizai na iya watsa cutar daga tsuntsaye zuwa mutum wanda ke da haɗuwa da ƙwayoyin cuta a cikin furotin.
A wani binciken, masu bincike a Guanzhou, China, sun gano cewa wasu dabbobi masu kama da bangolin da ke da ƙwayar cuta, waɗanda suke da ƙwayar cuta a cikin baki, waɗanda suke da magani a wasu mutanen China, na iya zama cibiyar cutar SARS-CoV-2 saboda kwayoyin su sun dace da kashi 99% na CoV da aka samo a cikin bangolin da SARS-CoV-2.
Amma, bambancin kashi 1% tsakanin kwayoyin halitta biyu na iya zama bambancin bambancin; kuma, mun sake nazarin sakamakon binciken (Hotuna (Hotuna 33).
Ba a gano wani abu da ya shafi SARS-CoV na farko ba.
SARS-CoV-2 da MERS-CoV za su iya kamuwa da cutar ta hanyar yin amfani da su a cikin kwanaki 48 a cikin kwari mai saurin kamuwa da cutar da kuma a cikin kwanaki 5 a cikin zafi na 20 °C da kuma a cikin yanayin zafi na 40% zuwa 50%.
SARS-CoV-2 na iya zama mai cutar.
An ce SARS-CoV-2 yana watsa ultraviolet da zafi sama da 56 °C a minti 30; ether, 75% ethanol, chlorine, peracetic acid, chloroform, da kuma kayan kifi masu ƙanshi, ba chlorhexidine ba, na iya kashe kwayar cutar da sauri.
Dukan al'umma ba su da maganin SARS-CoV-2 kuma haka ma yake da sabon kwayar cutar.
A halin yanzu, babu wani bincike da kuma bincike da aka yi game da yadda za a amsa SARS-CoV-2.
Har ila yau, muna bukatar mu yi la'akari da nazarin wasu nau'ikan CoV, musamman SARS-CoV da MERS-CoV (Hotuna (Hotuna 4).
Sau da yawa, lokacin da kwayar cutar ta shiga cikin jiki, ana samun ƙananan kwayoyin halitta ta hanyar masu karɓar lectin C (PRR), masu karɓar Toll (TLR), masu karɓar NOD (NLR), da masu karɓar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da cutar, ta hanyar samar da ƙwayoyin dendritic, cibiyar sadarwa ta I-type interferons (IFNs) da ke buƙatar watsa kwayar cutar kuma tana iya kashe kwayar cutar.
Duk da haka, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta samar da amsawar rigakafi.
Amma, maganin rigakafi na farko da zai iya kamuwa da cutar shi ne.
T lymphocytes da CD4+ da CD8+ T na iya zama masu amfani a cikin yaki.
CD4+ T-cell yana motsa B-cell don hana jikin mutum ya shiga cikin kwayar cutar, kuma CD8+ T-cell yana kashe ƙwayoyin da cutar ta shafa.
T-cell yana ƙyale cytokines da ke taimakawa ƙungiya ta yi nasara.
Amma, CoV na iya hana aikin T cell ta hanyar shigar da T cell apostosis.
Abubuwan da ke cikin jiki da ke nuna irin waɗannan abubuwa kamar C3a da C5a da kuma yadda suke shafar jini suna da muhimmanci wajen magance cutar.
Alal misali, mai ba da rigakafin jiki da ba a ba da izinin yin amfani da shi ba ga mai kamuwa da cutar ya kamu da cutar MERS-CoV.
A wasu lokatai, ƙwayar rigakafi tana ƙuntata yawan ƙwayar cuta a wannan yanayin wanda zai iya cutar da sauran ƙwayoyin cuta, kuma idan ba a yi amfani da shi ba, zai iya shafar yawancin ƙwayoyin cuta.
Cutar SARS-CoV, wadda ta fara ne daga jini, tana iya kamuwa da tsofaffi da wasu cututtuka a jiki da mata da kuma mata masu ciki.
Hakazalika, mutanen da suke fuskantar cututtukan ƙwayar cuta ko kuma waɗanda suke da nauyin jiki mai yawa suna da lokaci mai yawa don su rinjayi wasu a cikin yanayin su.
Lokaci na bayyanar cutar SARS-CoV-2 mai ƙarancin lokaci ya kai kwanaki 1 zuwa 14, wanda ya fi dacewa 3 zuwa 7 idan muka yi la'akari da nazarin mutane 425 a Wuhan.
Koyaya, binciken da aka yi a kan mutane 1,099 ya nuna cewa lokacin bayyanar cutar zai kasance kwanaki 3 kuma zai kasance daga kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka lissafa a sama, ya nuna cewa lokacin bayyanar yana da kusan kwanaki 4.8 (3.0-7.2) a cikin adadin marasa lafiya 8,866.
Ya kamata a shawarci ma'aikatan kiwon lafiya su yi la'akari da lokacin da za a iya yin rashin lafiya idan aka kwatanta da lokacin da za a iya kamuwa da cutar a jiki, don samun kwayar cutar a cikin jini amma ya nuna alamun cutar ta hanyar watsawa ga wasu mutane.
A mafi yawan lokuta, mutanen da suka kamu da cutar ko kuma suka kamu da cutar sun daina cutar, dole ne su kasance a cikin kwance na kwanaki 14.
Ko kuwa za a ƙara kwana ashirin da huɗu a lokacin da za a yi zamansa?
Rashin ƙarfi na iya zama farkon alamun cutar COVID-19, wanda zai iya zama alama ko wasu alamun da za su biyo baya kamar ciwon ciki, numfashi kamar tashin hankali, ciwon kai, ciwon kai, ciwon ciki, ciwon ciki, ciwon ciki, ciwon ciki, damuwa, kamar rashin jin daɗi, da kuma taɓawa.
Wasu marasa lafiya suna fama da rashin numfashi da kuma/ko kuma rashin iskar jini na mako guda bayan bayyanar cutar.
Sa'ad da ciwon ya ƙare, mai haƙuri yana da ciwon huhu, ciwon jiki, ciwon hanji, da kuma zubar da jini.
Marasa lafiya masu ƙoshin lafiya suna fama da ƙonewa da kuma bayyanar cututtukan numfashi, ko da yake hotuna na hotuna suna nuna ƙonewa, ana buƙatar bincika cutar don bincike na lokaci.
Wani binciken da aka yi a cikin watan Disamba na 2019 ya nuna cewa yawan alamun cututtukan sun kasance 98% na rashin ƙarfi, 76% na rashin ƙarfi, 55% na rashin ƙarfi, da 3% na rashin lafiya; 8% na marasa lafiya suna buƙatar taimako na iska.
Irin wannan binciken ya samo asali ne a cikin sababbin bincike guda biyu, na musamman na kwayoyin halitta da kuma na wasu kwayoyin halitta da suka samo asali daga kamuwa da cutar.
Koyaya, wani binciken da aka yi a shekara ta 2012 ya nuna cewa masu kamuwa da cutar MERS-CoV suna da rashin ƙarfi (98%), rashin ƙarfi (47%), da kuma rashin numfashi (55%) a matsayin farkon rahoton cutar.
Koyaya, kashi 80% na su na bukatar taimako ta iska, fiye da waɗanda ke da cutar COVID-19 kuma suna da mafi yawan mutuwar MERS fiye da COVID-19.
Rashin jini (26%) da kuma zubar da jini (26%) sun bayyana a cikin masu cutar MERS.
A cikin marasa lafiya na SARS, an nuna cewa rashin jin daɗi (99%-100%), zazzabi (29%-75%), numfashi (40%-42%), tashin hankali (20%-25%, da kuma zubar da jini (13%-25%) sune alamun farko na cutar kuma ana taimakawa da iska ta hanyar 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, adadin COVID-19 ya kai kashi 2% na adadin masu kamuwa da cutar da aka sani zuwa 66,576 a duniya.
A cewar wani kimomi, yawan mutuwar SARS a watan Nuwamba na 2002 ya kai kusan 10% na adadin kamuwa da cutar 8,096 da aka sani.
A cewar MERS, bisa ga binciken da aka yi a Zwing 2012, yawan mutuwar ya kai 37% a cikin mutane 2,494.
Nazarin farko ya nuna cewa R0 SARS-CoV-2 zai kasance 6.47 tare da wani tabbacin tabbaci (CI) na 95% na 5.71-7.23, yayin da R0 SARS-CoV zai kasance daga 2 zuwa 4.
Ana yin gwaji tare da SARS-CoV-2 da MERS-CoV da SARA-CoV tare da alamun su, mutuwa, da kuma R0 da aka nuna a Table 1.1.
Bayanan da ke kan wannan batu sun nuna cewa SARS-CoV na da damar yin sauri fiye da MERS-CoV da SARS-CoV, ko kuma kashe mutane kamar na biyu da muka lissafa.
Bugu da ƙari, yana da matukar wuya a hana cutar ta SARS-CoV-2 fiye da waɗanda ke da cutar MERS-CoV da SARS-CoV.
A cikin jirgin sama, an yi amfani da jirgin sama a kan wani jirgin sama ko a kan wani jirgin sama.
Yawancin marasa lafiya sun yi tafiya ko kuma sun yi amfani da gidajen su a Wuhan ko wuraren da cutar ta ɓace ko kuma sun kasance tare da mutanen da ke kusa da cutar ko waɗanda ke da cutar a cikin makonni biyu kafin barkewar cutar.
Duk da haka, ana iya cewa mutane za su iya kamuwa da cutar ba tare da bayyanar cututtuka na tsawon makonni biyu ba kuma marasa lafiya da aka yi musu jinya da suka bar asibiti za su iya kamuwa da cutar kuma, wanda ba zai iya hana bayyanar cututtuka ba don ya ɓace a lokacin da suke zama.
Marasa lafiya suna da yawan cututtukan jini da suka rage ko kuma suka ragu (tushen lymphocytes) a farkon lokacin da suka fara aiki.
Alal misali, ana samun lymphopenia da yawan jini mai ƙarancin jini < 4×109/L da kuma yawan lymphocytes < 1×109/L, da kuma karuwar aspartate aminotransferase da kuma viremia a cikin marasa lafiya na COVID-19 1,099.
Ko da yake an samu karuwar ƙwayar cuta da myoglobin a cikin jinin wasu marasa lafiya, kuma an samu karuwar furotin C-reactive da kuma samfurin erythrocyte.
A cikin marasa lafiya da suka kamu da cutar, yawan D-dimer, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Rediyon zuciya yana nuna aiki a cikin yawancin masu cutar COVID-19 kuma yana nuna kamar sauti ta hanyar iska ko kamar gudu ta hanyar wani wuri a cikin duhu a cikin iska.
A farko, marasa lafiya suna fama da cututtukan zuciya, rashin ƙarfi, rashin ƙarfi da rashin ƙarfi (ARDS).
Idan ARDS ta zo, aikin da ba a iya yi ba, yawan ruwa, da kuma yawan kwayoyin halitta da ke cikin jiki suna haifar da rashin ƙarfi.
Irin 1 da irin 2 masu aiki da kyau suna rage yawan surfactant kuma suna rage yawan tashin hankali, kuma suna rage yawan iska a cikin iska kuma suna iya hana iska ta karuwa.
Bugu da ƙari, hotunan ƙwaƙwalwa da za a iya yin wa rediyo a cikin lokaci mai tsawo suna da kyau idan cutar ta ƙare.
A ranar 18 ga Fabrairu, 2020, gwajin farko na COVID-19 ya nuna cewa ƙwayoyin cuta na huhu suna da kyau, hyaline yana da kyau, kuma lymphocytes suna shiga cikin tsakiya, kuma yawancin cututtukan syncytial a cikin marasa lafiya da suka mutu saboda cutar, suna da ciwon cutar da ARDS kuma suna da kyau ga SARS da MERS.
Ana amfani da RNA SARS-CoV-2 ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) a matsayin hanyar farko ta gwajin COVID-19.
Duk da haka, saboda ƙididdigar da ba ta dace ba, wanda zai iya haifar da cutar, an fara magance shi ta hanyar maganin rigakafi (wanda ba zai iya yiwuwa ba ne kawai ta hanyar RT-PCR) a China a ranar 13 ga Fabrairu, 2020.
Irin wannan aikin ya kuma taimaka wajen gudanar da gwajin SARS.
Bugu da ƙari, haɗuwa da tarihin cutar, alamun cututtuka, gwaje-gwajen gwaje-gwaje, da kuma binciken rediyo suna da muhimmanci sosai don yin gwajin da ya dace.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta gabatar da wata yarjejeniya ta CRISPR game da ɗaukar gwajin SHERLOCK don gano SARS-CoV-2, wanda ke ƙayyade RNA na SARS-CoV-2 na roba a 20 x 10-18 mol/L a 200 x 10-18 mol/L (hotuna 10 zuwa 100 a cikin millitir) kuma yana da izini a cikin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin
Muna fatan cewa, wannan sabuwar hanyar za ta iya inganta lokacin bincike da kuma amincin da ake samu a cikin magungunan asibiti.
Domin mutane da sabon CoV, likitoci za su iya fara duba masu cutar COVID-19, sannan su gwada hanyoyin da za a iya amfani da su ko kuma a bi da su kafin a yi maganin CoV irin su SARS-CoV da MERS-CoV da sauran cututtukan cutar (Table (Table 2).2).
Wadannan kayayyaki sun hada da na yanzu ko kuma na iya zuwa tare da maganin kashe kwayoyin cuta, maganin hana jiki, steroids, jini ga marasa lafiya masu magani, maganin kasar Sin, da kuma taimakon likita.
Abin da ke cikin jini a cikin marasa lafiya da za a gwada don magani.
Kamfanonin sayar da magunguna suna gwagwarmaya don samar da kwayoyin cuta da alluran rigakafi.
SARS-CoV-2 yana kamuwa da cutar a cikin huhu da farko ta hanyar kamuwa da cutar, amma ba tare da cutar ba, ta hanyar wasu cututtuka na jiki da ke nuna ACE2, kamar ciki da kuma zubar da jini.
Amma duk da haka, baƙin ciki na numfashi yana sa marasa lafiya su yi baƙin ciki, kuma wannan shine farkon wahalar da suke sha.
Bugu da ƙari, taimakon numfashi yana da kyau don rage alamun cutar da kuma ceton rayuka ta hanyar taimakon iska, iska mai iska, iska mai guba, da kuma iska mai guba wanda ke haifar da cutar.
Masu fama da cututtukan numfashi da kuma rashin lafiya na jiki suna bukatar taimako ta hanyar maganin numfashi na jiki (ECMO), wani tsarin farfadowa da numfashi wanda zai iya magance matsalolin numfashi da kuma numfashi.
Bugu da ƙari, kula da tsarin lantarki, rigakafi da kuma maganin cututtuka na yau da kullum da kuma amfani da su a jiki, da kuma kare lafiyar jiki na jiki na da amfani ga masu cutar SARS-CoV-2.
An gano cewa cutar cytokine ta haifar da ciwon jiki a cikin masu cutar SARS da MERS.
Tsarin cytokine yana aiki ne a matsayin mai karɓar amsa ta jiki wanda ke haifar da sakin cytokines kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Cytokines suna nuna cewa kwayoyin suna haifar da wasu ƙwayoyin cuta da ke haifar da cutar ARDS da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Maganin rigakafi yana da mahimmanci a cikin maganin cututtukan cytokine, musamman a cikin marasa lafiya masu cutar.
Corticosteroids da tocilizumab, wasu anti-IL6 da ke dauke da kwayar cutar da kuma kwayar cutar guda ɗaya, suna da amfani sosai wajen magance cytokine.
Sauran abubuwan da ke hana rigakafin rigakafi na cytokineson sun hada da masu hana kwayar T-cell; toshe IFN-γ, IL-1, da TNF; fitar da JAK; blinatumomab; mai ba da siginar cytokine 4; da kuma masu hana HDAC.
Steroids, kamar su magungunan ƙwayoyin cuta, suna da amfani sosai wajen magance SARS don rage yawan cutar.
Duk da haka, steroids masu amfani da su a cikin jiki suna da tasiri sosai a cikin marasa lafiya na SARS da COVID-19.
Hakanan, yana iya haifar da wasu cututtuka, musamman rashin jin daɗin iyali, wanda ke shafar gwajin cutar.
Duk da haka, ana bada shawara da karamin bincike kan ƙananan corticosteroids kuma ya kamata a yi la'akari da su a cikin maganin marasa lafiya masu cutar COVID-19.
A lokacin da aka rubuta wannan labarin, babu wani magani da zai iya kashe wannan kwayar cutar da kuma cutar da aka gano.
Duk da haka, zubar da remdesivir a cikin jini, kamar nucleotide, ba ta da amfani a jikin marasa lafiya da ke da COVID-19
Remdesivir sabon magani ne na rigakafin cutar da Gilead ta samar wanda ya kasance magani ne na cutar Ebola da Marlburg.
Daga bisani, remdesivir ya kuma gano cewa RNA na wasu ƙwayoyin cuta sun fito daga cikin kwayoyin cuta na MERS da SARS.
A wannan yanayin, Gilead ta ba da maganin a kasar Sin don gwaji game da cutar SARS-CoV-2, kuma ya bayyana cewa yana da amfani sosai.
Ka lura cewa baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin na iya zama da amfani wajen magance cututtukan da ke shafar numfashi.
Ana iya ci gaba da maganin maganin, kamar maganin shan taba, shan iska, da kuma wasu cututtuka.
Dole ne a yi la'akari da yadda ake amfani da wannan magani tare da wasu magunguna a cikin marasa lafiya.
Ba da jini ga marasa lafiya masu rauni da kuma motsa jiki
Abincin da aka yi amfani da shi ga marasa lafiya da suka kamu da cutar bayan an kamu da cutar ba don magance cututtukan da ke tattare da cutar ba ko kuma don kare lafiyar mutane daga kamuwa da cutar yana da tarihin da ya shafi juna.
Hakazalika, marasa lafiya da suka kamu da cutar na farko suna da adadin cututtukan da ke cikin jini.
Masu amfani da kwayoyin halitta sune immunoglobulin (Ig) wanda kwayoyin lymphocytes ke biya don haɗuwa da kwayoyin halitta da kuma abubuwa na waje da suka shiga cikin jiki kuma suna gano kwayoyin da ke cikin kwayoyin halitta da kuma shiga cikin kwayar halitta.
Idan muka yi la'akari da wannan, za a iya samun jini mai kyau daga cikin masu cutar da ke dauke da cutar ta COVID-19 kuma a tura su ga marasa lafiya 10.
Alamu sun kasance masu ƙyama a cikin kwanaki 24, ciwo ya ragu kuma adadin ƙwayoyin cuta ya ragu kuma iska ta ƙara shiga cikin jini.
Duk da haka, gwaji da kuma bincike suna da muhimmanci wajen tabbatar da cewa akwai wata hanya da za ta amfane dukan mutane kafin a samu magani mai kyau.
Bugu da ƙari, kamar yadda yake a magani, akwai wasu abubuwa da ba su da alaƙa da jini da za a tattauna a hankali.
Alal misali, ƙwayoyin cuta na iya mayar da martani ga maganin rigakafi da kuma maganin cytokine, wanda zai iya cutar da rayuwar mutum.
Ƙananan kwayoyin halitta a cikin jini na farko sun ragu, kuma ƙimar ƙanshin jini ya fi girma don magance cututtuka masu tsanani.
Yana da wuya a iya yin amfani da shi don gyara da kuma inganta ƙwayoyin cuta da za su iya magance cutar gaba ɗaya.
Har ila yau, yana da wuya a yi aiki da fasaha don samar da ƙwayoyin B a cikin marasa lafiya da suka kamu da cutar kuma yana da lambar ƙwayoyin da ke tattare da ƙwayoyin cuta ko kuma gwajin ƙwayoyin cuta na ƙwayoyin cuta masu mahimmanci.
Haka nan ma, za mu iya ƙididdige gaɓoɓin jikinmu.
TCM ta kasance magani ne na musamman a kasar Sin na tsawon dubban shekaru.
Duk da haka, amfanin ya dogara ne akan haɗuwa da abubuwa da yawa a cikin magunguna masu canji da kuma binciken da aka samu a cikin nazarin TCM.
Abu mafi muhimmanci a cikin kayan aiki shi ne rashin fahimta ko rashin fahimta saboda yana da wuya a samar da kayan aiki ko kuma haɗa su.
A yau, saboda maganin COVID-19 na musamman da kuma na musamman, TCM yana daya daga cikin hanyoyin da za a bi da marasa lafiya da ke da alamun rashin lafiya na yau da kullum ko kuma waɗanda suka ci abinci a cikin yanayin da ya fi muni.
Alal misali, Shu Feng Jie Du da Lian Hua Qing Wen sun gano wani magani da zai iya magance COVID-19 yadda ya kamata.
An samu adadin farko na asibitocin COVID-19 a lardunan da ba su da yawa na kasar Sin da suka ba da TCM ga kashi 87% na marasa lafiya, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya ba da TCM ga kashi 30% na marasa lafiya na COVID-19, ya samu karamin adadin magani (13%).
Amma, yana da wuya a yi tunani game da shi domin akwai wasu abubuwa kamar ƙidaya da kuma kula da marasa lafiya da za su kasance a cikin wannan gwaji.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinta sun fitar da wani bincike na gwaji don gwada maganin da wasu magungunan yamma (WM) da kuma maganin da ya hada da WM da TCM.
An gano cewa lokacin da jikin mutum yake bukata don ya warke, ya nuna alamun cutar, da kuma fita daga asibiti zai yi daidai da na sauran kungiyoyin WM+TWM.
Abin mamaki, yawan cututtukan da ke faruwa a baya (da kuma rashin lafiya) sun ragu a cikin kungiyoyin WM+TCM kawai (7.4% zuwa 46.2%) da kuma raguwa a cikin kungiyoyin WM+TCM kawai (8.8% zuwa 39%).
Duk da haka, amfanin da kuma lafiyar TCM ya sa an yi gwaji mai kyau a yanzu a cikin ƙananan yankuna da kuma a wasu wurare.
Zai yi wuya a ƙayyade yawan ayyukan da za a yi don daidaita kayan aikin TCM da kuma daidaita su ko kuma a haɗa su idan ya yiwu.
Wadanda suka kamu da cutar ko kuma waɗanda aka sani sun kamu da COVID-19 suna da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Duk da haka, bayyanar cututtuka kamar rashin ƙarfi, rashin numfashi, da kuma wasu abubuwa da magungunan magani suka yi amfani da su kamar rashin amfani da corticosteroids na iya haifar da rashin hankali da kuma rashin ƙarfi.
A farkon annobar SARS, yawan mutanen da ke fama da cutar ta kamuwa da cutar ta kamuwa da cuta, tunani, rashin hankali, rashin hankali, alamun cutar hanci, magana, da kuma kisa sun bayyana a fili.
Yin amfani da abubuwan da ke tattare da kasancewa a waje, kamar yadda ake yi a cikin martani ga cutar COVID-19, na iya haifar da tunani da damuwa ga mutane game da sadarwa, kasancewa a cikin gidajen waya, da kuma yadda mutane ke magana game da lafiyarsu da kuma abokan hulɗarsu.
Haka nan, dole ne a kiyaye lafiyar jiki ga masu cutar COVID-19, waɗanda za su iya kamuwa da ita, da waɗanda ke tare da su da kuma sauran al'umma da ke cikin bukata.
Dogaro ga juna ya kamata kuma ya ƙunshi samar da ƙungiyoyi na ilimi daban-daban don daidaita juna, ingantaccen rayuwa da kuma nazarin bayanai game da cutar SARS-CoV-2 da kuma kamuwa da cutar tare da shirye-shiryen magani da aiki da umarni da aikace-aikacen da masu ilimi ke da su don hana kasancewa a cikin yanayi ɗaya ko a'a.
Hanyar da ta dace tana da muhimmanci wajen hana kamuwa da cutar daga dabbobi da mutane masu cutar zuwa ga waɗanda za su iya ɗaukar ta a jikinsu kuma tana da alaƙa da maganin kamuwa da cutar a cikin rigakafin cutar da ke tattare da cutar.
An gabatar da wani tsari don samar da rigakafin da ya danganci furotin S don taimakawa kwayoyin halitta su gane da/ko su kare kansu daga SARS-CoV.
An gwada cutar ta mutum ko ta mutum a cikin SARS na dabbobi.
Duk da haka, amfanin allurar rigakafi a cikin jiki da aka gwada a cikin tsofaffi da kuma tabbatar da mutuwa da kariya daga kamuwa da cutar kwayar cuta ta dabba dole ne a fara gwadawa kafin a fara nazarin asibiti.
Wannan shi ne saboda SARS ta ɓace shekaru 17 kuma babu wani cutar da ta sake bayyana tun daga lokacin.
Duk da haka, akwai wasu cututtuka a wasu wurare da kuma cutar MERS ta ci gaba da bayyana a Gabas ta Tsakiya kuma tana faruwa a wasu wurare da ke fitowa daga dabbobi a wuraren da cutar ta kamu.
An kirkiro allurar rigakafi don cutar ta MERS ta hanyar amfani da ƙwayoyin cuta marasa cutarwa, plasmids na DNA, ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta kamar su coolage da kuma wasu ƙwayoyin cuta masu haɗuwa da wasu da aka ƙayyade a cikin dabbobi.
Samun allurar rigakafi mai amfani da kuma dacewa don SARS-CoV a cikin marasa lafiya yana da gaggawa da kuma dacewa don hana yaduwar cutar.
Duk da haka, yana da muhimmanci a san matsalar domin yana daukan lokaci mai tsawo (ƙididdiga na 18) kafin a yi allurar rigakafi da kuma canja Covin da za a iya yi.
A matsayin sabon kamuwa da cuta, COVID-19 ya fara nuna alamun bayyanar cututtukan a cikin dubban marasa lafiya.
Sau da yawa, marasa lafiya suna iya yin amfani da ƙananan ƙwayar cuta ba tare da sun yi rauni ba.
Amma, ba tare da SARS ba, COVID-19 yana da tasiri sosai a kan yawan mutuwa da kuma yawan marasa lafiya da ke fama da cutar.
Bugu da ƙari, samar da takardun shaida na gwaji yana da muhimmanci ga ƙungiyoyin kiwon lafiya don kula da ayyukansu, musamman a cikin yanayin da ya dace.
A cikin wasu nazarin da ake yi a yanzu, akwai wasu da suka shafi ko kuma suka shafi gwajin COVID-19 (Table (Table33):
Shekaru: Shekaru suna da muhimmanci wajen tantance SARS, wanda hakan ma gaskiya ne ga COVID-19.
COVID-19 ya fi yawaita a tsakanin shekaru 30 zuwa 65 da kuma 47.7% na marasa lafiya a cikin shekaru 50 da haihuwa a cikin binciken cututtuka 8,866, kamar yadda aka lissafa a sama.
Marasa lafiya da ake bukatar kulawa da su sosai suna nuna alamun cututtuka da kuma matsalolin da ke tattare da cutar kuma suna da sauran shekarun da ba su da yawa (tsakanin shekaru 66 zuwa 51), suna nuna shekaru a matsayin gwajin gwaji a cikin marasa lafiya na COVID-19.
Ƙari: SARS-CoV ya fi rinjayar maza fiye da mata (0.31/100,000 ko 0.27/100,000), kamar yadda aka lissafa a sama.
Yawan mutuwa da kuma cututtukan: Marasa lafiya da COVID-19 da ke bukatar kulawa da su sun fi fuskantar matsaloli masu tsanani na cututtukan zuciya da kuma ciwon zuciya.
Abubuwan da ke damun zuciya su ne kuma sanadiyyar mutuwar mutane da ke fama da cutar SARS.
An ce SARS-CoV-2 na iya haɗuwa da kwayoyin halitta masu kyau na ACE2 wanda zai iya yin aiki a cikin masu cutar COVID-19.
Akwai kuma sanarwa cewa shekaru da kuma cututtukan da ke faruwa suna faruwa kuma suna iya faruwa ko a'a.
Sakamakon bincike mai sauri: yawan C-reactive protein (CRP) a cikin jini yana nuna rashin amfani ko rashin amfani da hankali kuma yana iya haifar da bincike, amsa ga magani, da kuma ƙarshen magani.
An gano cewa CRP yana da tasiri sosai a gwajin COVID-19.
Bugu da ƙari, yawan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen rage yawan abin da zai faru.
Waɗannan abubuwa suna shiga cikin gaɓaɓuwanmu da yawa, musamman cikin zuciya da numfashi, kuma suna fita kamar yadda ake so.
Hakazalika, akwai alamun rashin ƙarfi da kuma rashin ƙarfi.
Alamomin cututtuka na yau da kullum: rediyo na zuciya da kuma ci gaban alamun cututtuka dole ne a haɗa su da wasu kayan aiki don tantance alamun cutar da kuma matsalolin COVID-19.
Yin amfani da steroids: Kamar yadda aka ambata a sama, steroids suna da kyau a jikin mutum kuma ana amfani da su a matsayin magani mai kyau don cututtukan jiki don rage ciwon jiki.
Yayin da ake amfani da maganin corticoid a maganin cutar SARS a mafi yawan lokuta, masu kamuwa da cutar da yawa suna fuskantar matsalolin rashin iyalansu da kuma matsalolin da ke tattare da rashin lafiyar jiki.
Kuma, idan ya cancanta, steroids dole ne a yi amfani da su cikin tsari kuma a cikin ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Amma ka lura: kamar yadda aka ambata a sama, a cikin COVID-19 yaƙi, mutane da yawa suna fama da rashin ƙarfi saboda rashin jin daɗi da rashin jin daɗi da kuma rashin jin daɗi da kuma rashin jin daɗi da kuma rashin jin daɗi da ke cikin iyalinsu.
Yana da muhimmanci a ba da taimako da kuma taimako a lokacin da ya dace don taimaka wa marasa lafiya su sami abinci da kuma samun kansu a matsayin masu daraja.
A cewar wani bincike na jama'a, COVID-19 na nuna bambanci tsakanin cutar da SARS.
Baya ga cutar ta hanyar cutar ta huhu, SARS-CoV-2 na iya yin tasiri sosai a cikin tsarin numfashi wanda zai iya sa mai cutar ya sami alamun rashin ƙarfi ko rashin lafiya a farkon cutar kamar sauran nau'ikan CoV masu cutar.
Amma, marasa lafiya da suka kamu da cutar a farkon lokacin ko kuma a lokacin da suka kamu da cutar suna iya samun ƙwayoyin cuta da kuma hasken rana, wanda ke sa ya zama da wuya a hana cutar.
Koyaya, kamuwa da SARS-CoV yana da matukar tasiri a cikin marasa lafiya, kuma cutar ta fara faruwa a cikin lokaci mai tsawo.
Bugu da ƙari, cutar COVID-19 ta yanzu ta fi rikitarwa da kuma rikitarwa a cikin gudanarwa fiye da cutar SARS.
Akwai wasu dabaru da suka shafi yadda ake yin amfani da cutar a kasar Sin da kuma yadda ake hana mutane fita daga Wuhan da garuruwan da ke kusa da ita da kuma yadda ake hana mutane fita daga gidajen su sa a daina samun kamuwa da cutar SARS-CoV-2.
Ko da yake ayyukan suna ba da tsaro da kuma rasa mutane da kungiyoyi a ƙasashe daban-daban, yawan sababbin cututtuka yana raguwa, wanda ke nuna cewa cutar tana gab da ƙare.
Masu ba da shawara da suka yi zato cewa cutar za ta ƙare a ƙarshen Maris kuma za a rage yawan cutar zuwa kashi 3 zuwa 4.
Duk da haka, waɗansu masu ba da shawara za su yi maka haka.
Paul Hunter, et al. sun yi imanin cewa COVID-19, wanda ya kasance mafi muni a farkon SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun ba da tabbacin cewa SARS-CoV-2 zai iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wasu kungiyoyin 'yan kasar Kanada sun bayyana cewa an gano SARS-CoV-2 ne a cikin kwayoyin da aka dauka a cikin shanu da kuma a cikin fata na marasa lafiya da aka yi wa abinci da kuma asibiti makonni 2 kafin, wanda ke nuna cewa sabon kwayar cutar da aka gano ba ta da kyau a cikin mutum ɗaya kamar cutar sankara.
Duk da haka, a kasar Sin, an samu wasu alamun da za su sa a yi farin ciki game da karuwar yawan sababbin cututtuka, wanda ya nuna cewa hanyoyin da ake amfani da su a yanzu za su iya taimakawa.
Mutane sun ce cutar Ebola za ta iya kamuwa da mutane miliyan daya kuma ta kashe rabin miliyan.
Amma, ta wajen kasancewa da hankali, cutar tana iya shafan mutane.
Zai yiwu, kamar SARS-CoV, cewa cutar SARS-CoV-2 ta ragu a cikin cutar kuma za ta iya ɓacewa ko kuma cutar ba za ta iya cutar da mutum ba.
Ana nuna alamun COVID-19 da SARS da MERS a ƙasa (Hotuna (Hotuna55).
SARS-CoV-2 na iya kamuwa da cutar ta hanyar ƙwayoyin cuta ko ƙwayoyin cuta, kuma yana iya kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar lalacewa.
An kuma gano wani kwayar cutar a cikin rami, wanda ke nuna cewa za ta iya shiga cikin rami a cikin rami.
Wani sabon bincike na mutum 138 ya nuna cewa kashi 41 cikin 100 na marasa lafiya na iya kamuwa da cutar da ke tattare da cututtukan dabbobi, kuma mutane 17 da wasu cututtukan da ke tattare da cututtukan jiki sun ƙare da shan magani na tsawon shekaru 40.
Dole ne a yi aiki da kyau don a kāre mutane, musamman ma masu kula da kiwon lafiya, masu kula da jama'a, masu kula da gidaje, masu sayarwa, masu kula da marasa lafiya da kuma waɗanda suke shan wahala.
Hanyar farko da za a iya amfani da ita wajen rage yaduwar cutar ita ce ta yin amfani da sutura don rufe fuska; yin amfani da sutura don rufe fuska da N95 mai ƙonewa (wanda aka yi amfani da shi a shekarun 1860) zai taimaka wajen watsa ƙwayoyin cuta.
Rufin fuska yana hana mutum ya sha iska ko ya taɓa wani abu, wanda zai iya kai ga wasu.
Duk da haka, ƙwayar cuta mai ɓoye na N95 (wanda aka yi amfani da shi a shekarun 1860s) na iya zama mai ƙarancin ƙwayar cuta na 10 zuwa 80 nm, kuma 5% na ƙananan ƙwayoyin cuta na iya shiga duka; SARS-CoV-2 yana kama da SARS-CoV kuma duka biyu suna da nau'i na 85 nm.
Tun da ana iya samun cutar a cikin allunan rufe idanun masu baƙi ko da sau shida, dole ne likitocin da ke kula da marasa lafiya su sa takardar N95 (wani lamba # 1860s) ko kuma su rufe idanun masu baƙi.
Baya ga rigakafin da ake amfani da shi a gaban mutum, dole ne ma'aikatan kiwon lafiya su saka rigakafin da ya dace don hana kamuwa da cutar.
Wannan kwayar cutar tana iya shafar idanun mutum.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana da takardar rufe baki na N95; ana iya ganin cewa cutar ta shiga jikinsa ta hanyar idanunsa masu aiki.
Kuma dole ne ma'aikatan jinya su saka rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar rigar
A cikin al'umma a wuraren da cutar ta shafa ko kuma za ta iya shafarta, yana da muhimmanci kowa ya tsabtace hannayensa da sabulu a kai a kai, ya yi amfani da sabulu a gida don kasancewa a gida kuma ya guji haɗuwa da mutanen da ke da cutar.
Dole ne mutum ya kasance a tsakiyar jama'a don ya yi magana da mai cutar.
Wadannan ayyuka suna da muhimmanci wajen rage kamuwa da cutar da kuma hana yaduwar cutar gaba daya.
Ko da yake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar a cikin ɗan adam, kamanceceniya da SARS-CoV kamar yadda aka lissafa a ranar 7 ga Janairu 2020 zai buɗe matsayin ikon China don sakamakon cutar SARS ta 2003.
Amma, ba a ranar 19 ga Janairu 2020 ba ne mai kula da kula da cutar Wuhan ya sanar da jama'a cewa sabon kwayar cutar tana da yawa kuma tana da yawa daga mutum zuwa mutum kuma zai zama babban abin da zai iya magance cutar.
Wannan sanarwa ta shafi jama'a, musamman ma da kasar da ke shirin bikin bazara, kuma a lokacin da za a ce za a kawo karshen cutar ba kamar yadda aka yi a Wuhan ba.
Ƙididdigar da ke cikin tsarin hana cutar a kasar Sin na iya zama abin tunawa da kuma yin la'akari da hanyoyin da za a bi a nan gaba.
Alal misali, waɗannan ka'idoji dole ne su (1) yi hankali sosai wajen samar da bayanai ga jama'a domin kowane magana tana da muhimmanci a idanun 'yan ƙasa kuma tana iya ɓata hakkinsu da kuma ra'ayinsu; (2) su kasance masu kulawa da kuma ba da izini ga sanarwar da ta dace game da maganin miyagun ƙwayoyi game da bayar da umarnin gwamnati ga masu kula da lafiya ko hukumomi; (3) su sami damar dakatar da cutar a farkon lokacin da akwai ƙarfafawar jama'a; kuma su samar da matakan da suka dace don tabbatar da haƙƙin jama'a game da cutar da ba a bincika da kuma tattauna da kuma ba da amsa ga jama'a a kan lokaci.
Cutar COVID-19 ta sabon kwayar cutar da ake kira SARS-CoV-2 ta fara ne a ƙarshen Disamba 2019.
A cikin shekaru biyu da suka gabata, ya bazu a kasar Sin kuma ya bazu a kasashe 50 a duniya a lokacin rubuce-rubuce.
Saboda cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da COVID-19 da SARS, cutar COVID-19 ta zama kamar tashin SARS.
Duk da haka, akwai bambance-bambance da yawa tsakanin COVID-19 da SARS, wanda ke da muhimmanci wajen hana cutar da kuma magance cutar.
COVID-19 na shafar tsofaffi fiye da mata, kuma yana shafar cututtuka da yawan mutuwa fiye da tsofaffi fiye da mata.
SARS ya fi COVID-19 kisa (10.91% zuwa 1.44%).
Masu kamuwa da COVID-19 suna kamuwa da cutar ko da sun riga sun nuna alamun cutar, amma masu kamuwa da SARS suna yin hakan ne kawai idan sun daina, wanda ke sa COVID-19 ya zama sananne ga SARS.
Wannan ya nuna cewa SARS-CoV-2 ya fi sauri da kuma yaduwa fiye da SARS-CoV.
Ana iya samun gwajin RNA na SARS-CoV-2 a wasu marasa lafiya na COVID-19.
A wasu lokatai, masu kamuwa da cutar za su iya kamuwa da cutar.
Wannan ya haifar da yaduwar cutar.
Domin irin wannan ci gaba a binciken COVID-19, dole ne a sami amsoshi ga wasu dalilai, kamar su:
SARS-CoV-2 ya fito ne daga wani abu?
Ko da yake an gano kusan kashi 96 cikin 100 na SARS-CoV-2 da SARS-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-
Dabbobin wasa sune matsakaiciyar gida tsakanin dabbobi da suka kamu da cutar daga farkon gida, da tsuntsaye, ga mutum?
Idan ba mu san amsoshin a cikin #1 da 2 ba, ba za mu iya samun cutar ba, kuma za mu iya sake yin cuta a kowane lokaci.
Ko da yake bincike na kwayoyin halitta da kuma nazarin halittu ya nuna cewa SARS-CoV-2 ya yi kama da ACE2, yaya za a iya samun kwayar cutar ta shiga cikin ƙwayoyin huhu kuma ta canza alamun cutar?
Shin kwayar cutar ta dace da gano kwayoyin ACE2 a wasu kwayoyin halitta?
Idan babu amsoshin da suka dace game da waɗannan ƙa'idodin, ba za a iya yin bincike da kuma neman magani ba.
Har yaushe za a yi wannan rashin lafiya?
Ta yaya cutar ta kasance tun daga farkon zuwa lokacin da mutum ya kamu?
Shin cutar za ta iya ɓace kamar SARS ko kuwa ta tashi a lokaci mai kyau kamar cutar?
Yana da muhimmanci a san cewa zai ɗauki lokaci kaɗan kafin a amince da waɗannan shawarwari da kuma wasu shawarwari.
Amma, idan muka yi rashin lafiya, ba mu da wata hanyar da za mu iya magance matsalar da za mu iya yi a lokacin da za mu iya yin rayuwa mai ma'ana.
Kwayar cutar korona ta mutum ta hanyar dabbobi
Sanarwa da kuma sauraron cutar korona (CoV) na iya haifar da kamuwa da cutar, har ma da mutum, a cikin shekaru masu zuwa.
Kafin 2003, an gano nau'ikan CoV na mutum (HCoVs) guda biyu da aka sani da su ke haifar da cututtuka masu tsanani, kamar cutar ƙwayoyin cuta.
Cutar da ta shafi cutar huhu (SARS) da cutar huhu ta Gabas ta Tsakiya (MERS) sun canza kansu kuma sun nuna yadda wannan cutar ke lalata inji.
Fitowar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ta hana CoV zuwa kasar Sin kuma ta hana mu kamuwa da cutar ta SARS-CoV mai cutar amma mai cutarwa.
HCoVs suna kamuwa da cutar ta dabba kuma sanin asalin HCoVs na dabba zai iya taimaka mana.
Yawancin HCoVs sun fito ne daga tsuntsaye kuma ba su da cutarwa.
Ana iya gano wuraren da HCoV na wani nau'i yake.
Yin amfani da dabbobi kamar gidaje yana da muhimmanci wajen sanin yadda za a sami mutum mai kyau da kuma yadda za a kula da kansa.
Gano halaye na CoV a cikin dabbobi yana nuna yadda CoV ke motsawa zuwa mutum.
A cikin wannan binciken, za mu nuna nazarin da muka sani game da nau'ikan HCoV guda bakwai da muka sani, da kuma nazarin tarihin su da kuma dabbobi da suka fito daga wurin da kuma yadda suka kamu da juna.
Bugu da ƙari, muna gwadawa da kuma tattauna bambance-bambance tsakanin HCoVs dangane da yadda cutar ke gudana da kuma yadda kwayoyin halitta ke haɗuwa.
An yi nazarin cutar COVID-19 ta 2019 a cikin wannan binciken.
Bugu da ƙari, muna yin la'akari da abin da ke sa ƙwayoyin cuta su canza jiki a cikin kwayoyin halitta daban-daban da kuma yadda suke shafar cutar.
Coronaviris (CoV) yana cikin jerin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Irin kwayar cutar da ke karɓar babban kwayar halitta mai nauyin kilobase 26 zuwa 32 a cikin kwayar RNA ana kiranta "CoV" saboda suna da ƙwarewa sosai idan aka kawo su cikin microscope.
A cikin wannan binciken, CoV ba shi da wani nau'in kwayoyin halitta da ke da kwayar halitta guda ɗaya.
Abubuwan da ke cikin kwayoyin halitta guda uku suna da nau'i biyu na kwayoyin halitta da ke motsawa don karatu (ORF1a da ORF1b), waɗanda ke komawa zuwa pp1a da pp1ab replicase polyproteins.
Ana amfani da waɗannan polyproteins don samar da furotin mai ƙarancin ƙwayoyin cuta 16, wanda ake kira nsp1~16.
Sauran kwayoyin halitta na da wani nau'i na ORF na kwayoyin halitta, ciki har da kai (S), ido (E), jiki (M) da nucleoprotein (N).
Akwai wasu sunadarai na furotin da ke da alaƙa da wannan asalin kuma suna da lambar asalin CoV na nau'i daban-daban.
Bisa ga bambancin kwayoyin halitta, CoVs za su iya zama rukuni hudu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), wanda a cikinsu beta-CoVs suna da mafi yawan CoVs kuma suna da rukuni hudu na asali (A, B, C da D).
Bayanan ilimin lissafi sun nuna cewa tsuntsaye da kuma masu cin abinci suna da farko a cikin tsarin CoV ji-alpha da CoV ji-beta, kuma sanyi yana da farko a cikin tsarin CoV ji-gamma da CoV ji-delta.
Shekaru dubu hudu, CoV ya samo asali ne daga dabba zuwa dabba, kuma wasu sun zama ƙwayoyin cuta da ke halaka jikin mutum.
A wannan lokacin, akwai nau'in mutum na CoV (HCoV) da aka sani.
HCoV-229E da HCoV-NL63 sun haɗa da nau'in alpha-CoV.
Wasu nau'ikan nau'ikan beta-CoV na yau da kullum sune HCoV-OC43, HCoV-HKU1, cutar sankarar zuciya (SARS-CoV), cutar sankarar huhu ta Middle East (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 sun fi nuna alamun cutar ta yau da kullum kamar cutar ƙwayoyin cuta da/ko cutar.
Duk da haka, sabon SARS-CoV, MERS-CoV da SARS-CoV-2 suna da matukar damuwa, kuma suna haifar da rashin lafiyar numfashi a cikin yawancin marasa lafiya waɗanda ke da sa'o'i masu yawa don kamuwa da cutar huhu mai cutarwa (ARDS) da kuma cututtukan numfashi kawai.
An gano nau'in farko na HCoV-229E, B814, a cikin wani nau'in cutar da aka sani a nan a shekara ta 1960.
Tun daga nan, an samu bayanai da yawa daga nazarin da aka yi na HCoV-229E da HCoV-OC43, dukansu sun nuna cewa akwai cututtuka daban-daban.
Duk da haka, an yarda da cewa cutar HCoV ba za ta kasance da ƙarancin lokaci ba kafin barkewar cutar SARS.
Cutar SARS ta bayyana a shekara ta 2003 kuma tana daya daga cikin cututtukan da suka fi tsanani a tarihin duniya, inda ta shafi mutane 8,000 kuma yawan mutuwar ta kai kusan kashi 10.
Shekaru goma bayan haka, cutar ta kumburi ta Middle East (MERS) ta zama sanadiyyar cutar da ta ƙare a yankin Larabawa da kuma ta yaduwar iska zuwa sauran duniya.
Sabuwar cutar HCoV 2019 (2019-nCoV), wanda aka canza sunan zuwa SARS-CoV-2, ita ce cutar coronavirus 2019 (COVID-19), wanda ta kashe kusan mutane 3,100 kuma ta kamu da fiye da mutane 91,000 a ranar 3 ga Maris, 2020.
Akwai rahotanni da ke cewa duniya tana bukatar shiri don cutar SARS-CoV-2 mai zuwa.
HCoVs sun samo asali ne daga tsuntsaye, tsuntsaye da dabbobi.
Yawancin bincike sun taimaka wajen gano cewa HCoV ya fito ne daga tsuntsaye, inda ƙwayoyin cuta ke canzawa kuma suna lalata juna amma suna nuna rashin lafiya daban-daban.
Cutar COVID-19 ta kawo matsaloli masu yawa ga likitoci, masu bincike, al'umma, da kuma masu bincike a kasar Sin da kuma duniya.
Gano asalin kwayoyin HCoV yana ba da damar fahimtar tarihin, abin da ya sa shi da kuma abin da zai iya haifar da canjin jiki.
Wannan na iya nuna ko kuma hana bincike na farko, na biyu da na dabba da kuma na halitta na SARS-CoV-2 na gaba ɗaya da kuma tsarin rigakafin cutar da zai iya kamuwa da mutane.
Wannan labarin ya ƙunshi nazarin dabbobi, kamuwa da cutar tsakanin kungiyoyi da kuma farkon cutar HCoV.
Sau da yawa, muna lura da kuma lura da cewa masu cutar HCoV ba za su iya kamuwa da cutar a gidajen su na farko ba amma za su iya kamuwa da cutar ta hanyar wasu dabbobi a cikin sabon gida.
Muna kuma tattauna yadda HCoV ke kamuwa da cutar ta hanyar rage yawan kwayoyin halitta.
An gano cewa za a yi bincike a kan cutar SARS-CoV mai yaduwa.
An gano CoV a cikin dabbobi tun daga 1930.
Kafin a fara samar da kwayoyin HCoV-29E B814 a cikin adadin masu kamuwa da cutar da muka sani, CoV ya bambanta a cikin dabbobi masu yawa masu kamuwa da cutar kamar dabbobi, yara, dabbobi masu ciki, ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta da kuma ƙwayoyin cuta.
A cikin shekaru goma da suka gabata, an gano nau'ikan HCoV guda bakwai da biyu.
Akwai tarihin gano HCoVs da aka lissafa a lokaci da kuma shekara (Table 1) wanda zai iya zama da amfani ga bayanai da kuma karatu.
An fara gano HCoV-229 a cikin huhu na marasa lafiya masu cutar huhu a shekara ta 1966, kuma an samu wani canji a jikinsa a cikin kwayar cutar WI-38.
Masu kamuwa da cutar HCoV-229E suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Daga baya a shekara ta 1967, an fitar da HCoV-OC43 don hana gwajin kwayoyin da kuma lambar ƙwayoyin halitta a cikin kwakwalwar mutum mai rauni.
Alamomin cutar HCoV-OC43 sun yi kama da na wasu cututtukan HCoV-229E, wanda alamun su na kama da na wasu cututtukan cututtukan huhu kamar su cutar A da cutar mura.
HCoV-229E da HCoV-OC43 sun bazu ko'ina cikin duniya, kuma ana iya samunsu daga dabbobi a lokacin sanyi.
Yawancin lokaci, lokacin bayyanar cutar yana wuce mako guda, yana ci gaba da zama mai cutar a cikin makonni 2.
A cewar wasu binciken, mutane masu lafiya da suka kamu da cutar HCoV-229E a jikinsu sun kamu da cutar.
Ƙananan marasa lafiya da ke da cututtukan jiki suna nuna rashin lafiyar huhu mai tsanani.
SARS, wanda aka fi sani da "ciwon huhu na yau da kullum", shi ne cutar farko da HCoV ya kamu da ita a tarihin al'umma kuma cutar ta etiologic ita ce SARS-CoV, HCov na uku da aka gano.
An fara samun cutar SARS a shekarar 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta yi sanadiyar mutuwar mutane 8,096 da 774, wanda ya bazu a ƙasashe da duniya.
Bayan an samu karuwar cutar, an gano cewa kowane mai cutar zai iya kamuwa da wasu cututtuka na yau da kullum, tare da lokacin bayyanar tsakanin kwanaki 4 zuwa 7 da kuma yawan cututtukan da suka fi tsanani bayan kwanaki 10 na kamuwa da cutar.
An gano cewa an riga an kamu da cutar SARS-CoV, ciwon fata, ciwon hanci, ɓacin jiki, ciwon fata da kuma ciwon ciki, wanda ya biyo bayan damuwa da numfashi, ciwon huhu, da kuma rashin lafiyar numfashi a matsayin ƙarshen alamun.
Lymphopenia, a cikin gwajin aikin hanta, da kuma creatine kinase sun kasance a cikin gwajin SARS a cikin dakin gwaje-gwaje.
An gano wasu ayyuka a cikin alveoli, ƙwayoyin epithelial cell, da kuma karuwa a cikin macrophages a cikin marasa lafiya na SARS.
Kusan kashi 20 zuwa 30% na marasa lafiya suna bukatar ƙarin magani kuma suna bukatar ƙarin magani.
Bugu da ƙari, rage yawan numfashi, wasu cututtukan jiki kamar ciwon daji, kumburi da kuma numfashi na iya kamuwa da cutar yayin da cutar ta ci gaba, sannan a wasu lokatai kuma tare da cutar cytokine, wanda zai iya kashe marasa lafiya.
Virus ya kasance mai ba da labari a cikin gwajin farko na biopsy na wani mai haƙuri wanda ya yi tafiya a Hong Kong Guangzhou.
Tun daga wannan lokacin, ba a yi wani bincike ba game da HCoV.
HCoV-NL63 ya kasance mai cutar a cikin wani yaro mai shekara bakwai da ya bar Netherlands a ƙarshen 2004.
Da farko an gano cewa yana iya faruwa ne a cikin yara, tsofaffi da kuma marasa lafiya da rashin lafiyar huhu.
Cutar zuciya, ciwon ido, rashin ƙarfi, da kuma cutar bronchiolitis sun kasance a cikin cutar HCoV-NL63.
Wani bincike ya nuna cewa an samu kwayar cutar ta hanyar shan inna a cikin jariri mai watanni takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, yanzu an yada shi a ko'ina cikin duniya.
An gano cewa HCoV-NL63 ya kai kusan kashi 4.7% na kamuwa da cutar huhu, kuma mafi yawan kamuwa da cutar ta faru a lokacin bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da ƙwayar cuta mai rufe ƙafarsa, wanda ake kira croup.
A wannan shekara, HCoV-HKU1 zai iya zama sananne ga wani mutum mai shekaru 71 da aka kwantar a asibiti don ciwon huhu da kuma cutar bronchiolitis a Hong Kong.
Baya ga kamuwa da cutar kwayar cuta da kuma cutar sankara, HCoV-HKU1 ya kasance yana da alaƙa da cutar kwayar cuta.
HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 ba su da cutar a duniya, kuma suna haifar da cututtukan numfashi.
HCoV mai yaduwa tsakanin al'umma yana raguwa a jikin mutum kuma galibi ana canza shi don ba da wasu cututtukan cututtuka masu cutarwa, ko da yake akwai wasu cututtuka masu cutarwa kuma mun san wannan kwayar cutar a cikin wasu nau'ikan HCoV-NL63 masu cutarwa, wanda a cikin dogon lokaci ana zargin yana haifar da cutar huhu a kasar Sin.
Yawanci, idan wani nau'in HCoV ya sami ingantaccen tsarin kwayar cutar da kuma ci gaba da rayuwa a jikin mutum, ba za a iya ganin cutar ba ko kuma a nuna alamun cutar.
MERS-CoV za a fara gano shi a shekarar 2012 a cikin wani sabon kamuwa da cutar da ke da shekaru 60 da haihuwa da ke fama da cutar pneumonia da kuma cutar sankarar cuta a kasar Larabawa.
An samu kamuwa da cutar da aka yi wa asibiti a Gabas ta Tsakiya, kuma an samu kamuwa da cutar da aka yi wa kasashen waje da ke da cutar a cikin gida guda a Turai da Tunisia.
Wani karo na biyu da aka yi a Koriya ta Kudu a shekarar 2015 ya kai mutum 186.
Alamun cutar MERS suna kama da SARS, wanda ke tattare da cutar huhu mai tsanani da ke haifar da cutar.
Ba kamar SARS ba, yawancin masu kamuwa da cutar MERS suna nuna cutar ƙwayoyin cuta, wanda ya bambanta da MERS a cikin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna nuna alamun rashin haihuwa da kuma rashin lafiya, kamar rashin lafiya da kuma rashin lafiya.
Tun daga ranar 14 ga Fabrairu, 2020, an gano cewa fiye da mutane 2500 da aka kamu da su a cikin binciken sun kamu da cutar da cutar ta hanyar mutuwar kusan kashi 34.4%, wanda ya sa MERS-CoV ya kasance daga cikin cututtukan da suka fi cutarwa a cikin kashi ɗaya cikin uku na mutane.
Daga tsakiyar zuwa ƙarshen watan Disamba, an gano wani samfurin cutar huhu a cikin marasa lafiya da aka gano a matsayin wanda ba shi da alaƙa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta bayyana cewa cutar ta fama da cutar ta huhu ta SARS-CoV-2 ta kasance a matsayin gaggawa ta Lafiya ta Jama'a a cikin ƙasa kuma ta kira cutar COVID-19.
Tun da dare na 3 ga Maris, 2020, an samu kamuwa da cutar 90,053 a duniya, kuma an samu mutuwar mutum 3.4 cikin 100.
Yawanci, yawan mutuwar a Hubei, China, ya kai 4.2%, amma a wajen ya kai 1.2%.
SARS-CoV-2 yana haifar da cututtukan huhu masu cutarwa kamar SARS-CoV da MERS-CoV, wanda ya nuna rashin ƙarfi, rashin ƙarfi da kuma wahalar numfashi.
Ana kuma ba da rahoton cutar a wasu cututtuka.
Ruwa yana da alama mafi muni kuma yana iya zama kamar rashin lafiya mai tsanani na numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 sun kasance na kowa saboda sun kasance suna da daidaituwa na nucleotide har zuwa 82%, an tsara su a cikin nau'i daban-daban na tsarin su.
SARS-CoV-2 ya fi kama da SARS-CoV da MERS-CoV.
Mutane da ke dauke da SARS-CoV-2 amma ba su nuna alamun cutar ba za su iya samunsa kuma za su iya zama sanadin yaduwar cutar a duniya.
Gwaji da kuma lura da SARS-CoV-2 da HCoV guda shida da kuma wasu sun nuna rashin daidaito da kuma bambancin da ke tattare da cutar.
Na farko, lokaci na bayyanar cutar HCoV da kuma ganowa sun kasance daidai.
Bugu da ƙari, SARS-CoV-2 yana bin tsarin HCoV na gaba ɗaya.
Na biyu, rashin bayyanar cututtukan COVID-19 ya kasance tsakanin SARS-CoV da HCoV guda hudu masu kamuwa da cutar (kamar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A wasu lokatai, cutar SARS-CoV-2 tana nuna alamun bayyanar cututtuka da aka samu a cikin cutar HCoV da ke kamuwa da HCoV da kuma bayyanar wasu alamun cututtuka, ko dai na asali ko na asali.
A wani ɓangare kuma, ƙananan ƙananan masu kamuwa da COVID-19 za su iya samun cututtukan cututtukan SARS-CoV, ko da yake adadin ya ragu sosai.
Na uku, kamuwa da SARS-CoV-2 yana nuna alamun bayyanar cututtuka masu kyau da ke tattare da kamuwa da cutar HCoV da SARS-CoV ta hanyar al'umma.
A wani lokaci, za a iya gwada kamuwa da SARS-CoV-2 da kamuwa da HCoV na HCoV a cikin al'umma.
A wasu lokatai, ana bukatar a sake duba ko za a iya samun karuwar kamuwa da cutar SARS-CoV-2 bayan an kai ta ga mutum kamar yadda ake yi da SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano cutar kamar HCoV na wani nau'i, SARS-CoV-2 a cikin ƙwayar cuta.
Idan kamuwa da SARS-CoV-2 daga bakin zuwa bakin yana da mahimmanci kamar yadda SARS-CoV ke da mahimmanci, to lallai ne a sake nazarin shi a cikin karatun gaba.
Ko SARS-CoV-2 zai iya faruwa a lokaci mai tsawo a matsayin wani nau'in HCoV wanda ba zai iya kamuwa da sauran al'umma ba.
Duk da haka, bayyanar cututtuka na SARS-CoV-2 da kuma kamuwa da cutar, bayyanar cututtuka, da kuma yaduwar cutar a jikin mutum zai taimaka wajen rage yawan yiwuwar kamuwa da cutar COVID-19 ta yanzu.
Dukkanin nau'ikan HCoVs da ke kamuwa da cutar ta hanyar jama'a suna haifar da alamun da ke gudana a jikin mutum.
A wani bangare kuma, yana iya zama gaskiya cewa cutar mutum na iya zama cikakkiyar cutar HCoV.
A cewarsa, duka biyu na iya zama farkon masu kamuwa da cutar HCoV.
HCoVs da ke haifar da cututtuka masu cutarwa ga mutane da kuma mutanen da ke da cutar HCoV na farko za su shiga cikin jerin.
A wannan yanayin, HCoVs dole ne su shiga cikin mutum domin su mutu kuma dole ne su haɗa da canje-canje masu dacewa da ƙwayoyin cuta.
Hakazalika, idan SARS-CoV-2 ya kamu da cutar a cikin mutane masu kamuwa da cutar, cutar za ta iya kamuwa da cutar a cikin jiki.
Idan ya yi kyau, za a iya yin amfani da maganin a kan hanya don hana rashin lafiya ko wasu hanyoyin hana cutar.
Shekaru da dama, CoV mai cutar da jama'a ya kasance yana yaduwa a cikin al'umma, yana ba da kariya ga ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
Wadannan kwayoyin ba sa bukatar wani wuri a cikin dabba.
Ana iya gano cewa cutar SARS-CoV da MERS-CoV suna da tasiri sosai a jikin mutum amma ba za su iya wucewa ba.
Suna bukatar su yi amfani da su wajen rarraba cutar a cikin gidajensu kuma su nemi hanyar da za su kai ga mutum a hankali, su shiga gida ko gidajen da ba su da cutar.
SARS-CoV-2 yana da alamun bayyanar cututtuka na SARS-CoV/MERS-CoV da HCoV na hudu wanda ba ya kamuwa da cutar.
Yana da matukar cutar kamar HCoV wanda ke kamuwa da cutar jama'a, a lokacin da aka ce ba a yi ba.
Amma, mafi muni ga HCoV shine rashin lafiyar jama'a da kuma rashin lafiyar SARS-CoV ko MERS-CoV.
Sai kuma ku yi la'akari da ko zai yiwu a yi wa mutum da kuma jama'a adalci ba tare da yin amfani da gida ko dabba don adana shi a jikinsa ba.
Kafin mu san yadda HCoV ke fitowa daga dabbobi, zai yi mana kyau mu san ainihin HCoV, asalinsa, na tsakiya da na kamuwa da cutar.
Dabbobi suna aiki kamar masu karɓar HCoVs idan sun kafa wani tsari wanda zai iya zama mai ƙwarewa a cikin nucleotide a jikin su.
Yawancin ƙwayoyin cuta suna tafiya da kyau kuma suna da mummunan tasiri a cikin ɗakin.
Hakazalika, cibiyar bincike ta kula da HCoV a cikin tsari da kuma a cikin tsari.
A cikin jinsunan biyu, dabbobi masu haɗuwa suna da ƙwayoyin cuta a jikin su kuma su ne asalin asalin HCoV ko kuma asalinsa.
Duk da haka, idan HCoV ya shiga cikin wani ɗaki na tsakiya kafin ko bayan ya shiga cikin mutum, zai iya yin aiki da kyau tare da wani sabon ɗaki kuma zai iya zama mai cutarwa.
Wannan cibiyar ta iya zama kamar hanyar watsawa daga dabba zuwa mutum kuma tana aiki kamar ɗakin sharar gida ta hanyar fitar da kwayar cutar daga cikin mutum kuma ta watsa ta zuwa mutum don isar da cutar.
HCoV zai iya kashe kansa idan bai wuce ta hanyar kwayoyin ba kafin ya shiga jikin mutum.
Bugu da ƙari, HCoV na iya shiga cikin gida mai tsakiya kuma yana iya kamuwa da cutar a tsawon shekaru.
Amma a ciki akwai ɗakin kwana na farko.
Rahotanni sun nuna cewa akwai wasu ƙananan cututtuka a cikin SARS da ke tattare da dabbobi na daji.
Binciken da aka yi game da rayuwar cutar ya nuna cewa masu sayen kwayoyi suna da ƙimar IgG na anti-SARS-CoV idan aka kwatanta da na al'umma.
Wasu dabbobi kamar dabba (Paguma larvata) da kuma wasu dabbobi kamar jarirai a cikin dabba sun kasance farkon masu kama da SARS-CoV wanda ya dace da SARS-CoV.
Wannan shi ne saboda an yi watsi da rahoton cewa babu wani SARS da aka ruwaito bayan an kashe waɗannan kwayoyin da suka ɓace.
Duk da haka, an ce dabbobi kamar su wasu dabbobi na daji ko na daji da ke shiga cikin dabbobi masu ido ba za su iya zama kamar SARS-CoV ba, wanda ke nuna cewa irin waɗannan dabbobi na iya zama kamar cibiyar da ke kusa da daji amma ba su da asalin SARS-CoV.
A cewarsa, yayin da kashi 80% na dabbobi daban-daban a yankin Guangzhou ke da maganin anti-SARS-CoV, akwai yiwuwar wasu ƙananan dabbobi kamar su ƙwayoyin cuta na SARS-CoV.
Wannan shi ne kusan ƙarshen cutar SARS-CoV.
Binciken da aka yi a kan dabbobi na asali na SARS-CoV ya gano wani nau'in CoV da ya fi na wasu tsuntsaye, wanda ake kira CoV HKU3 (SARSr-Rh-BatCoV HKU3) wanda ya yi kama da Rhinolophus, wanda aka samo a cikin wasu tsuntsaye a kasar Sin.
Wannan kwayar tana da kwayoyin halitta masu ƙyama na anti-SARS-CoV da kuma tsarin kwayar halitta na SARSr-Rh-BatCoV HKU3.
CoV na wannan nau'in da na wasu tsuntsaye suna da kashi 88-92% na cutar nucleotide da SARS-CoV.
Makarantu suna gina sababbin halittu inda tsuntsaye ke da halaye na mutum.
Ko da yake SARS-CoVs ba su da cutar a cikin tsuntsaye, amma babu wani nau'in wanda ke da alamar WIV1 da zai iya kamuwa da cutar kamar sabon kwayar cutar.
Halin da ake kira angiotensin 2 (ACE2) ya yi kama da na SARS-CoV.
WIV1 daga cikin kwayoyin halitta na tsuntsaye ya nuna tsuntsaye, tare da ACE2 na mutum a matsayin mai karɓar shigarwar sel.
Duk da haka, jini na masu kamuwa da cutar SARS da aka yi amfani da shi zai iya kamuwa da cutar ta WIV1.
Bugu da ƙari, WIV1 ya nuna cewa SARS-CoV shine mafi kusanci ga tsuntsaye, suna da kashi 95% na nucleotide.
Ko da yake akwai bambanci tsakanin waɗannan ƙwayoyin cuta biyu, mutane suna tsammanin cewa WIV1 ba zai zama asalin SARS-CoV ba kuma tsuntsaye ba za su kasance a cikin SARS-CoV ba.
Binciken phylogenetic na samfurin MERS-CoV da kuma nau'ikan kwayoyin CoV-HKU4 da CoV-HKU5.
CoV-HKU4 da MERS-CoV suna da mai karɓa guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar.
Tsarin RNA polymerase na RNA-dogon MERS-CoV sun kasance daidai da yadda suke da alaƙa da abin da aka samu a cikin beta-CoV na tsuntsaye da aka sani a Turai da Afirka.
A halin yanzu, babu sabon MERS-CoV da za a iya ganowa a cikin tsuntsaye.
MERS-CoV da kuma ƙwayar cuta mai kama da CoV-HKU25 suna da kashi 87% na nauyin nucleotide.
Bugu da ƙari, tsuntsaye ba su da tsakiya ga MERS-CoV.
A wani lokaci kuma, nazarin da aka yi a Afirka ta Kudu ya nuna cewa kwayoyin halitta suna da cutar MERS-CoV da ke shafar lafiyar jiki, irin cutar da kwayoyin halitta na Afirka ta Kudu suka samu a ƙasashe da dama.
Wani sabon kwayar cutar MERS-CoV da aka samu a cikin mutum da aka yi amfani da ita a cikin kwayoyin halitta, ya nuna cewa kwayoyin halitta sune ainihin masu karɓar MERS-CoV.
Ya kamata a lura cewa yawancin alamun cutar sun kasance a cikin ƙwayar cuta da aka gano a cikin kwayoyin da aka yi amfani da su don gwaji tare da MERS-CoV.
Kwayoyin da ke da cutar suna fitar da kwayar cutar ba ta hanyar numfashi kawai ba amma ta hanyar hanci da baki, wanda kuma shine farkon hanyar fitar da kwayar cutar.
Amma, a yanzu akwai wasu hujjoji da ke nuna cewa akwai wasu nau'ikan MERS da aka sani da ba su taɓa yin cuta da kwayoyin halitta ba kafin bayyanar cututtuka, kamar su cewa mutum ya kamu da cutar ta mutum ko na ƙauye da kuma asalin dabba wanda ke dauke da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na nucleotide da kuma CoV RaTG13 wanda ya fito ne daga kwayar cutar Rhinolophus affinis.
Kamar SARS-CoV da MERS-CoV, ƙwayoyin cuta tsakanin SARS-CoV-2 da RaTG13 suna da mahimmanci don hana su zama masu cutar.
A cewarsa, tsuntsaye ba za su iya zama gida ko gida na farko na SARS-CoV-2 ba idan an gano nau'in CoV na yau da kullum da aka gano a baya.
Muna tsammanin, dabba mai yiwuwa ta zama cibiyar SARS-CoV-2 za ta kasance a cikin dabbajin daji da ke kwance ko kuma ke kamuwa da cutar a cikin Hanan Animal Land, kuma abin da ke haifar da yawancin farkon kamuwa da COVID-19, wanda zai iya nuna cewa kamuwa da cutar ta zo daga dabba zuwa mutum.
Yawancin sababbin nazarin kwayoyin halitta sun nuna cewa akwai ƙananan kwayoyin halitta da ake kira pangolin (Manis javanica) da za su iya ɗaukar kwayoyin beta-CoV kamar SARS-CoV-2.
Sabbin kwayoyin halitta na coV pangolin sun ƙunshi kashi 85-92% na nucleotide da ke kama da SARS-CoV-2.
Duk da haka, sun kasance a kusa da RaTG13 tare da kashi 90% na nauyin nucleotide.
Suna da nau'i ɗaya na asali na SARS-CoV-2-virus wanda aka samo asali, ɗaya yana da nau'i na mai karɓar ƙwayar cuta (RBD) tare da SARS-CoV-2, tare da 97.4% na amino acid.
Duk da haka, RBD na SARS-CoV-2 da RaTG13 sun fi bambanta, ko da yake yanayin kwayoyin halitta sun yi kama.
A cikin binciken farko na cutar pandolines an gano wani kwayar cutar a cikin kwayar cutar, wanda ya yi kama da SARS-CoV-2.
Wannan binciken ya dauki tsari biyu na yin amfani da hannayen hannu don samar da wani nau'i na kwayoyin halitta wanda ke da kashi 86.3% na ƙwayar cutar.
Ba za mu bari binciken da ya nuna cewa pangolin yana cikin dabbobi masu ci gaba da cutar SARS-CoV-2 ba.
Amma, a yanzu babu wata hujja da ta nuna cewa cutar ta zama asalin SARS-CoV-2 saboda akwai bambancin yanayi tsakanin SARS-CoV-2 da beta-CoV SARS-CoV-2-pangolin.
Bugu da ƙari, cututtukan cututtukan SARS-CoV-2 da RaTG13 sun kasance ƙananan fiye da na SARS-CoV-2 da CoV da kuma nau'in beta-CoV na SARS-CoV-2-pangolin.
Ana buƙatar sake nazarin yadda SARS-CoV-2 ke yaduwa a cikin tsuntsaye, penguins da sauran dabbobi.
Kamar yadda aka fi sani a cikin RBD na SARS-CoV-2 da kuma pangolin, beta-CoV na SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da ƙwayoyin cuta a cikin tsarin kwayoyin halitta.
Mutane da yawa suna magana game da bambancin da ke tsakanin RBD beta-CoV da SARS-CoV-2 da SARS-CoV-2 da ke cikin gwajin don ci gaba da haɗuwa.
Akwai kuma wani bincike da ya nuna cewa akwai wani abu da ya shafi SARS-CoV-2 PANGOLIN da RaTG13 a cikin wani ɓangare na uku na asalin dabba.
A cewar ci gaba, an samu karuwar haɗuwa tsakanin nau'in beta-CoV.
Wakilan suna kula da dabbobi masu dauke da SARS-CoV-2.
A cikin ci gaban HCoV mai cutarwa, an lura da bayyanar HCoV-229E ta dabbobi, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Binciken asali ya nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga nau'in CoV na tsuntsaye, amma an gano asalin ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin kwayoyin halitta.
An gano cewa nau'in CoV na ARCoV.2 (Appalachian Ridge CoV) wanda aka samu a cikin nau'in tsuntsaye na Arewacin Amirka na da nau'i uku na HCoV-NL63.
A wani wuri, an danganta HCoV-229E da CoV na tsuntsaye, wanda aka sani da Hipposideros/GhanaKwam/19/2008, wanda aka samu a Ghana, kuma an dauki kwayoyin halitta a matsayin cibiyarsa.
Don yin magana mai sauƙi, an haɗa bayanan yanzu game da nau'in dabba da aka gano na HCoV a Hotuna 1 da Table 2.
Binciken barci ya nuna cewa akwai wani abu da zai iya watsa HCoV tsakanin dabbobi da mutane a tarihi.
Lokacin da HCoV-OC43 ya sa dabbobi su kamu da cutar ta hanyar dabbobi a cikin shekarun 1890, akwai wani irin rashin lafiyar numfashi.
Ana iya samun kyakkyawan sakamako a cikin gwajin mutum-dabba na HCoV-229E.
An gano wani nau'in alpha-CoV mai kama da HCoV-229E.
Daga cikinsu akwai alpha-CoV mai banbanci.
Babu wata alama da ta nuna cewa cutar ta fito ne daga tsuntsaye zuwa mutum.
Na farko, mutum ba zai iya yin tarayya da tsuntsaye ba a cikin wuri ɗaya.
Haka ma mutane suke yin gwaji da ƙazanta.
Na biyu, alpha-CoV mai suna HCoV-229E bai nuna alamun cutar a cikin tsuntsaye ba, amma alpha-CoV ba ya nuna cutar huhu a cikin dabbobi da suka kamu da cutar.
A ƙarshe, alpha-CoV ba a samo shi a cikin dabbobi na daji.
Bayan haka, tsarin ba zai iya haifar da cutar alpha-CoV hcOv-229E a cikin mutum ba.
A bayyane yake, ƙwayoyin cuta suna da cututtukan cututtukan da ke nuna alamun cutar a cikin mutum kamar cutar rabies, Ebola, Nipah da Hendra.
Bugu da ƙari, ƙwayoyin cuta na iya zama waɗanda suka ba da HCoV-229 ga mutum ba tare da wata hanya ba.
Ko kuma, kamar yadda alpha-CoV na tsuntsaye yake a matsayin wani ɓangare na HCoV-229E, alphabets da alkaloids na iya zama kamar matsakaiciyar hanyar da ke haifar da cututtukan cututtukan mutum, kamar yadda yake faruwa da MERS-CoV.
MERS-CoV ya kasance sanadiyar cutar da ke gudana daga tsuntsaye zuwa dabbobi da kuma daga dabbobi zuwa mutane.
An gano cewa cutar MERS-CoV tana fitowa daga tsuntsaye a farkon cutar kuma an kara samun ci gaba da sakamakon.
Gaskiyar ita ce, tsuntsaye suna kama da kwayoyin cuta don hana kwayoyin halitta daga haihuwa zuwa mutum.
Tattalin hankali, haɗuwa da ƙungiyoyi a cikin ɗaki ɗaya, kasancewa a cikin jama'a da kuma yin iska a cikin iska sune abubuwan da ke sa tsuntsaye su zama 'masu yaduwa'.
A wani wuri, an gano MERS-CoV a jikin kwayoyin halitta fiye da shekaru goma.
Yana da kyau sosai tare da ƙwayoyin da aka canza daga ɗakin zuwa ɗakin da ke sama.
MERS-CoV yana da matukar cutarwa kuma yana sa ƙwayoyin ba su da bambanci sosai.
Cutar da ke gudana daga mutum zuwa mutum na da matukar damuwa kuma mutum zai iya zama ƙarshen nau'in MERS-CoV saboda ba zai daɗe ba.
Ba kamar aikin kwayoyin halitta a cikin kwayar cutar MERS-CoV ba, aikin kwayoyin halitta, idan akwai, a cikin kwayar cutar SARS-CoV-2 ya bambanta.
Mafi yawanci, beta-CoV na cutar ta kamu da cutar ta hanyar bayyanar cututtuka.
Za a iya samun su a cikin nau'in beta-CoV na SARS-CoV-2, kamar su SARS-CoV.
Yawancin hanyoyin da za a iya watsa SARS-CoV-2 daga dabba zuwa mutum za a yi nazari a ciki da waje a cikin makarantu masu zuwa.
Na farko, tsuntsaye na iya zama farkon tushen cutar SARS-CoV-2 wanda ya yi kama da SARS-CoV-2.
Mutum zai iya samun wurin zama tare da tsuntsaye ta hanyar rarraba dabbobi ko kuma yin amfani da ƙasa.
Na biyu, ƙwayoyin cuta na iya zama cibiyar karɓar cutar SARS-CoV-2 wanda zai shiga cikin binciken na dogon lokaci.
Mutum yana kamuwa da cutar ta hanyar shan naman sa da kuma shan naman sa.
Ana iya samun cutar SARS-CoV-2 a cikin dabbobi da kuma cikin gida.
Binciken dabbobi na gida da na daji don masu shan magani yana da tasiri.
Na uku, kamar yadda aka ambata a sama, haɗuwa da gwajin SARS-CoV-2 na iya haifar da cutar a cikin dabbobi na uku da ke da cutar da tsuntsaye da kuma tsuntsaye.
Ana ci gaba da bincike kan cutar SARS-CoV-2.
Bayan wasu kwayoyin da ke dauke da cutar, akwai kwayoyin halitta guda uku da ke nuna cewa cutar tana da muhimmanci wajen gano cutar CoV.
Tun da farko, mun san cewa suna yin amfani da RNA na su.
Idan aka kwatanta da wasu ƙwayoyin cuta da ke da RNA guda ɗaya, za a iya ɗaukar adadin canjin CoV a matsayin dey zuwa dey kuma yawan canjin zai kasance daga ~10-4 a shekara a cikin sashe na 2, dangane da gwajin canjin CoV a cikin sababbin gidaje.
CoV yana da mai karɓar exoribonuclease, wanda idan aka karɓa zai iya canza haɓakar ƙwayar cuta zuwa raguwa ko mutuwa.
Abin farin ciki kuma, an gano cewa nucleotide na Remdesivir mai kama da shi zai iya taimakawa wajen gano CoV ta hanyar haɗa wannan exoribonuclease da RNA da ke cikin RNA polymerase.
Remdesivir yana daya daga cikin magungunan anti-SARS-CoV-2 da za a iya amfani da su a lokacin bincike.
A cikin wannan, yawan masu cutar CoV zai ninka miliyoyin sau na waɗanda suke cikin gida.
Amma, yawan yawan iska zai kasance kadan idan COV ta kasance da kyau tare da ɗakin.
Idan aka kwatanta da SARS-CoV wanda ke da yawan bambancin bambancin, yawan bambancin SARS-CoV-2 yana da ƙananan, saboda haka yana iya faruwa a jikin mutum.
Ka yi tunanin cewa, yana da wuya a gama shi da mai karɓa wanda ke kusa da mutum.
Baya ga SARS-CoV-2, an kuma yi amfani da shi wajen gano cutar MERS-CoV, wadda ke da alaƙa da jikin kwayoyin halitta.
A cikin magana, ba za a iya canza gene wanda ke haifar da allurar rigakafi ko maganin SARS-CoV-2 ba don tabbatar da ƙarfin ƙwayar.
Na biyu, manyan kwayoyin halitta na CoV suna tsara kwayoyin halitta a matsayin kwayoyin halitta don juyawa da haɗuwa, wanda ke haifar da ci gaba da ci gaba da kwayoyin halitta a tsakanin kwayoyin halitta, wanda ke da amfani ga sabon CoV idan kayan aiki sun zama masu kyau.
Wannan kwayoyin halitta suna shiga cikin jikin mutum kuma suna buɗewa da ƙwayoyin furotin da aka ƙayyade ta hanyar ƙwayoyin cuta 3.
Na uku, CoV yana canzawa a lokacin da RNA ke aiki ta hanyar da ake kira "copy-choice".
A cikin wani ɗakin da aka saba da shi a matsayin mai sarrafawa, za a iya samun canji a cikin ƙwayar yayin da RNA ke rubutawa.
Ana iya haɗa RNA mai ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
An fara gano asalin wannan haɗuwa a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoV na dabbobi kamar SL-CoV da CoV-HKU9.
Kwayar cutar ta kamu da cutar ta kamuwa da cutar
Baya ga nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan
A sakamakon haka, an dauki SARS-CoV a matsayin babban abin lura, wanda kuma ya nuna cewa akwai karuwar ƙwayar cuta a lokacin watsawa tsakanin dabbobi da mutane.
A cikin wani bincike na gwaji tsakanin SARS-CoV na mutum da na mutum, SARS-CoV ya bayyana a matsayin mai canzawa a cikin dabbobi ko mutane, musamman tare da canje-canje a cikin RBD protein S.
Sau da yawa, RBD a cikin wani furotin S CoV yana aiki tare da mai karɓar kwayar halitta kuma ana zaɓar shi ta hanyar amsawar mai karɓar kwayar halitta.
A cikin SARS-CoV, RBD yana ƙidaya tsakanin amino acid 318 zuwa 510 a cikin S1 cell, wanda ke haɗa ACE2 da kuma wanda ke karɓar shi don shigar da kwayar.
RBD na SARS-CoV na iya tabbatar da karɓar ACE2 a cikin dabbobi daban-daban, kamar su tsuntsaye, dabbobi, jarirai da jarirai, waɗanda ke da alhakin watsa kwayar cutar tsakanin dabbobi da mutane.
A gaskiya ma, an gano nau'ikan amino acid guda 6 a matsayin masu rarrabewa da ƙwayoyin cuta na mutum da kuma na mutum a cikin RBD kuma 4 daga cikinsu suna cikin mai karɓar haɗuwa don aiki tare da mai karɓar ACE2.
Kwayoyin SARS-CoV suna da K479N da S487T a cikin RBD, wanda zai iya haifar da ƙarancin ƙarancin ƙwayoyin ƙwayoyin ƙwayoyin cuta na mai karɓar mutum.
A cewarsa, waɗannan amino acid biyu masu canzawa na iya zama masu tasiri a cikin kwayar cutar a cikin mutum.
Yana da muhimmanci a lura cewa SARS-CoV-2 yana da mai karɓar kwayar halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 sun nuna cewa yanayin haɗin S da ACE2 na mutum ya canza.
A gaskiya ma, binciken cryo-EM ya nuna cewa akwai sau 10 zuwa 20 da yawa fiye da yadda ake nunawa tsakanin ACE2 na mutum da kuma sunadarai S ACE2 da SARS-CoV.
Zai kuma zama da muhimmanci a san ko akwai wani mai karɓa wanda zai iya kamuwa da cutar ta SARS-CoV-2.
A wani ɓangare, HCoV-NL63 yana da alaƙa da ACE2 amma yana da nau'i daban-daban na S.
Akwai sauran masu karɓar HCoV, kamar aminopeptidase N na HCoV-229E, da kuma 9-O-acetylated sialic acid na HCoV-OC43.
Suna iya zama da amfani wajen canja wurin CoV zuwa jikin mutum bayan an watsa su zuwa dabbobi daga ɗakin ajiyarsu.
Baya ga masu karɓar kwayoyin, ana iya gano cewa HCoV yana da yaduwa tsakanin dabbobi da wasu kwayoyin halitta ba su kare shi ba.
Bambancin gidajen furotin tsakanin mutane da kuma gidajen ajiyar HCoV na dabbobi kamar tsuntsaye, dabbobi, ko dabbobi na iya zama abin hana watsawa tsakanin dabbobi.
HCoV ya kamata ya kasance a cikin tsarin tsaro kuma ya canza abin da ke hana mutum samun kwayar cutar tsakanin kwayoyin halitta.
Hakazalika, masu gano kwayoyin a cikin wani ɓangare na kwayar cutar dole ne su ƙayyade shi kuma su ba shi aiki.
Akwai wasu gwaje-gwaje na cutar da ba a san su ba game da SARS-CoV-2 da kuma abubuwan da za a iya ragewa ta hanyar tsarin CRISPR da za a iya ba wa yara.
Sabbin HCoVs: Komawa zuwa farkon
Cutar CoV tana ba da dama ga sababbin HCoVs.
Bugu da ƙari, nau'in CoV na tsuntsaye yana cikin wani ɓangare na nau'in HCoV.
Bugu da ƙari, canjin kwayar halitta da kuma haɗuwa da asali na iya haifar da cutar HCoV da kuma haifar da ƙwayoyin cuta guda biyu.
Alal misali, haɗuwa ko ɓacewar sababbin kwayoyin halitta na iya canza tsarin ƙwayar cuta don mafi kyau.
Daga cikin furotin na SARS-CoV, ORF8 yana da mahimmanci a cikin juyin halitta na mutum, kamar yadda kwayar cutar SARS-CoV ta kasance a cikin tsari amma tana da lambar wasu furotin na ORF8.
An gano wani nau'in nucleotide na 29 wanda ke nuna SARS-CoVs a cikin kwayoyin da ke da alaƙa da cutar a farkon mutum.
Wannan cutar ta haifar da ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin za ta iya zama sanadiyyar sauyawar gida ko kuma sauyawar gida.
Duk da haka, SARS-CoV na iya samun tarihin haɗuwa da asalin CoV na alpha- da gamma, kuma an sami adadin ƙananan ƙananan ƙananan ƙananan ƙananan a cikin RNA polymerase mai yawa.
Ƙungiyoyin haɗin sun samo asali ne a cikin nsp9, musamman nsp10, da kuma nsp14 na gida.
Duk da haka, an gano cewa cutar MERS-CoV ta ƙunshi abubuwa na asali daban-daban, waɗanda suka faru a cikin kwayoyin halitta a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an gano wani abu na hadewa a cikin HCoV na jinsin daban, inda HCoV na jinsin ya danganta da CoV na jinsin dabba a cikin kwayoyin halitta da ba a san su ba.
Ya kamata kuma a lura cewa zaɓaɓɓu za su iya zama da amfani wajen canja kwayoyin halitta na ƙwayoyin cuta da ba su dace ba, musamman waɗanda suka taso daga ƙwayoyin cuta a cikin zaɓin amsa, kamar tsarin rigakafi na gida.
Wannan abu ne da ke haifar da ɓarna na ORF4 wanda ya haɗu da nau'in HCoV-229E, wanda ke da alaƙa da ƙwayoyin nucleotides guda biyu.
Duk da yake ana iya samun ORF4 a cikin ƙwayoyin cuta da ƙwayoyin cuta masu ƙwayoyin cuta da suka shafi HCoV-229E, alpha-CoV na alpha yana nuna shigar da nucleotide guda ɗaya, wanda ke haifar da canje-canje a jiki.
A ƙarshe amma ba a ƙarshe ba, ana gudanar da bincike na gaggawa a cikin asibitoci don gano HCoV.
Ana samun alamun cututtuka masu tsanani ko na mutuwa ne kawai a lokacin da tsuntsaye suka kamu da CoV, wanda ba ya nuna bambanci tsakanin CoV da tsuntsaye.
A zahiri tsuntsaye suna tafiya daidai da CoV ta hanyar jikinsu da kuma dukkan ayyukansu.
Alal misali, ƙwayoyin cuta a cikin ƙwayar cuta na iya rage yawan cutar da CoV ke haifarwa.
Bugu da ƙari, ƙwayoyin cuta na tsuntsaye suna haifar da ƙwayoyin cuta NKG2/CD94 da kuma rage yawan kwayoyin halitta.
Bugu da ƙari, yawan adadin iska mai yawa (ROS) ya taso ta hanyar aikin abinci a cikin tsuntsaye wanda zai iya hana karɓar CoV kuma ya shafi tsarin karatun ta hanyar exoribonuclease, wanda zai iya haifar da haɗari ga asalin tsuntsaye masu cutarwa idan sun shiga cikin ɗakin.
Yawancin kwayoyin CoV masu cutarwa na iya faruwa ta hanyar haɗuwa, wanda ke samar da sababbin sunadarai ko kuma siginar sunadarai don canzawa.
Bugu da ƙari, za a yi tsammanin cewa sabon nau'i uku na HCoV sun bayyana a cikin shekaru ashirin da suka gabata.
CoV ba zai zama mai cutarwa ba ko kuma zai nuna alamun cutar a cikin ɗakin da ake ɗauka kamar tsuntsaye da dabbobi.
Suna kuma yin addu'a ga waɗanda suke da rashin lafiya, ba tare da yin musu horo ba.
Domin akwai waɗansu da suke cikinku, waɗanda aka aiko su ba su da wata alama, suna kuma shan azaba.
Alamun rashin lafiyar jiki sukan faru ne saboda yawan garkuwar jiki da kuma rashin lafiyar cytokine, domin idan garkuwar jiki ta kasa, ciwon huhu zai iya ƙaruwa.
Duk da haka, a cikin masu ba da rahoto na yau da kullum, an rarraba amsar rigakafi da kuma tunanin CoV.
Irin wannan tsarin na rarraba maganin rigakafi na iya zama mahimmanci a cikin maganin anti-SARS-CoV-2.
Maganin interferon yana da tasiri sosai a tsuntsaye.
Saboda haka, ba da interferon na nau'i na I a kalla a farkon farkon cutar SARS-CoV-2 ga mutum zai zama dole.
Amma, an ce tsuntsaye suna haifar da cutar NLRP3 da sauri.
Bisa ga irin wannan tunani, ƙwayoyin NLRP3 da MCC950 na iya zama da amfani wajen magance COVID-19.
Sakamakon SARS-CoV-2 ya biyo bayan cutar ta farko da ta haifar da SARS-CoV da MERS-CoV.
Yayin da aka gano kashi 95% na rarrabawar nucleotide da SARS-CoV, akwai kuma karuwar CoV na 96% na rarrabawar nucleotide da SARS-CoV-2.
Duk da yake an gano wasu ƙwayoyin cuta da dabbobi a cikin daji a matsayin masu ƙunshe da ƙwayoyin cuta masu kama da SARS-CoV a cikin jikinsu, an gano wani wuri na farko na SARS-CoV-2.
An gano nau'in beta-CoV na penguin wanda ya dace da SARS-CoV-2, wanda ke nuna cewa kwayar cutar na iya zama kamar ɗakin ajiya na tsakiya ko kuma beta-CoV na iya zama ko kuma tushen gene a ƙarshen SARS-CoV-2.
Ko da kuwa akwai alamun cutar, ana iya sanin cewa SARS-CoV-2 ya kamu da cutar ba tare da sanin ko kuma ya kai ga cutar ba.
CoV ya sake dawowa saboda sabon kamuwa da cutar SARS-CoV-2.
Nazarin CoV a cikin tsuntsaye da sauran dabbobi ya canza tunaninmu game da yadda za mu iya amfani da bayyanar HCoV a cikin dabbobi da kuma gidajen ajiya don yin amfani da shi a jikin mutum.
Binciken da aka yi a ido ya nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun fito ne daga tsuntsaye kuma sun kamu da su zuwa mutane ta hanyar wasu dabbobi.
Lokacin da cutar SARS-CoV ta taso ta hanyar haɗuwa da mutum da kwayoyin halitta a cikin daji, toshe kwayoyin halitta da ke sayen dabbobi masu haɗari da kuma rarraba kwayoyin halitta a can zai iya zama kamar cutar SARS.
A irin wannan ra'ayi, dole ne a cire pangolin daga cikin kwayoyin halitta don hana su kamuwa da cutar ta hanyar dabbobi, kamar yadda wani gwaji ya nuna cewa akwai kamanceceniya tsakanin beta-CoV na pangolin da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 ya kamu da mutum ta hanyar cutar pandemics da sauran dabbobi kuma ta yaya za a iya magance shi a cikin binciken da zai zo.
A wasu lokatai, MERS-CoV ya kasance cikin tsarin halittu na zamanin d ̄ a.
Wadannan jiragen suna aiki ne na musamman don tafiya da kuma daukar kaya kuma suna ba da kayan aiki, kayan aiki, kulawa da kuma kulawa ga jama'a.
An rarraba su ko'ina a Gabas ta Tsakiya da Afirka.
Ba za mu iya kashe dukan halittu ba don mu iya magance cutar MERS, da kuma abin da suka yi a cikin cutar dabbobi a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake kamuwa da cutar MERS, an samu wasu hanyoyin samar da allurar rigakafin MERS-CoV, da kuma wasu hanyoyin hana cututtuka.
Domin ba za mu iya shigar da ƙwayoyin cuta ba, wasu kwayoyin halitta na iya haifar da wasu cututtuka.
Ana samun cutar CoV ta dabbobi a cikin daji.
Koyaya, CoV nau'in tsuntsaye ne wanda zai iya faruwa ta hanyar dabbobi.
Akwai hanyoyin da za a iya inganta yadda CoVs da ke yaduwa da dabbobi za su iya haɗuwa, wanda zai hana CoVs da ke yaduwa da cutar da za su iya kaiwa ga mutane a nan gaba.
Ana bukatar a bar dabbobi a wasu sassan kasar Sin don rage haɗuwa tsakanin mutane da dabbobi.
Tare da cututtukan SARS, MERS da COVID-19, dole ne a yi shiri sosai kuma a sami tsarin amsa mai kyau.
Hakika, ƙwayoyin cuta da yawa sun kasance a duniya tun daga farkon.
Suna cikin gidajensu a lokacin da aka yi musu rarraba.
Ko da yake tsuntsaye suna da hanyoyi masu yawa na watsa ƙwayoyin cuta, lokacin da mutum zai iya yin hulɗa da tsuntsaye da sauran dabbobi zai iya raguwa idan mutane suka yi tarayya da su.
Ci gaba da lura da dabbobi zai taimaka wajen sanin ainihin yanayin rayuwar CoV da kuma yanayin rayuwarsa, wanda zai nuna yadda za a iya kamuwa da cutar daga dabba zuwa mutum da kuma yiwuwar kamuwa da cutar a nan gaba.
A ƙarshe, hanya mai mahimmanci don hana kamuwa da cutar daga dabbobi shine mutum ya nemi wurin da za a adana kwayar cutar.
Yawancin abubuwa a cikin ƙwayar da ke nuna SARS-CoV-2 ta hanyar dabbobi ba su wanzu ba.
Na farko, idan tsuntsaye suka watsa SARS-CoV-2 a cikin kwayoyin halitta, zai zama da amfani mu fahimci yadda tsuntsaye da kwayoyin halitta ke rarraba wuri ɗaya.
Na biyu, idan tsuntsaye suna da iko a kan mutum, to, dole ne mutum ya kula da tsuntsaye.
Na uku, idan akwai dabba na uku da ke da matsayi na tsakiya, dole ne a daidaita yadda ake wasa da sauran dabbobi kuma ya haɗa da mutane, tsuntsaye da tsuntsaye.
A ƙarshe, da yake dabbobi da dabbobi masu yawa suna iya kamuwa da SARS-CoV-2, dole ne a yi amfani da rigakafi da bincike na cutar.
Ko da kuwa tsuntsaye ne, ko dabbobi, muna bukatar mu lura cewa SARS-CoV-2 ko kuma ƙwayar cutar da aka haifa a cikin ɗakin farko.
Bincike na gaba a wannan yanki zai magance yaduwar SARS-CoV-2 a cikin dabbobi, da kuma ci gaba da ingantacciyar hanyar rigakafi da bincike na COVID-19 a jikin mutum.
Yin amfani da tsarin bincike na "muguwar cuta" da "muguwar cuta" na COVID-19 yana da muhimmanci.
A ranar 6 ga Fabrairu, 2020, rukuninmu ya fitar da takardun shaida game da gwajin cutar coronavirus da magani na 2019 (2019-nCoV) kuma wannan takarda ta nuna fahimtarmu da kuma matakanmu na hana cutar ta duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabon abu ne, kuma tsarinmu da kayan aikinmu na ci gaba da ingantawa don samar da sakamakon bincike da alamun cututtuka na asibiti; kuma ana ci gaba da nazarin hanyoyin bincike da magani.
A cikin wannan labarin, mun amsa wasu rahotanni game da rahotonmu kuma saboda sabon tsarin bincike na "mutumin da ke da lafiya" da "mutumin da ke da lafiya" kamar yadda aka samo a cikin rahoton COVID-19 Test and Results (saƙon kwanan wata) da kwamitin kiwon lafiya na kasar Sin ya fitar.
A watan Disambar 2019, sabon kamuwa da cutar korona ta 2019 (2019-nCoV) ya bayyana wani kamuwa da cutar, wanda a yau ake kira cutar korona ta 2019 (COVID-19) kuma wannan cutar ta kasance cutar coronavirus 2 na huhu (SARS-CoV-2).
A ranar 11 ga Maris, WHO ta bayyana cewa COVID-19 ta zama annoba ta duniya.
Don gano cutar SARS-CoV-2, mu na da rahoton ɓarna da aka fitar a ranar 6 ga Fabrairu ta hanyar binciken lafiyar soja.
Wannan ya shiga cikin zuciyar dukan mutane tun daga farkon halitta.
Har ila yau, cutar COVID-19 ta kasance sabon abu, kuma muna da sababbin shirye-shirye da kuma bayanan da za a iya amfani da su don tabbatar da bincike da kuma magani a asibiti; kuma ana yin nazarin hanyoyin bincike da magani.
Alal misali, rahoton bincike da bincike na COVID-19 da kwamitin kiwon lafiya na kasar Sin (http://www.nhc.gov.cn/) ya fitar, tsakanin 6 ga Janairu, 2020 da 3 ga Maris, 2020, ya fitar da nazarin guda shida da biyu da kuma wasu bayanai da aka gyara.
Yanzu labarinmu ya ƙunshi labarin Zhou et al., sun gabatar da kayan aikin bayar da shawarwari game da abin da suka koya a asibiti.
Wannan sabon abu ne da aka samu a cikin mujallarmu kuma yana nuna mana muhimmancin bayani game da annobar duniya.
Muna godiya ga Allah domin aikin da ya yi mana.
Amma kuma aikin yana bukatar a yi nazari a kan shi kamar yadda aka tsara a cikin rahoton COVID-19 (Currently available data) da kuma sabon tsarin ilimi.
A ranar 3 ga Maris, 2020, don gano mutum da ke da cutar, dole ne a haɗa da bayanan tarihin cutar da kuma jerin alamun bayyanar cututtuka don gudanar da duk gwajin, ko kuma dole ne a haɗa da alamun bayyanar cututtuka guda uku idan babu tarihin da ya dace:
Tarihin kamuwa da cutar: (1) tarihin tafiya ko rayuwa a cikin birnin Wuhan da kuma yankunan da suka fi jinkiri, da kuma al'ummomin da aka ruwaito cewa an kamu da COVID-19 a cikin kwanaki 14 na ƙarshe kafin bayyanar cututtuka; (2) tarihin rayuwa tare da mutanen da suka kamu da SARS-CoV-2 (tare da gwajin nucleic acid mai inganci); (3) tarihin rayuwa tare da marasa lafiya da suka nuna rashin ƙarfi ko alamun numfashi a birnin Wuhan da yankunan da suka fi jinkiri, ko al'ummomin da aka ruwaito cewa an kamu da COVID-19 a cikin kwanaki 14 na ƙarshe kafin bayyanar cututtuka; (4) tarihin rayuwa tare da marasa lafiya da alamun da aka sani (wanda ya ƙunshi 2 ko fiye da gida da kuma masu fama da cutar da kuma/ko kuma alamun cutar da suka kamu da cutar a cikin makonni 2 a cikin gidajen abinci, asibiti, aiki, wasu wuraren aiki).
Alamomin cutar sune: (1) rashin ƙarfi na jiki/ko kuma rashin numfashi; (2) alamun hoto na COVID-19; (3) yawan adadin jini da aka hana a baya, ragewa, ko kuma yawan adadin lymphocytes da suka ragu a farkon.
Dole ne a kammala gwajin da aka sani da kuma tabbatar da alamun cutar ko alamun bayyanar cututtuka kamar haka: (1) PCR da aka ɗauka yana dauke da kwayar cutar SARS-CoV-2; (2) dukkanin kwayoyin halitta na kwayar cutar suna nuna bambanci da yawa da sabon kwayar cutar coronavirus da aka sani; (3) akwai wani IgM mai maye gurbin da IgG mai maye gurbin da ke cikin SARS-CoV-2 a cikin gwajin gwajin jini; ko kuma wani canji a cikin tsarin immunity na IgG da ke cikin SARS-CoV-2 ba zai kasance ba, ko kuma ya ninka sau 4 a lokacin cin abinci fiye da lokacin da aka yi amfani da shi.
Za mu iya yin gwajin PCR na nucleic acid a cikin numfashi ko jini a cikin na biyu (18 ga Janairu, 2020) da na uku (22 ga Janairu, 2020).
An samu karuwar jini a cikin jini na jini na jini na jini na jini na hudu (27 ga Janairu, 2020) da na bakwai (8 ga Fabrairu, 2020); kuma an samu karuwar jini na jini na jini a na bakwai.
Wannan bincike mai zurfi ya danganta da aikin da masu bincike suka yi wajen gano kayan gwajin nucleic acid da suka fi dacewa don gwaji mai tsawo, da kuma binciken da aka yi a cikin iska da jini, ba tare da wani nau'i ba, kuma yana da tasiri mai kyau wanda ya zama mai amfani da shi a cikin hanyoyin da ba a sani ba.
Duk da haka, akwai ƙarin bayanai da ke nuna cewa muna bukatar mu yi hankali da marasa lafiya da ke nuna alamun cutar ko ba su nuna alamun cutar ba.
Har ila yau, dole ne a bincika yanayin Zhou et al., saboda an ƙidaya mutanen da ba su nuna alamun cutar a matsayin "mafi yawan kwanaki".
Dole ne a yi la'akari da tsarin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
A ƙarshe, muna fatan cewa alamu suna zuwa kuma suna ƙarfafa masu karatu su ba da ra'ayoyi.
Don bincika "masu dacewa" da "masu ƙwarewa", muna ba da shawarar gano da kuma bin sababbin ƙa'idodin ƙasashensu.
Ƙungiyarmu za ta ba ku sabon bayani game da hanyoyinmu na taimakawa.
Bangladesh ta ba da rahoton mutuwar mutane da yawa sakamakon COVID-19, NS
Kenya, Bangladesh ta ba da rahoton mutuwar sabbin mutane shida a Kenya sakamakon COVID-19 a cikin kwanaki.
Wannan shi ne babban adadin da ake samu a kowace rana saboda cutar.
Daga Kenya, Cibiyar Kula da Cututtuka da Ciwon Cutar Bangladesh (IEDCR) ta ba da rahoton adadin masu kamuwa da cutar da suka kai mutane 114 da suka kamu da cutar da kuma 33 da suka ci abinci a gida.
An ba da rahoton jimillar mutane 17.
A cikin wani rahoto na duniya, mai ba da shawara ga IEDCR, Dokta Meerjady Sabrina Flora, ta ce daga cikin wadanda suka mutu akwai maza hudu da mace guda.
A cewar Dr Meerjady, mutane biyu sun kai shekaru 60 a baya, biyu suna tsakanin shekaru 51 zuwa 60 kuma daya yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka kamu da cutar sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta bayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in kula da harkokin likitanci ya shaida wa hukumar Anadolu, wata kungiya ta ce daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, mai kula da hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke asibiti a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani bidiyo na duniya, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya bayyana cewa tashin hankalin jama'a zai kasance mafi girma fiye da yadda muka yi alkawarin, a ranar Asabar mai zuwa.
Wannan zanga-zangar ta fara ne a ranar 26 ga Maris kuma za ta ci gaba da kasancewa a ranar Asabar, 4 ga Afrilu.
Ba mu da kome, ko itace, ko abinci, ko tufafi, ko tufafi.
An fara samun rahoton kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, inda aka samu mutum biyu da suka dawo daga Italiya da wata mace a cikinsu.
A ranar 19 ga Maris, duk ukun suka ci abinci.
SARS-CoV-2 ya kai mutum miliyan daya a duniya.
A Alamisa, adadin mutanen da ke dauke da cutar SARS-CoV-2 a duniya ya kai miliyan daya, in ji rahoton Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu sakamakon COVID-19, cutar korona ta haifar.
Abin takaici ya faru a wannan rana kuma Malawi ta ba da rahoton farkon kamuwa da cutar coronavirus da kuma Zambia ta fara kamuwa da cutar coronavirus.
Koriya ta Arewa ta ce, Lamisa, tana daya daga cikin kasashen da ba su da cutar korona a duniya a yanzu.
A Kenya, Hukumar Lafiya ta Duniya ta ba da rahoton kamuwa da cutar 1,051,635, da kuma kamuwa da cutar 79,332 a cikin kwanaki 24 kafin karfe 10 na yamma na ranar 4 ga Afrilu, a lokacin tsakiyar Turai (0800 UTC).
A Amurka, an samu karin mutane 244 da suka kamu da cutar korona, kuma an samu mutuwar akalla 5,900.
Wani rahoto daga CBS ya ce, bisa ga binciken da Jami'ar Johns Hopkins ta yi, akwai fiye da 1,000 da suka mutu a ranar Laraba sakamakon cutar coronavirus a Amurka.
A dukan duniya, ƙasashe suna yin amfani da hanyoyin da ba su dace ba don magance cutar.
A Alamisa, Sergei Sobyanin, wani ɗan ƙasar Moscow, ya ƙara da'awar cewa zai iya fita daga gida a ranar 1 ga Mayu.
A duk fadin kasar, Shugaban kasar Vladimir Putin ya sanar da cewa Rasha za ta ci gaba da karbar kudaden shiga duk da cewa ta fara aiki a ranar 30 ga Afrilu.
Majalisar dokoki ta Portugal ta yanke shawarar tsawaita dokar ta baci ta kasa da kwanaki 15; an yi zaben ne da mutane 215 suka ce sun tafi, mutane 10 suka ce za su tafi, kuma wani ya ce bai tafi ba.
Saudiyya ta sake ba da dokar hana fita daga gidajen a garuruwan Makka da Madina a wannan ranar; a baya, dokar ta fara da sa'o'i 3 na safe da 6 na dare.
Thailand na da jadawalin tashi daga karfe 10 na dare zuwa karfe 4 na yamma.
Gwamnan Ohio, Mike DeWine, ya sanar da gwamnati cewa jihar ta sake gudanar da taron kan zama a gida a ranar 1 ga Mayu.
Kasuwancin Australiya ya rage yawan kuɗin da ake saya don gidaje.
A cikin Al'umma da Asawe, kamfanonin Woolworths da Coles na Australiya sun rage haɗarin sayar da takalma biyu da jaka guda a cikin gidajen kasuwanci a duk faɗin ƙasar.
Allah ya kuma yi wa alfarwa ɗaya a bisa dutsen.
Wadannan abubuwan sun bayyana a matsayin bayanai a cikin shafin yanar gizon Facebook na kamfanin.
Ana kuma ba da umarnin masu sayarwa su yi amfani da kayan aiki don kiyayewa saboda tsoron COVID-19 idan ana iya kiyaye mutane a gida.
A ranar Laraba, Woolworths ta kuma rage yawan sayar da kayan gida ta hanyar ba da kayan gida ga kowa ba.
Wannan hadarin ya biyo bayan hadarin da aka samu a kan jiragen hudu da Woolworths da Coles suka kai a ranar 4 da 5 ga watan Maris.
Coles, a cikin wata sanarwa a ranar 8 ga watan Maris, ya ce, haramcin cinikin kaya a kan fakiti hudu da ke akwai, "yawancin kasuwancin yanzu suna cinyewa a kan abinci guda", kuma ya yi kira ga wannan sanarwa a matsayin "ba daidai ba", yayin da Allah, a cikin wata sanarwa a Facebook a ranar Talata, ya kira shi "ba daidai ba".
Wani mai sayar da kayayyaki a Woolworths ya ce sayayya ta "ƙaru sosai" a makon da ya gabata.
Gidan Costco na Canberra ya kuma rage shi zuwa fakiti biyu a makon da ya gabata.
Don rage takunkumi, Coles ta karɓi kayan kwalliya daga masu sayen kayan kwalliya a Coles, Woolworths ta karɓi kayan kwalliya, kuma ALDI ta shirya don buɗe kayan don sayen ranar Laraba.
Russell Zimmerman, shugaban kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayarwa sun yi kokari su kara yawan farashin kayayyaki, amma an hana su daga dokar hana kayayyaki ta gida.
Ya yi tsammanin zai ƙara yawan kuɗin da za a kashe don a sami waɗanda ba su yi ba, kuma ba su da sauran abubuwa.
A ranar Talata, ALDI ta sanar da cewa saboda matsalolin samar da kayayyaki, wasu kamfanoni ba za su yi abin da aka ce ba a ranar Laraba.
A cikin rahoton News.com.au, Dr Gary Mortimer, mai ba da shawara kan sayayya a Jami'ar Fasaha ta Queensland, ya ce kamfanoni suna yin aiki dare da rana.
Ya lura cewa karamin gidan kayan aiki ne mai saukin ganewa, wanda ke rage yawan kayan aiki a cikin shagon, kuma, idan an gama sayarwa, yana barin gidan da ba shi da kayan aiki, wanda ke ƙara tunanin cewa ba shi da kayan aiki.
Cooes da Woolworths sun yi tunanin [cewa] idan akwai abubuwa masu yawa a cikin shagon, idan abubuwa kamar karamin mota da kayan wankewa za su iya [sake] zama masu ban tsoro, za ku yi tsammanin za a yi musu ba'a, Russell Zimmerman ya gaya wa ABC News.
Wani mai wallafa jaridar Who Gives a Crap ya sanar da cewa duk ayyukan su sun ƙare a ranar Laraba.
Kimberly-Clark, mai samar da Kleenex Toilet Tissue, da kuma Solaris Paper mai samar da Sorbent, sun ce suna aiki 24/7 don samun kayan aiki, a cikin rahoton News.com.au.
Domain.com, wani dandalin sayar da gidaje da kuma rarrabawa, ya ba da sanarwar cewa masu sayen gidaje suna ba da kyauta ga masu sayarwa a Melbourne, a lokacin da ba su da yawa don masu sayarwa ba su da lokaci mai yawa a lokacin hutu na ranar Alkawari.
Alamisa NT News ta wallafa wani labari a Darwin, da kuma wasu wasiƙu guda uku da aka kawo don ziyarar gidan.
Kasuwanci suna cikin rashin tsaro don yin watsi da takunkumi, a cikin rahoton ABC Australia a ranar 3 ga Maris wanda ya ce ba su da wata hanyar hana mutane yin amfani da kayan aiki.
Russell Zimmerman ya kara da cewa mutane suna amfani da wasu abubuwa masu kyau, kamar su na'urori, kayan wanke hannu, kayan aiki, kayan wanke hannu, da kuma kayan aiki.
Amma, a waje da Australia, a Almaty da dare wani kantin sayar da Ocado na Birtaniya ya gano cewa sayen takalma na Andres ya ragu zuwa fakiti 12.
Hukumar Lafiya ta Duniya ta bayyana cewa COVID-19 cuta ce ta duniya.
A cikin wata sanarwa, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa cutar COVID-19, wanda cutar SARS-CoV-2 ta haifar, ta zama cutar ta duniya.
Ko da yake kalmar "halin duniya" tana nufin yadda cutar ta yadu a cikin ƙasa, ba don ta yadu a wani wuri ba, WHO ta bayyana amfanin sanar da gwamnatoci game da yadda cutar ta yadu a wani wuri, WHO ta bayyana bukatar gwamnatoci su yi aiki:
Kowa zai iya canja yanayin duniya.
Idan ƙasashe sun gano, magance, magance, magance, magance, kuma su sanar da al'ummarsu game da amsa, in ji Tedros Adhanom Ghebreyesus, Babban Jami'in WHO.
Muna fama da gurɓataccen yanayi da kuma rashin amfani da mutane.
A cewar Dr. Tom Frieden, tsohon mai ba da shawara ga Hukumar Kula da Cututtuka ta Amurka, cutar ba ta da wani abu.
Ya ce, a cikin rahoton CNN na watan Fabrairu, bayan wasu hare-haren, ba a gano wani cutar ta numfashi ba daga gaggawa a cikin ci gaba da yaduwar cutar a kasar".
Ghebreyesus ya yi magana a cikin wannan hanyar, yana cewa, "ba za mu taɓa magance cutar coronavirus ba".
Ya ci gaba da cewa, "ba za mu taɓa magance wata cuta ta duniya da za mu iya warkarwa a lokaci ɗaya ba".
Wani sabon labari game da annobar duniya ya biyo bayan sanarwar WHO a watan Janairu cewa annobar ta zama gaggawa ga lafiyar duniya.
Wani mai bincike a Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasar Amirka, Dokta Anthony Fauci, ya ce, "ba laifi ba ne a yi gaskiya".
Daga wannan rahoton, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya kashe mutane 4,600.
Cutar korona ta 2019-20 ita ce cutar ta duniya ta 2019 (COVID-19), wadda ta samo asali ne daga cutar huhu mai cutar Coronavirus 2 (SARS-CoV-2).
Cutar ta faru a Wuhan, China, a watan Disamba na shekarar 2019, a matsayin dokar ta baci ta kiwon lafiya ta kasa da kasa a ranar 30 ga Janairu, 2020, kuma a matsayin annobar duniya a ranar 11 ga Maris, 2020.
Tun daga ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, kuma an kashe mutane 97,000.
Waɗanda suka ci kuwa dubu ɗari uku da dubu talatin da huɗu ne.
Yawan mutuwar ya kai kashi 4% a kasar Sin, amma yana tsakanin 13.04 a Algeria da 0.08 a New Zealand.
Abubuwan da aka fi sani da cutar su ne rashin ƙarfi na jiki, na hanji da na numfashi.
Abubuwan da ke faruwa a cikin jiki na iya zama pneumonia da kuma numfashi.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka na farko yana da kwanaki bakwai, amma yana tsakanin kwana bakwai zuwa goma sha huɗu.
Babu magani ko magani da zai iya kashe wannan kwayar cutar da aka sani.
Maganin farko ya ƙunshi bayyanar cututtuka da kuma rashin bayyanar cututtuka. Hanyoyi masu taimako don hana cutar su ne wanke hannu, rufe baki yayin da kake yin amfani da shi, yin jima'i da wasu, hanawa da kuma ware mutane daga waɗanda suke ganin cewa suna da cutar.
Gwamnatoci a duk faɗin duniya sun amsa ta hanyar hana zirga-zirga, hana mutane shiga, hana mutane fita daga gida, hana wuraren aiki, da kuma rufe wuraren aiki.
Wannan cuta ta duniya ta shafi rayuwar jama'a da dukiyar mutane, rashin adalci ko rashin adalci, cin hanci da rashawa, siyasa da wasanni, da kuma rashin abinci mai gina jiki da ake yi wa mutane duk saboda tsoron wasu mutane su kawo karshen shi.
Makarantu da jami'o'i suna buɗewa a ko'ina cikin ƙasar ko kuma a cikin ƙasashe 193, wanda ke shafar kashi 99.4 cikin ɗari na ɗaliban duniya.
Rahotanni game da cutar sun bazu a duniya, kuma sun haifar da matsaloli masu yawa da suka shafi cutar ko kuma cutar da aka yi wa Sinawa, wasu mutanen Gabas da kuma wasu da suka shiga cikin kudu maso gabashin Asiya, da kuma wasu daga yankunan da cutar ta kamu da su.
Saboda raguwar zirga-zirga da kuma rufe masana'antu, an rage yawan iska da kuma carbon dioxide.
Jami'an kiwon lafiya a Wuhan, China (birnin farko na lardin Hubei) sun ba da rahoton wani samfurin kamuwa da cutar pneumonia a ranar 31 ga Disamba, 2019, kuma an fara wani bincike a farkon watan Janairu, 2020.
Yawancin cututtuka suna faruwa ne a cikin kasuwar sayar da kayan teku ta Huanan kuma ana tsammanin cewa kwayar cutar ta samo asali ne daga dabbobi.
Wannan kwayar cutar ta haifar da kamuwa da cutar SARS-CoV-2, sabon kwayar cutar da aka gano ta shafi kwayar cutar korona, cutar coronavirus, da SARS-CoV. An fara gano mutum da ya nuna alamun cutar a ranar 1 ga Disamba, 2019, kuma mutum zai kasance cikin mummunan lalacewar dabbobi da idanu.
A cikin samfurin farko na marasa lafiya da aka ruwaito a watan Disamba na 2019, an gano kashi biyu cikin uku na waɗanda suka ɓace.
A ranar 13 ga Maris, 2020, wani rahoto da muka samu a cikin jaridar South China Morning Post ya ce akwai wani sabon kamuwa da cutar da ya faru a ranar 17 ga Nuwamba, 2019, wani mutum mai shekaru 55 a lardin Hubei, wanda zai iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabon kamuwa da cutar ya ragu a China amma ya ragu a Italiya, Iran, da Koriya ta Kudu, adadin kamuwa da cutar a wajen kasar Sin ya fi na farko a kasar Sin.
Akwai wasu bayanai da ba za a iya ba da su ba, musamman ma a tsakanin waɗanda ke da alamun cutar.
A ranar 26 ga watan Fabrairu, an samu rahoton mutuwar mutane a cikin masu kula da lafiya, masu shekaru 19 da haihuwa, wanda ya kai kashi 2.4% na yawan cututtuka a duniya. Babban jami'in ilimin kimiyyar kasar Ingila, Patrick Vallance, ya yi imanin cewa kashi 60% na al'ummar kasar Ingila dole ne su kamu da cutar kafin a samu cikakken tsaro a cikin al'umma.
Masu kamuwa da cutar sun hada da yawan mutanen da aka gwada suna dauke da COVID-19, kuma waɗanda aka gwada ba su da wani abu kamar yadda aka lissafa a cikin takardun gwamnati.
A ranar 23 ga watan Maris, babu wata ƙasa da ta shafi fiye da kashi 3 cikin 100 na yawanta, kuma ƙasashe sun sami manufofin gwamnati ta hanyar kula da waɗanda ke da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
A ranar 16 ga watan Maris, an gano a kasar Sin cewa, a ranar 23 ga watan Janairu, kashi 86 cikin dari na masu kamuwa da cutar za su iya samun COVID-19, kuma kashi 79 cikin dari na masu kamuwa da cutar za su iya samun cutar.
Wani bincike da aka fitar a ranar 30 ga watan Maris ya nuna cewa yawan masu kamuwa da cutar a Italiya ya fi na al'umma.
A farkon binciken, yawan mutuwar farko (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike daga Cibiyar Kula da Cututtuka ta ce zai iya kaiwa 5.7.
Yawancin mutanen da ke da cutar COVID-19 suna cin abinci.
A cikin masu cin abinci, lokacin bayyanar cututtukan na farko ya kasance tsakanin kwanaki 6 zuwa 41, kuma yawanci kwanaki 14.
Tun daga ranar 10 ga Afrilu, 2020, kusan mutuwar 97,000 ne aka yi wa COVID-19.
A kasar Sin, tun daga ranar 5 ga watan Fabrairu, kashi 80% na mutuwar ta shafi mutanen da suka kai shekara shida, kuma kashi 75% na waɗanda ke fama da wasu cututtuka kamar cututtukan zuciya da ciwon sukari. Rahotanni na gwamnati game da mutuwar COVID-19 sun fi dacewa da waɗanda suka mutu daga COVID a matsayin waɗanda aka lissafa a cikin rahoton gwamnati.
Yawan mutuwar COVID-19 zai iya zama ƙasa, kamar yadda ba za a iya lissafa waɗanda suka mutu ba tare da gwaji ba, kamar, a gida, asibitoci, da sauransu.
Rahotanni na kasar Italiya sun gano cewa yawan mutuwar da ke faruwa a duniya ya ninka adadin mutuwar COVID-19 sau 4-5.
Wani mai magana da yawun Hukumar Kula da Cututtuka ta Amurka (CDC) ya lura cewa "mun san cewa [sadarwar sanannen mutuwar] tana raguwa", kuma wasu rahotanni sun bayyana cewa a Amurka akwai raguwa a lokacin annobar, kamar annobar H1N1 a shekarar 2009.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen birnin China, an yi fiye da mutuwar mutum 12 a duk kasar Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga watan Maris, fiye da kasashe hudu da yankuna sun ba da sanarwar cewa za a yi wani taro na kasa a Antarctica.
Wadannan kididdigar sun bambanta da wuri da lokaci, da kuma yawan gwaje-gwaje, darajar asibiti, tsarin magani, lokaci daga farkon kamuwa da cutar, da kuma bambance-bambance tsakanin al'umma kamar shekaru, rashin lafiya, da lafiyar jiki.
Idan muka yi la'akari da kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutum a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Yawan ya bambanta da wuri.
A kasar Sin, yawan mutuwar marasa lafiya ya ragu daga kashi 17.3% (na wadanda alamun cutar suka fara daga 1-10 ga Janairu 2020) zuwa kashi 0.07% (na wadanda alamun cutar suka fara bayan 1 ga Fabrairu 2020). Wasu ƙididdiga suna nuna yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gwada sun ƙare, wanda ya mutu saboda wani cutar da kuma yawan mutuwa (IFR), wanda ke nuna yawan mutanen da ke da cutar (wanda zai iya zama) da suka mutu saboda wani cutar.
Wadannan kididdigar suna faruwa ne a kan lokaci kuma ana bin su ta hanyar maganin cutar.
Yawancin malaman kimiyya sun yi ƙoƙarin rubuta waɗannan ƙididdigar a cikin al'umma mai ilimi.
Cibiyar Nazarin Kimiyya ta Jami'ar Oxford ta gano cewa yawan mutuwar mutane daga cututtukan duniya a duniya ya kasance tsakanin 0.1% da 0.39%.
Wannan lissafin ya dace da sakamakon gwajin COVID-19 na farko a Jamus, kuma binciken ya yi la'akari da tsarin gwajin CFR.
WHO ta ce za a iya dakatar da cutar a kasar.
A ƙarshe, za a iya gano waɗanda suka kamu da cutar ba tare da yin amfani da takarda ba kuma za a iya canza su daga wuri zuwa wuri.
Maciej Boni a Jami'ar Jihar Pen ya ce, dole ne a sake yin nazari, cutar ta riga ta tsere, kuma za ta ragu idan cutar ta ƙare da kuma sakamakon da ta samu.
Amma ba za a iya yin wani shiri daga yanzu ba".
Babban jami'in kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya ce "za a iya kawo karshen cutar Zwing" idan dukkan kasashen duniya suka yi aiki tare don bin ka'idodin WHO game da matakan hana yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Lafiya da Lafiya ta Tropical ta London ya bayyana cewa SARS-CoV-2 "zai yi tsanani, ya mutu cikin shekaru biyu ko biyu".
A cewar wani binciken da aka gudanar a Kwalejin Imperial wanda Neil Ferguson ya gudanar, ana haifan 'yan uwa da wasu hanyoyin "a lokacin da ake samun rigakafin (wannan yana da watanni 18 ko fiye)".
William Schaffner a Jami'ar Vanderbilt ya ce, "Ina tsammanin cewa cutar korona, saboda za ta iya samun wannan ci gaba, ba za ta iya zama irin wannan ba kuma za ta iya zama irin wannan cutar ta lokaci, kuma za ta iya zama shekara-shekara.
Ƙarfin da kwayar ke samu zai dogara ne akan yadda jikin mutum yake iya yin amfani da kwayar cutar don canzawa.
Alamun COVID-19 na iya kasancewa a cikin wannan yanayin ne kawai kuma mutanen da suka kamu da cutar ba za su iya nuna alamun cutar ba.
Abubuwan da suka fi kowa a cikin bayyanar cututtuka sune rashi (88%) da kuma ciwon hanci (68%).
Alamomin da ba su da yawa sun haɗa da rashin ƙarfi, ɓarna, rashin ƙarfi, numfashi, ciwo, ciwo da ciwo, ciwon zuciya, ciwon hanci, sanyi, jini a cikin jijiyoyi, haushi, ko kuma rashin kulawa. WHO ta ce kusan mutum ɗaya cikin bakwai yana da ciwon hanci da kuma rashin jin daɗin numfashi.
Hukumar Kula da Cututtuka ta Amurka (CDC) ta lissafa alamun cututtuka kamar tashin hankali da numfashi, ciwon zuciya da ke biyo baya ko kuma ciwon zuciya, jiyya, damuwa da kuma nuna bambanci, fuska da baki; dole ne a kula da masu kula da lafiya idan akwai alamun cutar. Har ila yau, cutar na iya haifar da cutar pneumonia, ciwon huhu, sepsis, septic shock da mutuwa.
Masu rarrabewa a cikin masu cutar ba za su iya nuna alamun cutar ba tare da bayanan gwaji na musamman ba, kuma masu bincike sun ba da shawarar cewa waɗanda ke da yanayin da ya dace da marasa lafiya dole ne a kula da su kuma a bincika su don gano cutar.
Kasar Sin ta yi hasashen cewa yawan mutanen da ke fama da cututtuka na cutar ya tashi daga kashi 44 zuwa kashi 100.
Lokacin da aka fi sani da shan magani (lokaci tsakanin kamuwa da cutar da farkon kamuwa da ita) yana gudana daga kwana 14 zuwa 14; yawanci kwana bakwai. A cewar wani sanannen sanarwa, yawan mutanen da ke dauke da COVID-19 da ba su da cutar zai ragu da kashi 30% a farkon, kuma ya ragu zuwa 15% a baya.
Wasu rahotanni game da yadda cutar ta yadu sun riga sun bayyana.
Wannan cuta tana kama da yaduwar farko ta hanyar haɗuwa da ƙwayoyin cuta da ke fitowa daga magana, magana, ko magana; kuma haɗuwa tana kama da mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya nuna cewa jirgin sama mai zurfi zai iya yin yawo a tsawon mita 4.5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu sun ce za a iya watsa kwayar ta ta hanyar ƙananan ƙwayoyin cuta da ke cikin iska, wanda za a iya halaka a lokacin rayuwa. Ƙwayoyin cuta da ke fitowa daga numfashi za su iya halaka a lokacin iska ta waje, kamar ƙwayoyin cuta, ko da kuwa iska ba ta iya halaka cutar ba.
"Amma da yake za su shiga cikin bakinsu, ko kuma a cikin haƙoran mutane, za su shiga cikin ƙura.
Wasu cututtuka na jiki kamar su cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktukan cututtukan cututtukan cututtuktukan cututtukan cututtuktukan cututtuktuktuktukan cututtuktuktukan cututtukan cutut
Za a iya kai ga wani mutum da ke da wannan ƙashin, kamar garken, inda ƙashin ya buɗe idonsa, ko bakinsa, ko kuma bakinsa.
A lokacin wahala za ta zo da sauri, amma ba za ta daɗe ba.
Gwamnatin kasar Sin ta yi watsi da yarda da yiwuwar watsa SARS-CoV-2 daga bakin. Kwayar cutar ta fi muni a farkon kwanaki uku bayan bayyanar cututtuka, ko da yake ana iya samun yaduwar kafin bayyanar cututtuka da kuma a ƙarshen cutar.
Mutanen da aka gwada sun kamu da cutar kwana uku kafin bayyanar cututtuka ta fara wanda ke nufin cewa za su iya warkewa kafin wasu bayyanar cututtuka su fara.
Kadan ne kawai marasa lafiya da aka gano a cikin lab sun nuna alamun bayyanar cututtuka a cikin takardun su, amma ana iya gano rashin bayyanar cututtuka a wasu ƙasashe ta hanyar bincike.
Hukumar Kula da Cututtuka ta Turai (ECDC) ta ce idan har an yi amfani da wani abu don gano yadda cutar ke yaduwa, mutum ɗaya zai iya kamuwa da mutane biyu ko uku.
A mafi yawan lokuta, ana iya gano cutar a cikin kwanaki uku a kan katako (polypropylene) da kuma 304 na roba, a rana ɗaya a kan takarda, da kuma a cikin kwanaki hudu a kan tagulla.
Wannan, duk da haka, ya bambanta dangane da yawan kiwo da kuma yawan kiwo. Wasu dabbobi na gida da na daji suna dauke da COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya kamuwa da cutar a cikin gida, ko da yake hukumomin Birtaniya sun ba da shawarar kada a yi amfani da dabbobi don yin amfani da dabbobi, kamar yadda idan ka taɓa wani dabba da cutar ta shafa.
Cutar huhu ta Coronavirus 2 (SARS-CoV-2) ita ce sabuwar cuta, wadda aka fara ganowa a cikin mutane uku da cutar huhu da kuma wani samfurin cutar huhu mai tsanani a Wuhan.
Sabbin cututtukan SARS-CoV-2 sun bazu a cikin kwayar cutar a cikin daji. A waje da jikin mutum, sabulu ya kashe kwayar, wanda ke rufe shi da ƙuƙwalwa. SARS-CoV-2 ya yi kama da SARS-CoV na farko.
An yi zaton dabbobi ne suka samo asali.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta kamu da cutar ta Betacoronavirus, a cikin ƙananan rukuni na Sarbecovirus (B) da kuma ƙwayoyin cuta da suka fito daga tsuntsaye biyu.
Yana da kashi 96% na kwayoyin halitta da kuma wasu kwayoyin cuta (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci na amino acid guda daya a tsakanin kwayoyin halitta na mutum da na mutum.
A yanzu haka, an gano kusan kashi 92% na kwayoyin halitta da aka rarraba tsakanin coronavirus pandolin da SARS-CoV-2, wanda ke da mahimmanci wajen nuna cewa waɗannan pandolines sune cibiyar tsaro.
Ana iya gano cutar ta hanyar bayyanar cututtuka, ko da yake ganowa ya kamata a yi ta hanyar nazarin polymerase chain reaction (rRT-PCR) na maganin.
Wani bincike da aka yi a Wuhan wanda ya yi gwajin PCR da CT ya nuna cewa CT ya fi ƙarfin PCR, ko da yake ya fi ƙasa, kuma yawancin alamun hoto sun shafi cututtukan cutar huhu da cututtuka.
Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ce "Kwatancin CT na uku za a yi domin gudanar da bincike ko kuma gudanar da bincike na farko na COVID-19".
Hukumar ta WHO ta fitar da wasu bayanan gwajin RNA na SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga watan Janairu.
Wannan gwajin yana aiki ne tare da nazarin polymerase chain reaction (rRT-PCR) a baya.
Wannan cutar za ta iya faruwa a cikin jini da kuma numfashi.
Alamu suna fitowa ne a cikin ƙananan kwayoyi a kowace rana.
Ana yin gwajin ne a cikin dabbobi ko kuma a cikin fata. Yawancin cibiyoyin bincike da dakunan halitta suna gwagwarmaya don samar da kayan aikin gwajin jini, wanda ke tabbatar da lafiyar jiki.
Tun daga ranar 6 ga Afrilu, 2020, babu wani daga cikinsu da ya tabbatar da cewa zai iya amfani da shi a duniya.
A Amurka, Cellex ta kirkiro tsarin gwajin jini wanda aka amince da shi don amfani a cikin dakunan gwaje-gwaje masu inganci kawai.
Bayanan hoto na rediyo da kuma na CT na mutane masu nuna alamun sun haɗa da yin aiki a cikin duhu da kuma ba tare da ruwa mai yawa a cikin iska ba.
Ƙungiyar Radiological ta Italiya tana tattara bayanai daga ƙasashe daban-daban game da yadda za a nuna hotunan marasa lafiya da suka san suna da cutar.
Saboda wasu cututtuka kamar adenovirus, hotunan da ba a gano ta PCR ba suna da iyaka wajen gano COVID-19.
Wani bincike a kasar Sin ya gwada CT na kwakwalwa da PCR kuma ya nuna cewa ko da yake yana da matukar damuwa, yana da sauri kuma yana da tasiri sosai, wanda ya nuna cewa yana da amfani a matsayin kayan bincike a wuraren cutar.
An tsara siginan sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina na sigina.
Hanyoyi na hana kamuwa da cutar sun hada da yin amfani da kayan shafa, wanke hannu, hana taɓa idanu, hanci, ko baki da kuma hannayen da suka lalace, da kuma yin amfani da su a cikin tufafi da kuma ba da su a cikin wasu kayan shafawa.
Ana ba da shawarar cewa waɗanda za su iya kamuwa da cutar su sa suturar rufe fuskar mai binciken a cikin jama'a.
Ana kuma ba da shawarar yin amfani da tsarin haihuwa da kuma al'umma don hana kamuwa da cuta. Gwamnatoci sun rage ko kuma sun ba da shawarar dakatar da zirga-zirga zuwa ko daga ƙasashe da yankunan da cutar ta shafa.
Amma, cutar ta kai ga yaduwar al'umma a wasu sassan duniya.
Kamar yadda ake cewa kwayar ta yadu a cikin al'umma, da kuma yadda wasu 'yan al'umma ke kula da yadda za su kamu da cutar. Ana ba da shawarar cewa likitocin da ke kula da wanda zai iya kamuwa da cutar su yi amfani da hanyoyin da za su iya ganowa, su yi amfani da hanyar da za a iya gani, da kuma rufe idanu.
Taron da aka yi na wayar tarho da gwamnatoci a kan wannan batu ya shafi batun amincewa da mutane, ciki har da Amnesty International da kuma wasu fiye da 100.
Akwai aikace-aikacen wayar hannu da yawa da ke samuwa ko kuma za a iya amfani da su don amfani da kai, kuma tun daga ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi goma sha biyu na masu amfani suna aiki akan tsarin da aka zaɓa da kai, kamar Bluetooth don shigar da oda tare da wasu mutane da kuma wayoyin hannu.
Masu amfani suna riƙe da saƙo idan suna tare da wani wanda aka ɗauka yana da COVID-19. Wasu bayanai masu sauri game da yadda za a hana kamuwa da cutar; misali, wanke shanu da wanke fata da ruwa mai wanke ba su da amfani.
Babu allurar rigakafin COVID-19, ko da yake yawancin ƙasashe suna aiki kan bayyanar.
Addu'o'in hannu suna taimakawa wajen hana yaduwar cutar.
CDC ta ba da shawarar cewa jama'a su wanke hannayensu da sabulu da ruwa na akalla dakika ashirin, musamman bayan sun yi tafiya a cikin gida ko kuma idan hannuwansu ba su da tsabta; kafin su yi wanka; da kuma bayan sun yi wanka, suna shan giya, ko kuma suna yin wanka.
Domin a waje da jikin mutum, sabulu yana kashe ƙwayoyin cuta, yana rufe jikin mutum.
CDC ta kuma bada shawarar yin amfani da ruwa don wanke hannu tare da akalla 60% barasa idan sabulu da ruwa suna cikin yankin.
WHO ta ba da shawarar jama'a su yi amfani da waɗannan uku don su taɓa idanu, hakora, baki da kuma hannayen da ba su da tsabta.
Ana iya yin amfani da wasu hanyoyi (a cikin minti daya idan an yi amfani da kayan a cikin abincin abinci), kamar 62-72% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Wasu abubuwa kamar benzalkonium chloride da chrohexidine gluconate, ba su da ƙarfi sosai.
Hukumar ta CDC ta ba da shawarar cewa idan wani ya kamu da COVID ko kuma ya kamu da cutar a wani wuri kamar motar aiki ko asibiti, duk wuraren da ke aiki, wuraren liyafa, wuraren cin abinci, wuraren da ake rarraba umarni, wuraren da ake kira da waya, wuraren da ake rubuta umarni, telecommutes, da kuma wuraren ATM da mai haƙuri ke amfani da su ya kamata a tsabtace su.
Hukumomin lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hakora da hannu ko da takalma a lokacin da suke wanke ko kuma suna wanke su, kuma su wanke duk wani irin takalma.
Ana ba da shawarar yin amfani da masks don rufe bakunan mutane da suka kamu da cutar, saboda yin amfani da masks zai iya rage yawan hawan jiki da kuma rashin lafiya idan muna yin magana, magana, motsa jiki, ko kuma motsa jiki.
Hukumar ta WHO ta fitar da bayanai game da yadda za a saka abin rufe fuska.
A cewar Stephen Griffin, wani masanin binciken cutar a Jami'ar Leeds, "sa kayan rufe fuska na iya rage yawan mutane su taba fuskarsu, wanda shine farkon hanyar kamuwa da cutar ba tare da yin amfani da su ba". Ana kuma ba da shawarar yin amfani da kayan rufe fuska ga masu kula da waɗanda za su iya kamuwa da cutar.
Hukumar ta WHO ta haramta sanya rigar rufe fuska ga mutanen da ba su da cutar idan sun kamu da cutar, kamar waɗanda ke kula da wani wanda ke da COVID-19, ko da yake sun san cewa sanya rigar zai iya hana mutane yin amfani da rigar rufe fuska.
Al'ummai da yawa sun soma yin amfani da sutura don rufe fuskokin mutane.
A Amurka, CDC ta ba da shawarar yin amfani da sutura mai tsabta da aka yi da tufafi. China ta haramta yin amfani da sutura masu tsabta da aka ba da su daga baya ta hanyar mutane marasa lafiya, idan sun kusanci (ƙafa 1 (ƙafa 3) ko kuma sun isa) wasu mutane.
An bada shawarar cewa a Hong Kong a saka sutura don rufe fuskar mai binciken a lokacin da yake cikin mota tare da wasu mutane ko a cikin ofisoshin jama'a.
Hukumomin Thailand na ba da shawarar mutane su sanya rigar rufe fuska a gidajensu kuma suna yaki da duk abin da ya faru.
Jamhuriyar Czech da Slovakia sun hana fita ba tare da yin sutura ba ko kuma rufe bakinsu.
A ranar 16 ga watan Maris, Vietnam ta hana kowa saka rigar rufe fuska yayin da yake tafiya a cikin jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga shagon sayar da kayan da aka saka a rufe fuska ya yi laifi.
Sai dukan mutanen Isra'ila suka yi ta rufe fuskokinsu da sutura.
Taiwan, wadda ke yin sutura na fuska na miliyoyin da suka fito a tsakiyar watan Maris, ta ba da umarnin cewa masu amfani da motoci da ke tafiya a birane su saka sutura ta fuska a ranar 1 ga Afrilu.
Panama ta ba da umarnin yin amfani da suturar rufe fuska a lokacin da kake fita, kuma ta ba da umarnin yin suturar rufe fuska a gida ga waɗanda ba za su iya sayan suturar rufe fuska ba.
Ana amfani da kayan rufewa a Zapong, Koriya ta Kudu, Malaysia, da Singapore.
Yin amfani da jama'a (wanda kuma ake kira yin amfani da jiki) yana nufin yin amfani da maganin cututtuka don rage yaduwar cutar ta hanyar yin amfani da mutane.
Hanyoyi sun haɗa da yin rajista; hana zirga-zirga; da kuma rufe makarantu, ofisoshi, gidajen wasan kwaikwayo, gidajen wasan kwaikwayo, ko wuraren cin kasuwa.
Mutane za su iya yin amfani da hanyoyin da ake amfani da su wajen yin zaman lafiya ta wajen kasancewa a gida, rage yawan zirga-zirga, yin tafiya a wurare masu yawa, yin amfani da hannayen hannu ba tare da taɓa hannu ba, da kuma yin amfani da jiki ko a'a.
Gwamnatoci da dama sun yi kira ko kuma sun ba da shawarar yin taro tsakanin al'umma a wuraren da cutar ta shafa.
Yawan mutanen da za su iya shiga cikin wani taro da hukumomin gwamnati da na kiwon lafiya na Amurka suka gabatar ya ragu daga 250 (idan ba a samu yaduwar COVID-19) zuwa 50 ba, daga bisani zuwa 10 ba.
Bayan 22 ga Maris, 2020, Jamus ta haramta yin jima'i da mutane fiye da biyu. Mutanen da suka wuce shekaru biyu da haihuwa da waɗanda ke fama da wasu cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, rashin jini da kuma rashin ƙarfi, da rashin ƙarfi na tsarin rigakafi suna da damar kamuwa da cutar da kuma matsalolin da CDC ke ba da shawarar kasancewa a gida kamar yadda suka iya a wuraren watsa labaran jama'a. A ƙarshen Maris, 2020, WHO da sauran likitocin lafiya sun yanke shawarar canza "raunin jama'a" da "raunin lafiya", don tabbatar da cewa suna da irin wannan yanayin don rage rashin lafiyar jiki ta hanyar mutum, ta hanyar umarni ko kuma ta hanyar haɗuwa da abinci.
Kalmar "jama'a" ta sa mutane su kasance da bambanci a cikin ra'ayinsu, game da ƙarfafa su su kasance tare da wasu mutane ta wasu hanyoyi. Wasu gwamnatoci sun gabatar da wasu hanyoyin kiwon lafiya a cikin gidaje a lokacin annobar.
Wannan ya haɗa da rashin jin daɗin zama tare da abokin tarayya, wanda ba shi da cutar ko alamun cutar.
Ana ba da shawarar yin nesa da kai ga mutanen da ke da cutar COVID-19 da waɗanda suke da tabbacin cewa sun kamu da cutar.
Hukumomin kiwon lafiya sun ba da rahoton yin zaman lafiya na sirri. Gwamnatoci sun yi ko kuma sun yi watsi da zaman lafiya na sirri ga jama'a da ke cikin wuraren da cutar ta shafa.
An samu rahotanni game da zaman lafiya na mutum don kungiyoyin da ke da damar yin amfani da lokaci.
Wadanda suka kasance a cikin dangantaka da wani wanda ya kamu da COVID-19 da kuma waɗanda suka yi tafiya na dogon lokaci a cikin ƙasa ko yankin da cutar ta yadu, dole ne su yi hutu na tsawon kwanaki 14 daga lokacin da suka kasance a cikin yanayin cutar.
Hanyoyi na hana cutar su ne su daina ko su daina, kuma su rage su.
Kasancewa da rashin lafiya a farkon cutar yana nufin gano waɗanda ke da cutar da kuma samar da wasu hanyoyin hana cutar da alluran rigakafi don hana cutar yadawa ga sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, dole ne a koma ga matakin ragewa: dole ne a yi amfani da matakan da za a rage yaduwar da kuma rage tasirinsa a fannin kiwon lafiya da zamantakewa.
Ana iya haɗa hanyoyin dakatar da raguwa biyu a lokaci guda.
Hanyar da za a iya amfani da ita ta zama mafi mahimmanci don magance cutar ta duniya ta hanyar rage yawan rashin lafiyar ta hanyar 1%. Wani tsari na cutar da ke da cutar ta musamman ya ƙunshi rage yawan cutar, wanda aka sani da cututtukan cututtuka.
Wannan yana rage yawan masu aikin likita da kuma ba su lokaci mai tsawo don samun allurar rigakafi da magani.
Abubuwan da za a iya yi wa masu kula da lafiya da za su iya magance cutar sun haɗa da matakan kariya, kamar wanke hannu, saka sutura, da kuma guje wa cutar; hanyoyin da jama'a za su iya amfani da su don hana su rufe makarantu da kuma hana jama'a zuwa wurin; ƙarfafa jama'a su yarda da yin amfani da su; da kuma hanyoyin da za su iya hana mu daga cutar kamar tsabtace gidaje. Wasu ayyuka masu tsanani da suka shafi hana yaduwar cutar sun kasance a kasar Sin a lokacin da cutar ta faru, kamar su hana birane yin amfani da su da kuma hana jiragen sama.
Wasu ƙasashe sun ɗauki wasu matakai don rage yaduwar cutar a cikin birane.
Koriya ta Kudu ta gabatar da bincike na jama'a da kuma fitar da mutane daga cikin gidajen da ba a yarda da su ba, kuma ta kafa matakan hana mutane samun cutar.
Singapore ta ba da kuɗi don taimakawa waɗanda suka kamu da cutar da kuma waɗanda suka yi wa kansu rauni kuma ta ba da kyauta ga waɗanda suka yi hakan da yawa.
Taiwan ta ci gaba da samar da rigakafin fuska da kuma hana kayan kiwon lafiya. Wani bincike na Birtaniya da Amurka ya nuna cewa rage (ba tare da hana cutar ta yaduwa ba) da kuma ganewa (saurin kamuwa da cutar) suna da matukar tasiri.
Ka'idojin rage yawan shan magani na iya rage yawan mutuwar masu amfani da magani da kashi biyu bisa uku, amma duk da haka dubban mutane suna shan miyagun ƙwayoyi da yawa.
Dole ne a yi gargadin cewa cutar ta riga ta bayyana a cikin jama'a (ko kuma a gano rigakafin, idan an fara fitar da ita), domin cutar ta koma ƙasa.
Yin amfani da tsarin magance cutar yana haifar da rashin kuɗi a cikin al'umma da kuma a cikin ƙasa.
Babu wani magani da aka sani da kuma maganin da zai iya kashe cutar COVID-19, amma akwai wasu hanyoyin da za a iya amfani da su, wanda ya haɗa da gwajin magani da aka kammala.
Shan miyagun ƙwayoyi, shan giya, da kuma hutawa na iya rage alamun cutar.
Idan ana so a gano cutar, za a iya yin maganin ruwa, magani, da kuma taimakon numfashi.
Yin amfani da steroids na iya zama sakamako mai tsanani.
Yawancin abubuwa masu amfani a cikin maganin wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Hukumar ta WHO ta ce akwai "kayan gida da na gida" da zai iya rage alamun cutar SARS-CoV-19.
Wani asibiti da aka tsara don taimakawa wajen magance cutar COVID-19 ya bayyana a WHO a matsayin hanyar magance cutar.
ECDC da kuma Hukumar Kula da Lafiya ta Turai da WHO sun samar da hanyoyin da za a ba asibitoci da cibiyoyin kiwon lafiya don samar da kayan aiki a wurare masu yawa, da kuma inganta ƙarfin cibiyoyin gwaji ta hanyar gwajin COVID-19, da sanin hanyoyin da za a iya zaɓar inda za a iya yin aiki, da rarraba da kuma mayar da marasa lafiya da ke dauke da COVID-19, da kuma inganta tsarin kiwon lafiya ta hanyar koyar da ma'aikata da kuma ƙara yawan umarnin hana iska da kwanciya.
Akwai ra'ayoyi da dama game da yadda mai haƙuri na farko (wanda ya ce mai haƙuri na farko) zai iya tashi.
An fara gano wani sabon kamuwa da cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu kamuwa da cutar korona a Hubei ya ragu kadan.
An haife shi ne daga cikin dabbobi masu rai na Huan, wanda ke da mummunan rauni a duk idanunsu, kuma a wasu kalmomi, cutar ta samo asali ne daga cikin wadannan kwayoyin: , ko a wasu kalmomi, an samo asali ne daga kwayoyin. An gano wani abu a cikin ruwan da muke ciki a ranar 26 ga watan Disamba kuma likita Zhang Jixian ya yi masa magani a Hubei Provincial Hospital, wanda CDC ta sanar da Wuhan Jianghan a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, ƙungiyar likitoci a Wuhan Central Hospital ta sanar da abokan aikinta game da "taurin cutar SARS".
Wasu uku daga cikin masu tsaron gida, ciki har da Li Wenliang, sun yi ikirarin cewa sun yi amfani da bindigogi, kuma wani, Ai Fen, ya yi garkuwa da jami'an su don yaƙi.
Hukumar Lafiya ta Wuhan ta fitar da wata sanarwa a ranar 31 ga watan Disamba, kamar yadda WHO ta sanar.
Yawancin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A farkon da tsakiyar watan Janairu, cutar ta yadu da wasu lardunan kasar Sin, tare da taimakon jiragen sama na Sabuwar Shekara a kasar Sin da Wuhan, wanda shine cibiyar jiragen sama da kuma mafi yawan hanyoyin sufuri a can.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton sabbin mutane 140 a rana guda, mutane biyu a Beijing da kuma daya a Shenzhen.
Sabbin bayanan gwamnati sun nuna cewa, mutane 6,174 ne ke da cututtukan cutar tun daga ranar 20 ga Janairu 2020. Tun daga ranar 26 ga Maris, Amurka ta fi China da Italiya yawa kuma ta fi kowace ƙasa a duniya yawan masu cutar. Tun daga ranar 9 ga Afrilu, 2020, mutane sama da miliyan 1.63 ne ke da cutar a duniya; mutane 97,000 ne suka mutu kuma fiye da 364,000 sun kamu.
Kasashe da yankuna 200 suna da akalla mutum ɗaya da ke fama da cutar.
Saboda annobar duniya a Turai, ƙasashe da dama a yankin Shengen sun sami takunkumi don yin amfani da lokaci kuma sun kafa takunkumin tsaro.
Tsarin ƙasa ya haɗa da matakan hanawa kamar kasancewa a cikin gida (wanda aka sani da tarurruka na gida, tarurrukan hutu a gida ɗaya, ko haɗarin fita) da kuma hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, za su kasance a cikin gidajen gida a Amurka, fiye da mutane miliyan 50 da aka hana fita daga Philippines, kusan mutane miliyan 50 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun kasance a cikin gidajen ajiya, wanda daga baya ya karu zuwa biliyan 2.6 a cikin kwanaki biyu, kusan kashi ɗaya bisa uku na yawan jama'ar ƙasar.
An fara samun kamuwa da COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a riga an samu ba ya nuna cewa mutum na farko ya kamu da cutar a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya yi nazarin wasu cututtukan cutar huhu da suka kamu da cutar a ranar 26 ga watan Disamba, kuma asibitin ya sanar da CDC Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin farko na gwajin a cikin marasa lafiya a ranar 29 ga Disamba 2019 ya nuna cewa akwai cutar coronavirus da ta dace da SARS.
Hukumar Lafiya ta Wuhan ta fitar da wata sanarwa a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
Bayan da aka samu rahoton, sai aka sanar da likitoci a Wuhan da 'yan sanda don "fitowa da bindiga" a kan cutar.
Jami'an tsaro na kasar Sin sun fara da cewa babu "hakikanin tabbaci" game da yaduwar mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wata sanarwa mai ban tsoro da ta nuna cewa tsohon sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, ya yi "a matsayin mai ba da shawara ga jama'a" don hana yaduwar cutar.
A cikin abin da ake kira "babban rikici a tarihin 'yan adam", an sanar da dokar hana fita ta ranar 23 ga watan Janairu da ke hana zirga-zirga ta shiga ko ta fita Wuhan, kuma an tura ta zuwa wasu birane 15 a Hubei, wanda ya shafi yawan mutane miliyan 57.
An hana yin amfani da mota.
Ranar bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu) tana da ban sha'awa a wurare da dama.
Gwamnati ta kuma sanar da cewa an gina asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
Daga baya aka gina wani asibiti, wato, asibitin Leishenshan, don kula da wasu marasa lafiya.
A cikin sabon asibitin da aka gina, kasar Sin ta sake gina wasu wurare 14 a Wuhan, kamar wuraren taruwa, dakunan shan magani, da kuma wuraren shan magani na baya. A ranar 26 ga watan Janairu, gwamnati ta gabatar da wasu matakan hana kamuwa da COVID-19, kamar bayyana rayuwar masu tafiya da kuma inganta bikin bazara.
Jami'o'i da makarantu a duk faɗin ƙasar za su rufe.
Ƙasar Hong Kong da Macau sun yi wasu ayyuka, musamman a kan makarantun da jami'o'i.
An kuma yi amfani da tsarin aiki daga gida a wasu sassan kasar Sin.
Rashin tashin hankali ya yi tsanani a cikin da kuma wajen Hubei.
Al'umma ta canza, kuma duk gidajen tarihi a kasar Sin sun riga sun rufe.
Ana samun cutar ta hanyar hana mutane shiga cikin birane da dama, kuma kusan mutane miliyan 760 (ƙasa da yawan jama'a) suna cikin gida. Bayan da cutar ta kai ga matakin duniya a watan Maris, gwamnatin kasar Sin ta dauki matakan da za su hana kamuwa da cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar hana fita na kwanaki 14 ga duk wanda ya yi tafiya a kasashen waje kuma yana so ya shiga birnin. A ranar 23 ga Maris, babban yankin kasar Sin ya yi rahoton cewa mutum daya ya kamu da cutar a cikin ƙasa kafin mutum shida su mutu, wani kuma ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Shugaban kasar Sin Li Keqiang ya sanar da cewa cutar ta tashi a birnin kuma cutar ta ƙare a kasar Sin.
A ranar 26 ga watan Maris, 2020, an dakatar da yin tafiya a birnin Wuhan, bayan an yi wani abu mai ban mamaki game da zaman gida. An sake sanar da kasar Sin cewa a ranar 26 ga watan Maris, 2020, za a dakatar da shi daga neman takardar visa ko takardar shaidar zama a kasar, daga ranar 28 ga watan Maris, kuma za a ba da ƙarin bayani game da lokacin da za a kammala.
Masu shiga kasar Sin dole ne su nemi takardar visa a ofisoshin gwamnatin kasar Sin a wasu ƙasashe.
Gwamnatin kasar Sin ta rufe masana'antu da masana'antu a ranar 30 ga watan Maris, kuma ta ba da kuɗin farfadowa ga masana'antun. Gwamnan kasar ya sanar da cewa za a fara bincike da kuma gudanar da bincike na minti uku da karfe 10:00 na yamma a ranar 4 ga Afrilu, wanda kuma ya shafi bikin Qingming, ko da yake gwamnatin tsakiya ta dakatar da ayyukanta don nuna cewa tana da karfi a kan makwabta kuma dole ne ta yi nazarin ilimin lissafi don hana cutar COVID-19 ta cutar.
COVID-19 ya bazu a Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga kasar Sin.
Hukumar kula da lafiya ta kasar ta ruwaito cewa adadin wadanda suka kamu da cutar ya karu sosai a ranar 20 ga watan Fabrairu, saboda yawan jama'a da ke da damuwa a Daegu saboda sabon addini da ake kira Shincheonji Church of Jesus.
Shincheonji da ke zuwa Daegu daga Wuhan sun kasance masu daukar hoto.
A ranar 22 ga watan Fabrairu, daga cikin masu zanga-zangar 9,336, 1,261 ko 13% na su na da alamun cutar. Koriya ta Kudu ta ba da rahoton mafi muni a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya kai 3,150 a ranar 29 ga Fabrairu.
Dukkanin sojojin Koriya ta Kudu sun kasance cikin damuwa bayan binciken da ya nuna cewa sojoji uku sun kamu da cutar.
Shirye-shiryen jirgin sama na da tasiri sosai kuma yana da matukar tasiri. Koriya ta Kudu ta gabatar da abin da ake ɗauka a matsayin mafi girma da kuma mafi daraja a duniya shirin magance cutar a cikin al'umma, yana kaiwa wadanda suka kamu da cutar zuwa ga masu bincike da kuma kula da waɗanda suka kamu da cutar.
Ayyukan gwajin sun hada da sanar da bayanan mutum na mutum ga mutanen da suka dawo daga wata ƙasa ta hanyar aikace-aikacen waya, gwajin cutar da sakamakon da zai fito a cikin kwanaki masu zuwa, da kuma inganta tsarin gwaji don samun masu bincike 20,000 don bincika duk wani abu.
Shirin Koriya ta Kudu ya kasance mai ban sha'awa wajen magance matsalar ko da kuwa birane sun yi ta fama da matsalar.
Yawancin 'yan Koriya sun yi watsi da takardar neman izinin Moon saboda suna tsammanin gwamnati za ta iya magance cutar, ko kuma za mu iya amsawa.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu tana da mafi ƙarancin adadin mutane a kowace rana a cikin makonni huɗu.
A ranar 29 ga Maris an sanar da cewa daga ranar 1 ga Afrilu, mai shiga ƙasar zai kasance a cikin ƙasa har tsawon makonni biyu.
A cewar wani rahoto da aka bayar a ranar 1 ga Afrilu, Koriya ta Kudu ta samu izini don tallafawa gwajin cutar a cikin kasashe 121 daban-daban.
Iran ta fara bayyana kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda, a cewar rahoton da aka samu daga Ma'aikatar Lafiya da Ilimin Lafiya, mutane biyu suka mutu a baya a wannan rana.
An fara sanar da cewa gwamnatoci sun hana bukukuwa da sauran ayyukan wasan kwaikwayo, wasanni, da kuma rufe ranar Jumma'a, da kuma rufe makarantu, makarantu, da makarantu.
Iran ta samar da asusun bincike na tiriliyan shida don magance cutar.
Gwamna Hassan Rouhani ya bayyana a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na yin amfani da wuraren da ke da cutar a cikin doka, kuma ana iya yin amfani da mutane kawai a cikin doka.
An sanar da shirye-shiryen rage zirga-zirgar jiragen sama tsakanin birane a watan Maris, duk da cewa akwai karin zirga-zirga tsakanin birane kafin Sabuwar Shekara ta Farisa Nowruz.
Gidajen shan magani na Shia a Qom sun bude wa masu zanga-zangar a ranar 16 ga Maris 2020. Iran ta kasance cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin binciken da ake yi don gano yadda cutar ta yadu a Iran, fiye da kasashe goma sun koma asibitin da suka kamu da cutar a Iran a ranar 28 ga Fabrairu, inda suka ce cutar za ta iya kaiwa adadin mutane 388 da gwamnatin Iran ta sanar a yanzu.
An rufe jami'an Iran, kuma an samu rahoton cewa mutane 23 daga cikin 290 sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci jami'an gwamnati da ke kula da harkokin yara a Iran da su yi wa wadanda ke tsare da wani mutum da ba shi da laifi ba, da kuma wadanda ba su da laifi sosai, aikin da za a yi.
An ruwaito cewa lokaci na yaduwar cutar ya fi muni a wuraren da aka rufe kamar gidajen ajiya, inda babu ingantaccen tsarin kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ce an kashe mutane 100 a rana guda, wanda ya fi yawa tun lokacin da cutar ta fara.
Akalla 'yan siyasa na yanzu ko na baya a Iran da kuma jami'an gwamnati sun mutu sakamakon cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 da suka kamu da cutar a kowace rana da kuma mutuwar mutum daya a kowane minti 10 sakamakon cutar korona.
A cewar wani jami'in WHO, adadin masu kamuwa da cutar ya ninka na Iran sau bakwai.
Ka lura cewa, gwamnatin Amurka a Iran na iya shafar kudaden kasar don magance cutar guda.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya ce a rage yawan tattalin arziki a kasashen da cutar ta shafa.
An gano cewa cutar ta kai Italiya a ranar 31 ga watan Janairu, lokacin da aka gwada wasu 'yan kasar Sin biyu da cutar SARS-CoV-2 a Roma.
Mutane sun yi ta kuka, kuma gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama zuwa ko daga China kuma ta ba da sanarwar gaggawa.
A ranar 21 ga watan Fabrairu, jami'an jihar Feelore sun sanar da wani sabon taro don hana kamuwa da cutar, inda suka kori mutane fiye da 50,000 a larduna 11 daban-daban na arewacin Italiya.
Shugaban gwamnatin kasar Giuseppe Conte ya ce, a lokacin annobar, babu shiga da fita.
A ranar 4 ga watan Maris, gwamnatin Italiya ta ba da sanarwar rufe dukkan makarantu da makarantun lafiya a kasar nan bayan da Italiya ta kammala aikin da aka yi na kashe mutane 100.
Yawancin wasanni, kamar wasan kwallon kafa na Serie A, dole ne su gudana a cikin wani wuri da aka rufe a watan Afrilu, amma a ranar 9 ga Maris, an dakatar da wasanni duka na akalla wata daya.
A ranar 11 ga watan Maris, shugaban hukumar Conte ya gabatar da wani taro kan dakatar da yawan asarar gidajen shan magani da kuma kantin magani. A ranar 6 ga watan Maris, Kwalejin Italiyanci ta Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta gabatar da wani tsari na rashin lafiyar game da zaɓin manufofin da za su iya yin aiki daidai.
A ranar 19 ga watan Maris, Italiya ta fi China girma a yawan mutuwar mutane daga cutar coronavirus a duniya bayan an samu rahoton mutuwar 3,405 sakamakon cutar.
A ranar 22 ga watan Maris, an ruwaito cewa Rasha ta tura jiragen saman soja guda takwas da ke dauke da magunguna zuwa Italiya.
Tun daga ranar 5 ga watan Afrilu, an samu kamuwa da cutar 128,948, 15,887 sun mutu, kuma 2,8115 sun samu magani a Italiya, kuma mafi yawan wadanda suka kamu da cutar sun kasance a yankin Lombardi.
Wani rahoto na CNN ya ce haɗakar da al'ummar Italiya da ba su da wata hanya ta kula da waɗanda ke da cutar a yanzu na iya rage yawan mutuwarsu.
Sakamakon da Birtaniya ta bayar game da cutar ya zama daya daga cikin manyan abubuwan da suka fi yaduwa a tsakanin kasashen, kuma a ranar 18 ga Maris, 2020, gwamnatin Birtaniya za ta gabatar da wani tsari na yin amfani da cutar a matsayin hanyar da za ta iya hana mutane yin jima'i da jama'a ko kuma ta hana su yin jima'i da jama'a.
A ranar 16 ga watan Maris, shugaban kasa Boris Johnson ya fitar da wata sanarwa da ta ba da shawarar hana yin tafiya idan ya dace da yin tarayya da jama'a, kuma ya ce jama'a su yi aiki daga gida idan ya yiwu a wuraren shakatawa kamar pubs, gidajen cin abinci, da kuma gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa dukkanin wuraren shakatawa kamar pubs da wuraren wasanni za su rufe wuraren shakatawa, kuma za su biya 80% na kudin ma'aikata amma fiye da £2,500 a wata don mutane uku sun rasa ayyukansu a lokacin rikicin. A ranar 23 ga watan Maris, Shugaba ya sanar da matakan da za su sa a yi wa jama'a aiki mafi kyau, a dakatar da cin zarafin mutane sau biyu da kuma rage tafiye-tafiye da kuma ayyukan waje da suka fi dacewa.
Ba kamar yadda aka saba ba, 'yan sanda suna amfani da su wajen hana mutane yin amfani da wutar lantarki da kuma yada labarai.
Kasuwanci sukan rufe don irin wannan haɗari, amma ana iya rufe su don "kasuwanci", kamar kantunan sayar da kayayyaki, kantunan magani, kantunan ajiya, masana'antu, kantunan sayar da kayayyaki, da kuma kantunan sayar da motoci.
A ranar 20 ga watan Janairu, an gano wani mutum na farko da ya kamu da cutar COVID-19 a jihar Pacific Northeast Washington a jikin wani mutum da ya dawo Wuhan a ranar 15 ga watan Janairu.
Kwamitin kula da cutar Coronavirus na fadar White House za a fitar da shi a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar ta baci ta kiwon lafiya, ta hana masu ƙaura daga kasar Sin shiga kasar.
A ranar 28 ga Janairu, 2020, Hukumar Kula da Cututtuka, cibiyar kula da lafiyar jama'a ta farko ta gwamnatin Amurka, ta sanar da cewa ta bayyana sakamakon gwajin ta.
Duk da haka, Amurka tana da ƙwarewar bincike, wanda ke sa ran cutar za ta bazu cikin lokaci.
Ana samun matsala game da yadda kayan aikin gwaji suke aiki wanda gwamnatin tarayya za ta gabatar a watan Fabrairu, saboda gwamnati za ta amince da tsarin gwajin gwaji na gwamnati (ma'aikatar lafiya, cibiyoyin bincike da asibitoci) a ƙarshen Fabrairu, da kuma rage yawan hanyoyin da jama'a za su samu gwajin a farkon Maris (wanda ba shi da takardar sayan magani).
A ranar 27 ga Fabrairu, The Washington Post ta ba da rahoton cewa za a yi gwaji 4,000 a fadin Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa za a yi gwaji fiye da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun rashin lafiya da kuma rashin lafiyar likita sun ɗauki kwanaki ko kwanaki don gwaji". Bayan an fara samun mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da gaggawa na gaggawa, wanda wasu ƙasashe suka bi a baya.
Makarantun da ke yankin Seattle sun dakatar da karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantun da ke cikin ƙasa sun rufe makarantu. A ranar 6 ga Maris, an ba da shawarar Amurka game da yiwuwar sabon coronavirus a cikin ƙasa ta hanyar ƙungiyar masu binciken irin wannan cutar a Kwalejin Imperial ta London.
A wannan ranar ne Shugaba Trump ya gabatar da Dokar Shirye-shiryen Coronavirus da Dokar Amincewa da Ƙarin Kudin, wanda ya ba da dala biliyan 8.3 a cikin taimakon gaggawa ga hukumomin ƙasa don magance cutar.
Kamfanonin aiki sun yi watsi da zirga-zirga ga ma'aikatansu, sun soke aiki, kuma sun sa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da rage yawan zirga-zirgar jiragen sama ga yawancin kasashen Turai, sai dai Birtaniya, a cikin kwanaki 30, daga ranar 13 ga watan Maris.
A ranar da ta biyo baya, ta yada wannan rashin cin nasara a Ingila da Ireland.
A ranar 13 ga Maris, ya sanar da dokar ta baci ta ƙasar, wanda ya sa aka ba da kuɗin zuwa wani babban taro don magance cutar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko kuma rage jiragen sama a Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an samu rahoton kamuwa da cutar a jihohi 50 da kuma a cikin District of Columbia. A ranar 23 ga watan Maris, an ruwaito cewa New York City ta samu kamuwa da cutar ta coronavirus 10,700, wanda ya fi yawan kamuwa da cutar a Koriya ta Kudu.
A ranar 5 ga watan Maris, gwamnati ta ce an yi amfani da dokar hana fita, lokacin da adadin marasa lafiya da ke ci gaba da kamuwa da cutar ya ragu daga kwanaki 2.0 zuwa 4.7.
Tun daga ranar 28 ga watan Maris, an samu kamuwa da cutar 32,308 a birnin New York, inda mutane 672 suka mutu sakamakon kamuwa da cutar. A ranar 26 ga watan Maris, an ruwaito cewa Amurka ta fi kowace kasa a duniya kamuwa da cutar coronavirus, kamar China da Italiya. Tun daga ranar 8 ga watan Afrilu, an samu kamuwa da cutar 400,335 a Amurka, inda 12,841 suka mutu.
Kamar yadda aka ruwaito a ranar 30 ga Maris, Shugaban Amurka Trump ya yi alkawarin tsawaita tsarin cin zarafin jama'a a ranar 30 ga Afrilu.
Daga cikin wadannan, USNS Comfort, asibiti mai kama da asibiti mai asibiti 1000, ya tsaya a New York.
A ranar 3 ga watan Afrilu, Amurka ta kiyasta mutuwar mutane 884 sakamakon cutar korona a cikin shekaru 24.
A jihar New York, an samu adadin masu kamuwa da cutar sama da 100,000 a ranar 3 ga Afrilu. An gano cewa fadar White House tana da matukar damuwa game da cutar kuma tana rage yawan rayuka ta hanyar tura jami'an lafiya da jami'an tsaro don kare rayukan jama'a da kuma sakamakon cutar da kuma bin umarnin shugaban kasa na biyu Mike Pence.
Dukkanin hanyoyin da Trump ya yi na magance cutar sun bayyana cewa mutane suna ɗaukar su daban.
Wasu shugabannin Amurka da masana sun yi watsi da tsammanin Amurka game da kayayyakin da ba su da daraja a waje, kamar su magunguna na farko, a China.
Wani bincike game da iska mai iska da aka yi don nuna rashin amincewa da yadda ake yaduwar iska da aka buga a cikin Journal of Travel Medicine a tsakiyar watan Janairu na 2020.
A cewar rahoton 2018 na International Air Transport Association, Bangkok, Hong Kong, Tokyo, da Taipei suna da yawan mutanen da ba sa yin tafiya daga Wuhan.
Dubai, Sydney, da kuma Melbourne sun kuma kasance wuraren da mutane suka bar Wuhan suka yi tafiya mai kyau.
An ba da rahoton cewa Bali ta kasa da sananne a matsayin wuri na tafiya tsakanin biranen 20 da ke da mafi yawan ayyukan tafiye-tafiye da aka tsara, a wasu lokuta biranen Ostiraliya sun fi tsarawa. Ostiraliya ta fitar da Dokar Tsayayya da Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Akwai sauran bayanai da yawa game da COVID-19, kuma Australia na bukatar ta kara yin amfani da matakan tsaro da tsaro a cikin martani ga cutar.
A ranar 21 ga Maris, an sanar da gaggawa a Australia.
Domin a yi wa masu tafiya da kuma masu tafiyar da jama'a a Wuhan da Hubei, kasashe da dama sun yi shirin kwashe 'yan kasarsu da kungiyoyin tsaro daga yankin, da farko ta hanyar jiragen sama da kasarsu ta shigo da su, tare da taimakon gwamnatin kasar Sin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance daga cikin wadanda suka fara shirin fitar da al'ummarsu.
Pakistan ta ce ba za ta yi watsi da al'ummarta a kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta saki 'yan kasar Brazil 34 da suka kai hari a gida, ban da 'yan Poland hudu, daya daga cikin su na kasar Sin, da kuma wani dan kasar Sin.
'Yan Poland, China, da Indiya sun sauka a Poland, inda jirgin Brazil ya tsaya kafin ya bi ta zuwa Brazil.
An dakatar da wata al'ummar Brazil da ta kai ziyara Wuhan daga shiga wani sansanin soja da ke birnin Brasilia.
A wannan rana, mutane 215 na Kanada (176 a cikin jirgin farko, da 39 a cikin jirgin na biyu da gwamnatin Amurka ta yi aiki da shi) sun tashi daga Wuhan a CFB Trenton don a tura su cikin jiragen sama biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama na Kanada mai dauke da mutane 185 daga Wuhan ya sauka a CFB Trenton.
Gwamnatin Ostiraliya ta saki mazauna ta 277 a ranar 3 da 4 ga Fabrairu a ranar Juma'a na Kirsimeti Island, inda ta bayyana cewa ita ce yankin da aka haramta, kuma sun kasance a can har tsawon kwanaki 14.
Jirgin saman New Zealand ya isa Auckland a ranar 5 ga Fabrairu; masu safarar (da wasu daga Australia da Pacific) sun sauka a tashar jiragen ruwa ta Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta zama dan kasar Amurka tare da tagulla na Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama mai dauke da fasinjoji 129 na Kanada da ya tashi daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara dawo da al'ummarta daga Iran. A ranar 14 ga Maris, wani jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta tsara ya kai al'ummar Afirka ta Kudu 112.
Za a gudanar da bincike na lafiya kafin a fara cutar, kuma za a iya ganin cewa 'yan Afirka ta Kudu hudu da ke nuna alamun cutar korona sun yi jinkiri don rage cutar.
Ƙungiyoyin Afirka ta Kudu da aka gwada ba su da cutar sun zama ƙasashensu.
Binciken ya nuna cewa duk jama'ar Afirka ta Kudu, da kuma 'yan jirgin sama, masu ba da shawara, kungiyoyin otal, 'yan sanda da sojoji da ke aiki a madadin jama'a, a matsayin tsarin tsaro, suna cikin tsari kuma suna cikin iyakacin lokaci na kwanaki 14 a Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye sojojinta daga Iraqi saboda cutar.
A ranar 5 ga watan Fabrairu, jami'an kasar Sin sun sanar da cewa kasashe 21 (kamar Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun yi zanga-zanga don neman taimako a yankunan da cutar ta shafa a kasar Sin, da kuma wasu kungiyoyi a yankin Chicago da ke fama da rashin amincewa da sayar da kayan rufe fuska na N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga watan Janairu. Kungiyar taimakon jama'a ta Direct Relief, tare da haɗin gwiwar FedEx, ta aika da kayan rufe fuska na 200,000 da sauran kayan tsaro, kamar kayan rufe hannu da kuma kayan aiki, ta hanyar jigilar gaggawa zuwa asibitin Wuhan Union a ranar 30 ga watan Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da sanarwar tallafawa WHO da dala miliyan 100 don bincike kan alluran rigakafi da hanyoyin magani da kuma hana "ƙungiyoyin Afirka da Kudancin Asiya da ke da haɗari".
Interaksyon ta ruwaito cewa gwamnatin kasar Sin ta ba da takardar shaidar rufe fuska ga 'yan Filipinos 200,000 a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da takardar shaidar rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 a matsayin tallafi ga kasar Sin.
Japan ta ba da takardar shaidar rufe fuska a Wuhan, Turkiyya ta rarraba umarnin kiwon lafiya, Rasha ta tura fiye da tan 13 na magunguna da kayan kiwon lafiya zuwa Wuhan, Malaysia ta ba da rahoton samar da kayan kiwon lafiya na mutane miliyan 18 zuwa China, Jamus ta tura kayayyakin kiwon lafiya daban-daban tare da cutar Hazmat 10,000, kuma Amurka ta ba da tan 17.8 na magunguna da kayan kiwon lafiya ga China kuma ta ba da ƙarin dala miliyan 100 a matsayin tallafi da kuma kudade ga kasashen da cutar ta shafa. Bayan da adadin cututtuka a China ya ragu, kasar ta fara neman taimako daga wasu kasashen da cutar ta shafa.
A watan Maris, kasar Sin, Cuba da Rasha sun tura kayan aikin kiwon lafiya da kuma likitoci don taimakawa Italiya wajen yaki da cutar coronavirus.
Jami'in Jack Ma ya aika da umarnin bincike na miliyoyin 1.1, da na rufe fuska na miliyoyin 6, da kuma na rufe fuska na 60,000 zuwa Addis Ababa, Habasha don rarraba ta Majalisar Dinkin Duniya.
Daga bisani ya aika da kayan bincike 5,000, takardun rufe fuska 100,000 da kuma umarnin yin iska 5 a Panama.
Ƙasar Kanada ta kuma ba da tallafi ga tsarin kiwon lafiya. Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun nuna damuwa game da maganin rufe fuska da aka yi a kasar Sin da kuma gwajin gwaji.
Alal misali, Spain ta samar da wani bincike na 58 000 da aka yi a kasar Sin wanda ya nuna cewa akwai kashi 30 cikin dari na rashin lafiya, yayin da Netherlands ta gano wasu kwayoyin da ke rufe ruwan inabi na kasar Sin da ke dauke da rashin lafiya 600,000.
Belgium ta gano kayan rufe fuska 100,000 da ba za a iya sawa ba bayan da aka gano su a Columbia.
A wani lokaci, an karɓi taimakon China a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Majalisar Dinkin Duniya ta fara ayyukan gaggawa na taimakon gaggawa a ƙasashe da dama.
WHO ta yi watsi da matakan da gwamnatin kasar Sin ta dauka wajen hana cutar.
Hukumar ta WHO ta fahimci bambanci tsakanin annobar SARS ta 2002-2004, wadda gwamnatin kasar Sin ta dauka ta yi da gangan kuma ta dauki matakan hanawa da kuma hanawa, da kuma annobar da gwamnatin tsakiya ta "bayar da bayanan da za a yi wa mutane uku kafin ranar sabuwar shekara ta watan".
A ranar 23 ga watan Janairu, a cikin martani ga wata takarda da gwamnatin tarayya ta yi na rage haɗarin a cikin tsarin cututtuka a Wuhan, mai ba da shawara ga WHO Gauden Galea ya lura cewa "babu wani mataki da WHO ta ɗauka", shi ne "babban matakin da WHO ta ɗauka na dakatar da cutar a cikin mafi munin yanayi" kuma ya yi kira da cewa "ba a taɓa yin irin wannan a tarihin kiwon lafiya ba". A ranar 30 ga watan Janairu, bayan da aka gano kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin da kuma karuwar yawan marasa lafiya a wasu ƙasashe, WHO ta bayyana cutar a matsayin Cutar Lafiya ta Duniya (PHEIC), wanda ya kasance na farko a cikin tsarin PHEIC tun lokacin da aka sake gano cutar a shekara ta 2009.
Shugaban WHO Tedros Adhanom ya ce, PHEIC na da "damuwa a duniya, musamman a ƙasashen da ba su da isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen
A cikin martani ga raguwar zirga-zirgar jiragen sama, Tedros ya ce "ba za a yi watsi da tsarin da ke hana zirga-zirga zuwa wasu ƙasashe da kuma kasuwanci ba" kuma "WHO ta ba da shawarar rage yawan zirga-zirga ko kuma rage yawan zirga-zirga".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su shirya shirin samar da tallafin dala miliyan 675 ga kasashe marasa arziki, ta hanyar neman gaggawa don tallafawa kasashen da "ba su da damar kula da mutanen da ke fama da cutar, ko da kuwa sun kamu da ita".
Tedros ya kara da cewa "mu na da karfi kamar yadda jikinmu na da rauni" kuma ya yi kira ga al'ummar duniya da su "yi hankali yanzu ko kuma su yi aiki a nan gaba". A ranar 11 ga Fabrairu, WHO a taron yada labarai ta zabi COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya ce shugaban Majalisar Dinkin Duniya António Guterres ya amince da "ba da duk wani abu na siyasa ga Majalisar Dinkin Duniya a matsayin abin da ya dace".
Wasu kungiyoyin da ke kula da cutar na Majalisar Dinkin Duniya suna aiki a matsayin masu ba da amsa, suna taka dokar Majalisar Dinkin Duniya, wadda WHO ta ce za ta ba da amsa ga "tsaron lafiyar jiki na yanzu da sauran kungiyoyi za su iya yin amfani da su don magance cutar a cikin al'umma, da kuma lafiyarmu".
A ranar 14 ga watan Fabrairu, Hukumar Kula da Ayyuka da ke Tarayyar da China ta yi kira ga kasashen waje da WHO a kasar Sin don taimakawa wajen hana da kuma kimanta "halin da ke tattare da yaduwar cutar" a kasar ta hanyar sadarwa da kuma hadin gwiwa da manyan cibiyoyin bincike da ke kasashen waje don magance "halin da ke tattare da ayyukan a yankunan larduna da birane, da birane da garuruwa". A ranar 25 ga watan Fabrairu, WHO ta ce "duniya tana daukar matakan da za su iya magance cutar coronavirus mai zuwa", kuma ta ce a lokacin da za a iya magance cutar ta duniya, kasashen da ke cikin duniya dole ne su kasance a "tsarin shiri".
Don amsawa ga cutar da ke gudana a Iran, WHO ta tura wani Kwamitin Ayyuka na Ƙungiyar don magance matsalar da ke gudana a wurin. A ranar 28 ga Fabrairu, jami'an WHO sun ce gwajin cutar coronavirus a duniya zai fara ne daga "saukar" zuwa "ƙofar" na'ura, wanda shine ƙarshen gwajin ci gaban cutar.
Mike Ryan, mai kula da shirin gaggawa na kiwon lafiya na WHO, ya bayyana a wani labarin cewa "Wannan shi ne gwajin da aka yi a kowace gwamnati a duniya: Bari mu gano.
Wannan cutar na iya kasancewa a cikin yanayin da take ciki kuma dole ne a shirya", ta hanyar yin amfani da hanyoyin da za a iya magance matsalar da za ta iya haifar da duniyar nan ta ƙarshe "wanda ke da mummunar tasiri a ciki".
Ryan ya kara da cewa wannan sanarwa na yanzu zai ba da tabbacin cewa hukumomin kiwon lafiya za su yi amfani da cutar a duniya, kuma ya ce wannan sanarwa na nufin "mun yarda da cewa kowane mutum a duniya zai kamu da cutar".
A watan Maris, WHO ta bayyana coronavirus a matsayin annoba ta duniya.
Shugaban na farko ya ce WHO tana "da matukar damuwa da cututtukan da ke faruwa da kuma yaduwar cutar, da kuma matakan tsaro". WHO na iya samun muhimmiyar sanarwa game da irin abubuwan da ke faruwa a cikin kula da cutar ta duniya, da kuma kawo karshen bayanai kamar gaggawa na kiwon lafiyar jama'a da kuma shigar da cutar a cikin kungiyoyin da ke fama da cutar ta duniya.
Rahoton ya kuma hada da sanarwar da shugaban WHO Tedros Adhanom ya bayar na sakin aikinsa, wanda mutane 733,000 suka rattaba hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, jami'an Majalisar Dinkin Duniya za su yi aiki na musamman don yin wa kowa da kowa da ya kamata a yi masa horo a lokacin annobar COVID-19.
An ce a lokacin da aka yi wa 'yan sanda da aka yi wa fyade, an yi wa gwamnati ta'aziyya.
Ƙungiyar ta ce rashin tsaro ko rashin lafiya ba zai zama hanyar da za ta sa a yi watsi da sauran al'umma ba.
Masu zanga-zangar sun kuma tuna da cewa kowa yana da alhakin lafiya, har da marasa lafiya na haihuwa, waɗanda ke cikin ƙananan ƙungiyoyi, tsofaffi, waɗanda suka canza rayuwarsu a cikin ƙasa, marasa gida, waɗanda ke cikin matsanancin yanayi, waɗanda ke cikin kurkuku, da masu tsaro da sauran ƙungiyoyi da ke buƙatar taimakon gwamnati.
Hukumomin duniya suna gwagwarmaya don magance matsalolin tattalin arziki da zamantakewar da COVID-19 ta haifar.
Kwamitin Ci gaban Tsaro na Duniya ya bayyana cewa yana da tabbacin samar da cikakken bayani game da tsarin siyasa a duk ƙasashe a duniya, tare da ra'ayoyi da ra'ayoyi.
Daga manufofin da za a yi don inganta tsarin kiwon lafiya da tsaro a duniya don kawar da matsalolin zama a gida da kuma rage yawan tafiye-tafiye, cibiyar ta yi aiki da taimakon kasa da kasa, da nufin taimaka wa kasashe su koyi ko kuma su tabbatar da tsaro na duniya ga cutar coronavirus.
Gwamnatin kasar Sin ta nemi ta daga Amurka, Shugaban ofishin majalisar dattijai na Birtaniya Michael Gove, da shugaban Brazil Jair Bolsonaro da Eduardo Bolsonaro don magance cutar ta duniya, wadda ta fara ne a lardin Hubei, kasar Sin.
Shugabannin wasu yankuna na Jam'iyyar Kwaminis ta China (CPC) za su yi kira ga su yi wa'azi game da cin zarafin 'yan Adam a yankin Tsakiya na kasar Sin, da kuma yadda za a magance matsalar ta siyasa a yankunan da ke yankin.
Wasu masana sun yi imanin cewa wannan taron zai taimaka wajen kare tsohon shugaban jam'iyyar kwaminis ta kasar Sin Xi Jinping daga yin magana game da cutar coronavirus.
Wasu shugabannin kasar Sin, kamar Zhao Lijan sun fara gano cutar coronavirus da ta fara a Wuhan, bisa ga tsarin kamuwa da cutar COVID-19 da ta samo asali a Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta kira coronavirus "Cutar China" ko "Cutar Wuhan" kuma ta ce China "ta bayyana wani irin cutar da ta zama cutar ta duniya", abin da wasu masu ba da shawara suka yi da'awar cewa shi ne asalin cutar kuma "ta yi la'akari da laifin da gwamnatin ta ke da shi wajen hana cutar".
Jaridar Daily Beast ta samu wata sanarwa daga gwamnatin Amurka da ke bayyana tsarin rayuwar da ke tasowa ta hanyar jin dadin zaman lafiya na kasa, da kuma cewa tsarin zai "damar da duk abin da ya shafi kasar Sin.
An ce dole ne a gwada yadda ake kallon wannan labarin a wasu hanyoyi, da kuma yadda ake yin amfani da shi don sadarwa da kuma nunawa a talabijin".Kasuwancin sayayya kamar su Politico, Foreign Policy, da Bloomberg sun nuna cewa duk hanyoyin da kasar Sin ke amfani da su wajen ba da tallafi ga kasar Sin suna da kyau kamar yadda ake amfani da su wajen nuna kansu a duniya.
Ministan harkokin wajen kasa Josep Borrell ya ce akwai "yanayin siyasa da na yanki da za a bi a nan gaba kamar su bin doka ta hanyar zabe da kuma "yanayin tallafi".
Borrell ya kuma ce "China tana da matukar damuwa da wannan bayanin, ba kamar Amurka ba, ita ce babbar abokiyar cin amana".
China ta kuma bukaci Amurka ta janye takunkumi daga Syria, Venezuela da Iran, kuma tana tura mataimakan da suka rage a jerin.
Jack Ma da kuma takunkumin rufe fuska 100,000 a Cuba za su dakatar da Amurka daga yin hakan a ranar 3 ga Afrilu.
Gwamnatin Amirka ta yi ƙoƙari ta gyara taimakon da aka yi wa wasu ƙasashe a ƙasarsu.
Akwai wasu rahotanni game da rufe fuska a wasu ƙasashe, kamar Jamus, Austria, Switzerland; da Czech Republic da Italiya.
Bugu da ƙari, Turkiyya ta ba da umarnin yin iska mai iska a kan iska mai iska da aka yi amfani da ita a Spain.
A farkon watan Maris, gwamnatin Italiya ta soke Majalisar Tarayyar Turai saboda rashin goyon bayan da ake yi wa Italiya a kan cutar korona.
Maurizio Massari, mai ba da shawara ga Italiya a kan EU, ya ce "Kasar Sin ta yi kira ga bangarorin biyu.
Hakika, wannan zai zama alama ce mai kyau ga dukan ikilisiyoyin Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da shugaban Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya tuntubi sojojin Rasha don su duba magungunan soja, motocin tsabtace ruwa, da kuma wasu umarnin magunguna a Italiya.
Wani rahoton jaridar La Stampa ta Italiya ya ce "babban rashin siyasa ne" amma babu wani tabbacin cewa kashi 80% na taimakon da Rasha ke bayarwa "ba zai yi tasiri ko kuma ba zai yi tasiri sosai a Italiya ba".
Wannan wasiƙar ta ce Rasha tana shiga cikin "haƙƙin siyasa da na siyasa" da ƙasashen waje.
Gwamnan Lombardy, Attilio Fontana, da shugaban wasu ƙasashe Luigi Di Maio sun gabatar da wasiƙun labarai da kuma nuna alamarsu.
Rasha ta kuma tura jiragen sama don jigilar kayayyaki da kuma taimakon kiwon lafiya a Amurka.
Wani mai magana da yawun Kremlin Dmitry Peskov ya ce "a lokacin da yake ba da tallafi ga abokan tarayya na Amurka, [Putin] ya yi imanin cewa idan masana'antun kiwon lafiya na Amurka sun sami ƙarfi, za su iya dawo da shi idan sun sami damar".
Tsarin horo na NATO na soja "Defender 2020" a Jamus, Poland da Baltic States, shine mafi girma a NATO tun lokacin da aka kammala kungiyar tsaro, ba shi da yawa.
Shugaban Hukumar Kare Hakkin Kasa Kate Hudson ta kammala aikin Defender 2020: "A lokacin da ake fama da cutar ta yau da kullum, za a iya shafar sojoji da suka fito daga Amurka da sauran kasashen Turai da ke aiki da kuma al'ummar kasashen da wannan makarantar ke gudana. "Gwamnatin Iran za ta kamu da cutar, kuma 'yan kungiyar 'yan adawa na kasar da ke fama da cutar sun fi kashi biyu cikin dari na masu fama da cutar da kuma 'yan siyasa na yanzu ko kuma goma sha takwas.
Shugaban kasar Iran Hassan Rouhani ya rubuta wata sanarwa ga shugabannin kasashen duniya a ranar 14 ga Maris, 2020, inda ya ce kasar tana fama da cutar saboda rashin samun damar shiga cikin hadarin kasashen duniya sakamakon matakin da Amurka ta dauka kan Iran. Wannan cutar ta haifar da kira ga Amurka da ta bi ka'idojin da ke faruwa a wasu kasashe masu arziki, da suka hada da kiwon lafiya na duniya, kiwon lafiya ga yara, kula da iyalinta da ake biya, da kuma taimakon kiwon lafiya da kudi da kuma hanyoyin da ake amfani da su.
Masu ruwa da tsaki na siyasa sun yi ikirarin cewa za a iya jinkirta zaben Donald Trump a zaben shugaban kasar 2020.
Koriya ta Kudu ta yi watsi da "damar da ake yi na hana a yi wa mutane laifi da kuma yin lalata" bayan da Japan ta ba da umarnin cewa duk wanda ya fito daga Koriya ta Kudu ya yi sati biyu a cikin wani wuri da gwamnati ta shirya don haka.
Koriya ta Kudu ta riga ta rabu dangane da yadda Shugaba Moon Jae-In ya amsa wannan batu.
Koriya ta yi kira ga wata sanarwa da za ta sa a yi watsi da wata sanarwa da ke nuna cewa gwamnati za ta iya hana cutar, ko kuma ta ba da amsa.
Wasu masana sun yi zaton cewa zai iya zama lada ga gwamnatoci don yin amfani da ikonsu a cikin yanayi mai wuya.
A Hungary, majalisar dattijai ta yanke shawarar ba da lada ga Firayim Minista Viktor Orbán, don ya ci gaba da gudanar da wannan aikin, ya dakatar da majalisar dattijai da kuma gudanar da zabe da kuma ya kori wadanda suka yi watsi da bayanan da ba daidai ba game da cutar da kuma yadda gwamnati ke bi don magance matsalar.
Cutar korona ta haifar da haɗari da yawa kamar haɗarin wuta, saboda asibitoci suna aiki da wuta mai yawa don kula da cutar a duniya, haɗarin cin abinci, dakatar da masana'antu da kuma tafiya.
Hukumar Kula da Magunguna ta Amurka ta fitar da bayanai don yin tunani game da masana'antun magunguna da kuma umarnin likita saboda yawan kwayoyin sun ragu kuma masana'antun sun ragu.
Ƙari ga haka, wurare da yawa sun yi watsi da tsananin ɓarnar da aka yi a cikin manyan abubuwa kamar abinci, gidajen da aka yi amfani da su, da kuma ruwan sha, wanda ya sake yin ɓarna.
Yawancin fasaha suna dogara ne akan tsarin da aka tsara don yin amfani da abubuwa kamar umarni.
A cewar shugaban WHO Tedros Adhanom, yawan amfani da kayan shafa ya karu da kashi 100.
Wannan dabba tana da siffofi masu kama da na dabba guda huɗu.
Haka kuma, kayan shafawa a duniya suna da wuyar ganowa, kuma WHO ta ce hakan zai iya shafar lafiyar masu amfani.
A Ostiraliya, annobar ta ba masu sayen kayayyaki damar sayen kayayyakin Ostiraliya daga China.
Wannan harin ya sa aka samu kananan yara a kantunan sayar da abinci kuma an hana su daga gwamnatin Ostiraliya. Duk da yawan mutanen da suka kamu da COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma bukatar karin kayan abinci, dukansu yankuna ba su da matsalar abinci.
Hanyoyin da kasar Sin da Italiya ke yi na cinikayya da kuma cinikayya da ke da nasaba da cinikayya suna ci gaba, wanda ke nuna cewa an samu raguwar yawan cin abinci a Turai da Arewacin Amirka.
Kasashen Italiya da kuma ƙasar da ke da albarkatun ƙasa za su iya rage yawan amfanin gona, amma farashin zai iya ƙaruwa a rayuwar talakawa.
Abincin ya ƙare a wani lokaci, a birnin Wuhan, lokacin da jami'an gwamnatin kasar Sin suka kafa wani tsari na samar da abinci mai gina jiki don samar da abinci mai gina jiki ga jama'a.
Irin wannan dokar ta kasance a Italiya wadda ta ba da shawara ga masu shirya abinci da gaggawa.
An ruwaito matsalar cutar a duniya a kasar Sin: a cikin rahoton wasu cututtuka a ranar 16 ga Maris, cutar ta kasar Sin za ta shafar ta sosai a farkon rabin shekarar 2020 saboda matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma sayen kananan kayayyaki ya ragu da kashi 20.5%.
Kamar yadda kasar Sin ta kasance cibiyar samar da kayayyaki da kuma samar da kayayyaki, bayyanar cutar ta shafi tasirin tasirin tasirin duniya.
Agathe Demarais na Cibiyar Ilimin Tattalin Arziki ta ce za a yi amfani da wutar lantarki a cikin wani wuri mai kyau da kuma wani wuri mai kyau da za a iya gani a ciki.
A watan Janairun 2020, wasu masu bincike sun yi imanin cewa sakamakon cutar zai fi na annobar SARS ta 2002-2004 girma.
Wani masanin kimiyya a Jami'ar Washington a St. Louis ya ce, za a kashe fiye da dala biliyan 300 a kan tsarin magance cutar a cikin shekaru biyu.
Kungiyar Kasashen da ke Fitar da Man Fetur (OPEC) ta ce "ta yi watsi da" bayan da farashin man fetur ya bayyana a matsayin rashin amfani saboda kasar Sin ta dakatar da cinikin.
An yi kira ga kasashen duniya a ranar 24 ga Fabrairu don karuwar yawan mutanen da suka kamu da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda ra'ayoyin da ake samu game da annobar coronavirus, wasu lambobin Amurka da suka hada da NASDAQ-100, S&P 500 Index, da Dow Jones Industrial Average sun soke bukatarsu ta farko daga 2007-08.
Dukkanin lambobi uku sun kammala mako da sama da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta fitar da lambar kasar Sin, amma ta bar ta a matsayin mai ba da izini.
An sake samun raguwa saboda tsoron coronavirus, wanda ya faru a ranar 16 ga Maris.
Mutane da yawa sun yi tunanin cewa zai iya zama abu ne mai ban mamaki.
Shugaban kasar Mohamed El-Erian ya yi godiya ga matakan gaggawa da cibiyar tsaro ta kasa da kasa ta dauka a kan lokaci.
Hukumomin tsaro na tsakiya suna ba da izini bisa ga abin da suka yi a cikin kudaden shiga na 2008.
Kasashen da ke da tasiri sosai a kan ayyukan da ake yi na hana zirga-zirga, rufe ofisoshin gwamnati da kuma tafiye-tafiye na kasuwanci, da kuma yadda gwamnatoci uku ke yin tafiya a duniya.
A sakamakon haka, jiragen sama da jiragen sama da dama sun daina aiki domin masu amfani da jiragen sama, kamar British Airways, China Eastern Airlines, da Qantas, a lokacin da kamfanin jirgin sama na yankin na Birtaniya Flybe ya yi watsi da su.
Ku yi addu'a da hankali, ku yi addu'a da hankali, ba tare da yin addu'a ba.
Jirgin ruwa da jirgin ruwa sun rufe ƙofofin.
Wannan ya shafi Chunyun, lokacin da ake yin tafiya da kuma bikin Sabuwar Shekara a kasar Sin.
Yawancin ayyukan da jama'a ke yi a cikin al'umma suna da yawa daga gwamnatoci da hukumomi, tare da bikin Sabuwar Shekara na shekara-shekara, da kuma haɗin gwiwar da ke rufe gidaje da wuraren shakatawa na musamman kamar Hong Kong Disneyland da Shanghai Disneyland.
Abubuwan da ke faruwa a watan Nuwamba da kuma abubuwan da ke faruwa a yau za su kasance a buɗe ga jama'a na musamman, ciki har da birnin da aka hana a Beijing da kuma ofishin baje kolin gidajen ibada.
A larduna 24 da 31 na kasar Sin, birane da yankuna, hukumomi sun yi bikin tunawa da Sabuwar Shekara a ranar 10 ga Fabrairu, kuma sun rufe manyan ofisoshi da yawa ta hanyar bude su a lokacin.
Wadannan yankuna suna kashe kusan 80% na GDP na kasar da 90% na fitar da kayayyaki.
Hong Kong ta kara karfafa martani ga annobar da ta kai ga annobar da ta yi sanarwa da gaggawa, ta rufe makarantu a watan Maris, ta dakatar da bikin Sabuwar Shekara. Ƙananan wuraren cin kasuwa sun shafar duniya, tare da rage yawan lokutan cin kasuwa ko rufewa.
Kasuwancin kananan masu sayayya a Turai da Latin Amurka ya karu da kashi 40%.
Kasuwancin kananan yara a Arewacin Amirka da Gabas ta Tsakiya sun ragu da kashi 50 zuwa 6%.
Wannan ya sa yawan masu sayarwa a cikin shaguna ya ragu da kashi 33-43% a watan Maris idan aka kwatanta da Fabrairu.
Hukumomin cinikayya a duniya sun yi amfani da wasu matakan, kamar ƙara kula da lafiya, samar da kayan shafawa don magance rashin lafiyar masu amfani, da kuma hana kayayyaki. Hukumar tattalin arziki ta Majalisar Dinkin Duniya don Latin Amurka ta kiyasta cewa, wannan mummunar cuta da ta haifar da raguwar kayayyaki na iya barin mutane miliyan 14 zuwa 22 a cikin ɓoye a Latin Amurka a lokacin da cutar ba ta da tasiri a duniya.
A cikin Janairu da Fabrairu 2020, a lokacin da annobar ta barke a Wuhan, kimanin mutane miliyan 5 a China sun rasa ayyukansu.
Ma'aikatan kasar Sin da ke aiki a kasashen waje sun kai miliyan 300 da ke zaune a gidajensu a larduna ko kuma a lardin Hubei. A watan Maris na shekarar 2020, fiye da Amurkawa miliyan 5 a kasar Sin sun rasa ayyukansu kuma ba su da taimakon gwamnati.
Ana iya ganin cutar korona za ta iya shafar ayyukan yi miliyan 47 a Amurka kuma rashin aikin yi zai iya kaiwa kashi 32%, kamar yadda Hukumar Tsaro ta Tarayya ta St. Louis ta yi hasashen. Kasancewa a gida a Indiya ya haifar da aikin yi ga ma'aikatan da suka shigo Indiya na kusan miliyan 10 (wanda ake biya su bisa ga yawan kudade). Wani bincike daga Cibiyar Angus Reid ya gano cewa kashi 44% na 'yan Kanada sun rasa aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka koya musu su kasance a gida a tsakiyar watan Maris 2020.
A watan Maris na shekarar, ma'aikata miliyan hudu na Faransa sun yi watsi da aikin da aka ba su saboda rashin aikin yi da kuma miliyoyin ma'aikata na Birtaniya sun yi watsi da tsarin samar da kayayyaki. Kusan rabin miliyan na masana'antu a Jamus sun tura ma'aikata a karkashin tsarin gwamnati a cikin wani lokaci mai tsawo da aka sani da Kurzarbeit.
Ƙarfin da aka yi a Jamus a cikin ɗan lokaci ya kuma shafi Faransa da Ingila.
Yanki irin su cin zarafin hannu ko kuma tarihin gida suna da tasiri sosai a kan cutar, wanda kuma ya shafi tsarin aiki da jama'a, duka ma'aikata da aka ɗauka da kuma ma'aikata, a duniya.
Ƙungiyoyi kamar su masu zanga-zangar hannu ko na gida suna ƙoƙarin sake gina ayyukan su (wanda galibi gwamnati ke ba da kuɗi) don buɗe gidajen tarihi ga jama'a, kula da lafiyar ma'aikata da jama'a, da kuma kungiyoyi idan ya yiwu.
A watan Maris na shekarar 2020, a cikin yanayi daban-daban, gidajen tarihi, makarantu, wuraren baje kolin kayan gargajiya, da sauran wuraren jama'a sun rufe ƙofofin su kuma duk abubuwan da aka nuna, ayyuka da ayyukan su an dakatar da su ko kuma a dakatar da su.
A sakamakon haka, an yi wasu ayyuka don hana wasu kauyuka yin amfani da tsarin mulki. Wani dalili kuma da ya sa cutar ta yi tasiri shi ne hana ayyukan da ake yi, wasanni, da sauran ayyukan jama'a, kamar su yin waƙa da yin rawa, haɗuwa da fasaha, da kuma nuna sauti.
An kuma san cewa ana dakatar da yin bidiyo. Vatican ta sanar da cewa za a dakatar da yin bikin Juma'a a Roma, wanda ake gudanarwa a karshen mako don tattara jama'ar Allah.
Yawancin gidaje suna sa tsofaffi su kasance a gidajen su don su ziyarci haikalin da Al'atu; wasu kuma suna yin hakan ta hanyar rediyo, rediyo, talabijin ko kuma wasu mutane suna yin hakan a cikin motoci.
Cocin Roman Katolika na Roma ya rufe wuraren ibada da kuma wuraren ibada a Babila St. Peter ba tare da masu koyar da Masallaci ba, wasu addinai kuma sun dakatar da ayyukan ibada kuma sun rage tarayyar jama'a a cikin wuraren ibada na Masallaci, al'adun Muhammadu, wuraren ibada da gurdwaras.
Jami'an kungiyar Iran sun bayyana cewa an dakatar da yin amfani da ranar Jumma'a a yankunan da cutar ta shafa kuma an rufe gidajen abinci, a lokacin da Saudiyya ta hana masu gabatar da kara na kasashen waje da na kasar shiga wuraren da ake kira Makka da Madina.
Cutar ta duniya ta hana abubuwa da yawa daga cikin tsarin duniya na duniya na duniya na Duniya na biyu.
Yawancin wasanni za a dakatar ko kuma a soke su, kamar gasar zakarun Turai ta 2019-20 UEFA Champions League, gasar Premier ta 2019-20, gasar zakarun Turai ta 2020, gasar NBA ta 2019-20 da gasar NHL ta 2019-20.
An dakatar da shirye-shiryen gasar Olympics ta bazara ta 2020, wanda aka yi a matsayin wanda aka fara a ƙarshen Zuwayi; kwamitin Olympic na duniya ya sanar a ranar 24 ga Maris cewa ayyukan "an shirya su ne a farkon shekarar 2020 amma ba za su ƙare ba a tsakiyar shekarar 2021". Kasuwanci da sauran wuraren wasan kwaikwayo a duniya za su rufe kuma su buga wasan poker za a iya dakatar da su ko kuma a dakatar da su.
Wannan ya sa masu sauraron wasannin suka yi watsi da taron, kuma manyan kungiyoyin mawaƙa sun ba da rahoton ƙaruwar yawan masu halarta. An yi watsi da wuraren wasan kwaikwayon da ke da waƙa, da kuma kungiyoyin mawaƙa da suka hana ko kuma suka hana ayyukansu.
Yawancin gidajen wasan kwaikwayo kamar na Broadway sun dakatar da duk ayyukan su.
Wasu 'yan wasan sun nemi wasu hanyoyin da za su ci gaba da yin aiki da kuma rarraba aikin su a cikin jama'a kamar su yin wasan kwaikwayo a fili, kamar yin magana a fili ko kuma yin "fasali" game da aikin su, yin hukunci, da kuma nuna aikin su.
A wani ɓangare kuma, ƙwayoyin cuta na duniya da ke da al'ada da yawa sun fito daga waje kuma wasu sun bayyana shi a matsayin gussa da kuma tserewa a tsakiyar matsala.
Tun lokacin da COVID-19 ya fara, ƙiyayya, ƙiyayya, da kuma nuna bambanci sun kasance a tsakanin jama'ar kasar Sin da kuma mutanen da ke fitowa daga Gabashin Asiya, da kuma mutanen da suka fito daga yankunan da cutar ta shafa a Turai, Amurka da sauran ƙasashe.
A ƙasashe da yawa kuma muna da al'ada, hankali, da kuma al'ada musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya-Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin masu kamuwa da cutar suka yi baftisma a China) sun nuna cewa akwai hadayu a cikin kungiyoyi daban-daban na jama'ar kasar Sin da suka ce cutar ta kai su ko kuma sun amince da ita a matsayin allahntaka.
Wasu ƙasashen Afirka ma sun nuna rashin kulawarsu ga jama'ar kasar Sin.
Mutane da yawa a Wuhan da Hubei sun yi rahoton cewa ana yin zabe ne saboda asalin su.
Kasar Sin ta samu kariya, a cikin gida da kuma bakin, da kuma a wuraren da cutar ta kamu.
Saboda ci gaba da kamuwa da cutar a kasashe da suka kasance a cikin wannan cutar, mutane daga Italiya, kasar farko a Turai da ta ba da rahoton kamuwa da cutar COVID-19, na iya zama masu haɗari ko kuma masu haɗari. Ƙungiyoyin ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara aiki da hannu kan takardun da ke neman hana shigowar jama'ar Sin zuwa ƙasashensu don magance cutar.
A Japan, hashtag #ChineseDontComeToJapan ya gudana a kan Twitter.
Ƙungiyoyin Sin da sauran Asiya a Ingila da Amurka sun ba da rahoton ƙaruwar ƙididdiga saboda asalin, da sauran matsaloli.
Shugaban Amurka Donald Trump ya yi watsi da kiran cutar coronavirus " cutar kasar Sin " , wata kalma da ta zama kamar wata alama a idanun masu yin la'akari da ita.
Wata ƙungiya da ke zaune a Ukraine ta dakatar da motocin da ke dauke da 'yan Ukraine da kuma 'yan kasashen waje daga Wuhan zuwa Novy Sanzhary.
Daliban da suka dawo Arewa maso Gabashin Indiya, wanda ke da iyaka da China, da kuma waɗanda ke karatu a garuruwan Indiya sun kasance ba su da haɗari saboda cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata Party a jihar West Bengal Dilip Ghosh ya ce kasar Sin ita ce duniya kuma "Allah yana sa su yi fushi da ita".
Wani masanin jama'ar kasar Sin a Kolkata ya bayyana wannan a baya, ya kira shi "ba". A kasar Sin, nuna bambanci da kuma nuna bambanci ga al'ummar da ba sa zama na kasar Sin ya karu da cutar ta duniya, kuma baƙi an dauke su "abubuwan da za a iya ba da hadaya" da za a "ba da hadaya".
An yi amfani da takardun fassara da yawa da kuma takardun shaida don samun wasu ko duk wani bayani game da coronavirus.
Masu bincike da yawa sun yi magana game da wannan cuta ba tare da yin la'akari da wani abu ba.
Wasu masu bincike sun zaɓi rarraba bayanan su a kan layi kafin su buga su a kan takardu kamar bioRxiv.
Cutar da ta taso a baya, cuta da ta kamu da sabon cututtuka, yawanci ta haifar da ciwon daji ko kuma ciwon daji.
Duniyar da ke fama da annoba - bincike da yaduwar annoba
Yawan kamuwa da cuta da annoba a duniya - Yawan mutuwar da ake samu daga cututtuka marasa yaduwa
Dabbobin da ke kamuwa da cutar dabba - Dalilai na kiwon lafiya da ba su da alaƙa da kasuwancin dabba da ke shigowa.
Binciken gwajin cutar coronavirus 2019 (COVID-19) a cikin dakin gwaje-gwaje da kuma kwayar cutar da ba ta da alaƙa da SARS-CoV-2 ya haɗa da hanyoyin da za a iya tabbatar da cewa akwai cutar da kuma waɗanda ba su da lafiya da suka fito a matsayin amsa ga cutar.
Ana iya gano kasancewar kwayar cutar a cikin kwayoyin halitta ta hanyar RT-PCR, wanda ke tabbatar da RNA na coronavirus.
Wannan gwajin ya bambanta kuma ya shafi RNA na SARS-CoV-2 cutar.
Zai taimaka wajen gano sababbin cututtuka ko kuma cututtuka masu aiki.
Ana iya amfani da ƙididdigar jiki (ƙididdigar jini) don tantancewa da kuma kula da jama'a.
Binciken likitanci na iya bayyanawa mutane yadda suke da cutar, irin su waɗanda alamun cutar suke da yawa don su bayyana ko bayyana a fili.
Ana iya tantance yawan mutuwar da ke tattare da rashin lafiyar jama'a ta hanyar binciken da aka yi.
Saboda karancin bincike, a watan Maris na shekarar 2020 babu wata ƙasa da ta samu cikakken bayani game da yawan kamuwa da cutar a cikin al'umma.
A ranar 23 ga Maris, babu wata ƙasa da ta kai kashi 3% na yawanta, kuma akwai rahotanni da yawa game da yadda ake gudanar da bincike a cikin ƙasashe.
Wannan annoba tana shafar yawan mutuwar da ake samu daga cututtuka masu yawa, waɗanda yawanci mutane ke faɗaɗa su ta hanyar magana a wasu ƙasashe.
Yin amfani da gwajin polymerase chain reaction (rRT-PCR) na baya zai iya haifar da cutar huhu da aka samu ta hanyoyi daban-daban, kamar cutar ƙwayoyin cuta ko cutar hanci.
Sau da yawa, bayyanar cututtuka tana faruwa a cikin 'yan kwanaki ko kwanaki 2.
Gwajin RT-PCR da aka yi a kan kwayoyin halitta ya sa aka yi watsi da shi a cikin makon farko na cutar.
Daga baya, kwayar cutar za ta iya shiga cikin hanji kuma ta shiga cikin numfashi.
A cikin mutanen da aka gwada a mako na biyu, ana iya ɗaukar wasu kayan aikin numfashi ta hanyar numfashi ta hanyar yin amfani da kateter ko na'urar wanka (sandwich).
Daya daga cikin gwajin PCR na farko da aka yi a Charité a Berlin a ranar 20 ga Janairu, 2020 ta hanyar amfani da nazarin polymerase chain reaction (rRT-PCR) a baya, ya samar da kayayyaki 250,000 don rarrabawa ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta bayyana tsarin gwajin a ranar 23 ga Janairu 2020. Cibiyar samar da kwayoyin Kogenebiotech ta Koriya ta Kudu ta saki kayan gwajin SARS-CoV-2 na PCR (PowerChek Coronavirus) ga ma'aikatan asibiti a ranar 28 ga Janairu 2020.
Yana nazarin kwayoyin "E" na kowane beta coronavirus da muke da shi, da kuma kwayoyin RdRp na SARS-CoV-2. A China, BGI Group na ɗaya daga cikin cibiyoyin bincike na farko da suka amince da aikin gaggawa na gaggawa a Hukumar Kula da Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan K
Ɗaya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsarin gwajin da aka yi a baya ya nuna alamun rashin ƙarfi ga miyagun kwayoyin, da kuma wahalar gwaji a CDC a Atlanta; wannan ya ba da adadin gwaji na ƙananan zuwa 100 a kowace rana da aka gwada da kyau a cikin watan Fabrairu na 2020.
Binciken da kuma abubuwa biyu za su nuna tabbataccen bayani a ranar 28 ga Janairu, 2020, kuma bayan haka cibiyoyin bincike na gwamnati da na kasa za su samu damar fara bincike.
An amince da wannan binciken ne daga Hukumar Abinci da Magunguna a karkashin izinin Amfani da Gaggawa. Cibiyoyin bincike na kasuwanci sun fara binciken a farkon Maris 2020.
Daga ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a gudanar da gwajin COVID-19 na RT-PCR a gaban jama'a.
Quest Diagnostics ta kuma sanar da cewa ana samun gwajin COVID-19 a duk faɗin ƙasar tun daga ranar 9 ga Maris, 2020.
Babu wani bayani game da wannan adadi; an yi amfani da gwajin da aka yi a kan kwayoyin halitta kamar yadda CDC ta ba da shawara.
A Rasha, gwajin COVID-19 ya samo asali ne kuma an fara shi ne ta hanyar Cibiyar Nazarin Virology da Biotechnology ta VECTOR.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta amince da gwajin. A ranar 12 ga Maris, 2020, an ruwaito cewa asibitin Mayo ya fitar da gwajin gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta amince da FDA don ƙarin gwajin da zai iya faruwa a cikin kwanaki 3.5 da dubu, wanda ke ba da izinin yin gwaje-gwaje 4,128 a cikin kwanaki 24.
A ranar 19 ga Maris, 2020, FDA ta ba da takardar izinin gaggawa (EUA) a Abbott Laboratories don gwaji game da tsarin Abbott m2000; FDA ta ba da takardar izinin irin wannan a Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta amince da EUA daga FDA don gwajin da zai ɗauki kusan minti 45.
FDA ta amince da wani gwaji wanda ke amfani da fasaha na isothermal nucleic acid amplification a cikin PCR.
Don hana canje-canje a cikin saurin aiki da kuma sauƙin tsarin, za a iya ɗaukar sakamako mai kyau a cikin minti shida da kuma sakamako mara kyau a cikin minti 13.
Akwai umarni na irin wannan nau'in a Amurka kuma Abbott na son samar da shi don samun damar yin gwaje-gwaje 50,000 a rana. Ana amfani da wani gwaji na jiki da kafa ɗaya wanda ya ƙunshi nucleocapsid protein (N protein) sabon coronavirus a Taiwan, tare da tsammanin cewa za a iya samar da sakamako a cikin minti 15 zuwa 20 a matsayin gwajin gwaji kawai.
Wani bincike na wallafe-wallafen a watan Maris ya nuna cewa "radio-radiyo na zuciya yana da ƙananan sigogi a farkon matakan, amma CT [hoton hoto da kuma sauti] zai iya kasancewa kafin bayyanar cututtuka ta fara.
Sauran alamun CT sun haɗa da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Amma kuma yawanci ana samun ci gaba a cikin rashin lafiya, aiki da kuma rashin lafiya suna da nasaba da ci gaban cutar.
Wani binciken da aka yi na PCR da CT a Wuhan a lokacin da cutar ta fara ya nuna cewa CT ta fi dacewa da PCR, ko da yake ba a amince da shi ba, kuma ana iya samun hotunan hoto na zamani da sauran cututtukan pneumonia da cututtukan cutar.
A watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ce "ba za a iya amfani da CT ba don ganewa ko a matsayin hanyar farko na magance COVID-19". A watan Maris na shekarar 2020, CDC ta soke PCR don ganewa na farko.
A matsayin tushen tsarin rigakafi na mutum, ana samar da kwayoyin halitta kamar IgM da IgG.
Zai iya zama da amfani wajen gano cutar a cikin mutane tun daga farkon kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don gano nauyi, da kuma a cikin kulawar jama'a. Ana iya samun cututtuka ta hanyar cibiyar gwaji (CLT) ko kuma ta hanyar gwajin asibiti (PoCT).
Tsarin gwaji na zamani a cikin dakunan gwaje-gwaje da yawa na iya ƙayyade waɗannan shigarwar amma kasancewa su a cikin sauƙi ya dogara da yawan fitarwa na kowane tsari.
Ana amfani da CLT a cikin jini wanda yawanci ana amfani da shi a cikin jiki, ko da yake ana iya amfani da kwayoyin da ke bin shi don bin tsarin rigakafin jiki.
Ana daukar cutar PoCT ta hanyar zubar da jini ta hanyar yin allurar rigakafi.
Ba kamar tsarin PCR ba, matakin da aka bayar zai zama mai amfani kafin a yi gwaji. A ranar 26 ga Maris, 2020, FDA ta lissafa abubuwa 29 da ke ba da bayanan asibiti kamar yadda aka sani kuma yanzu za su iya yin gwajin likita.
A ranar 7 ga Afrilu, 2020, an gudanar da gwajin gwaji guda daya wanda FDA ta amince da shi don magance aikin gaggawa. A karshen watan Maris na 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun samu nasarar tabbatar da cutar.
Yawan gwajin zai iya yin gwajin jini a cikin kwayoyin halitta kuma ya fi sauri fiye da gwajin RNA na kwayar PCR da aka sani.
Ana lura da masu ilimin likitanci a cikin kwanaki 14 bayan fara cutar. A farkon watan Afrilu, Ingila za ta sami wani daga cikin kayan aikin gwajin likitancin da ya sayi da kuma amfani da su.
Hong Kong ta sake yin wani shiri na yin gwajin da ake zaton cewa mai cutar tana cikin gida, "masana gaggawa za su ba da maganin cutar ga mai cutar", su yi bincike a can, su yi bincike a kai, su kuma gano sakamakon daga baya. NHS ta Ingila ta ce tana jiran izinin yin gwajin gida, wanda zai kawar da matsalar da ke tattare da kamuwa da cutar ga wasu a asibiti, ko kuma ya hana motar daukar kwayar cutar. A lokacin gwajin mota don masu cutar COVID-19, likitan lafiya yana ɗaukar kayan aiki da kayan aiki.
Cibiyoyin gwajin mota sun taimaka wa Koriya ta Kudu ta gudanar da gwaje-gwaje masu yawa, kuma sun bazu a kowace ƙasa. A Jamus, National Association of Statutory Health Insurance Physicians ta ce a ranar 2 ga Maris, za a iya fitar da gwaje-gwaje 12,000 a cikin wuraren da za a iya hawa da mota kuma za a gwada 10,700 a cikin makon farko.
Likitan likita ba zai biya wannan gwajin ba idan likitan ya yi masa gwaji.
A cewar mai kula da cibiyar Robert Koch, Jamus za ta iya ɗaukar mutane 160,000 a mako guda.
A ranar 19 ga Maris, an yi wa motocin bincike a birane da yawa.
A ranar 26 ga Maris, 2020, an sanar da cikakken jerin gwaje-gwajen da aka yi a Jamus, domin an ba da rahoton cutar ne kawai.
Bayanai na farko na asibitin sun nuna cewa tun daga ranar 12/2020 an gwada akalla kwayoyi 483,295 a ranar 12/2020 tare da kwayoyi 33,491 (6.9%) da aka gano sun kamu da SARS-CoV-2). A Isra'ila, masu bincike a Technion da Rambam Hospital sun bayyana cewa an yi amfani da wani tsarin gwajin kwayoyi na sauran mutane 64 a lokaci guda, ta hanyar rarraba kwayoyi a cikin tsari guda kuma ana bin sahun idan sun hada da kwayoyi. A Wuhan, asibitin gaggawa na farko da aka gano "Huo-Yan" (Furaburruwa: 火眼, ko "Gite Yite" a cikin harshen Sin) ya rufe a ranar 5 ga Fabrairu 2020 ta hanyar BGI, wanda ya kiyasta cewa ana iya samun kwayoyi 10,000 a cikin kwanaki.
Tare da gina ginin da shugaban BGGI Wang Jian ya yi, wanda zai dauki kwanaki 5, binciken ya nuna cewa yawan marasa lafiya a Hubei zai karu da kashi 47% kuma kudin kula da mutane a cikin gidajen da ba a kula da su zai ninka idan adadin gwaje-gwajen ya bayyana a kan yanayin.
Cibiyar Wuhan Laboratory da cibiyar gwajin Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, da kuma cibiyoyin bincike a birane 12 a kasar Sin.
A watan Maris na shekarar 2020 adadin gwajin ya kai 50,000 a rana. An bude tsarin, an samar da wasu gwaje-gwaje na Origami wadanda zasu iya duba gwajin marasa lafiya 1122 da gwajin 93 kawai. Ana iya watsa wadannan gwaje-gwajen a kananan dakunan gwaje-gwaje ba tare da an yi amfani da ruwan robotic ba.
A watan Maris, adadin reagent ya ƙare kuma wannan ƙananan ya zama matsala ga gwaje-gwaje masu yawa a cikin EU da Ingila da Amurka.
Wannan ya sa wasu masu bincike sun yi bincike kan hanyoyin samar da magani wanda ya shafi yin amfani da kwayoyi a 98 °C (208 °F) a cikin minti 5 don fitar da kwayoyin RNA don wasu kwayoyin. A ranar 31 ga Maris, an sanar da Majalisar Larabawa cewa suna gudanar da bincike na musamman na coronavirus a kowace ƙasa, kuma yana da wuya a samu damar samun gwajin zuwa ga al'umma.
Wannan shi ne ta hanyar haɗa tsarin bincike na cikin mota, samar da cibiyoyin bincike masu iya ɗaukar mutane zuwa Group 42 da BGI (tare da cibiyoyin gwajin gaggawa na "Huo Yan" a China).
An gina dakin gwaje-gwaje na kwanaki 14 kuma zai iya karɓar dubban gwaje-gwajen RT-PCR a rana ɗaya kuma shi ne na farko a cikin irin wannan yanayin a wajen China.
An samu gwaje-gwaje daban-daban da suka shafi kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da tsarin Jamus na samar da kayayyaki masu kyau ga ƙasashe masu ƙarancin yawan kayayyaki da ba za su iya samar da nasu ba.
An fitar da tsarin Jamus a ranar 17 ga Janairu, 2020; kuma Hukumar Kula da Lafiya ta Amurka ba za ta bayyana ba kafin ranar 28 ga Janairu, wanda ke nufin cewa an kammala gwajin a Amurka. Sin da Amurka suna da matsala game da yadda za a iya amincewa da wannan gwajin a farkon annobar, kuma kasashen biyu da Ostiraliya ba su iya samar da kayan aikin gwaji na al'ada ba wanda zai iya amsawa ga bayanan da ke cikin gwajin likitocin.
A wani lokaci, masana sun ce gwajin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Tsarin gwaji, galibi a cikin dakunan gwaje-gwaje na kasuwanci, an samar da shi ne na shekaru da yawa ta gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta yi kira ga samar da shirye-shiryen gwaji a matsayin muhimmin mataki na rage yaduwar COVID-19. Ana gudanar da gwaje-gwaje masu tsanani saboda yaduwar cutar ta hanyar gwajin injiniya a cikin dakunan gwaje-gwaje na kasuwanci a Amurka, kuma kayan aikin sarrafa kwayoyin halitta da reagents suna da wuya.
A watan Maris na shekarar 2020, Cayni ta yi rahoton rashin amincewa da tsarin binciken ta.
A Amurka, kayan aikin bincike na kasar Sin da CDC ta fitar suna da "rubuce-rubuce", kuma gwamnati ta kafa takardun da za su iya sa a yi bincike ta hanyar wasu cibiyoyin bincike na gwamnati. Spain ta sayi kayan aikin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta gano cewa sakamakon bai dace ba.
Ma'aikatar ta ce, za a iya samun sakamako mai kyau a kan amfani da kwayoyi ko kuma yin amfani da kayan gwaji.
Ƙungiyar ta Spain ta ce za ta samar da kayan aikin bincike wanda zai dawo da bayanan da ba daidai ba, kuma za ta maye gurbin su da sauran kayan aikin bincike na Shenzhen Bioeasy. 80% na kayan aikin bincike da Czech Republic ta saya a China sun ba da bayanan da ba daidai ba. Slovakia ta sayi kayan aikin bincike miliyan 1.2 a China wanda aka gano cewa ba daidai ba ne.
Shugaban majalisar Matovič ya yi jayayya cewa ya kamata a yi amfani da shi a cikin kogin Danube. Ateş Kara na Hukumar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta sayo a China suna da "labarin amfani" kuma "ba za su yi amfani da su ba". "Ingilishi ya sayi kayan gwajin miliyan 3.5 daga China amma a farkon watan Afrilu ya ba da rahoton cewa ba za su yi amfani da su ba.
Bincike, biyo bayan sake dawo da waɗanda aka gano suna da cutar da kuma bincika waɗanda suka kasance ko sun kasance tare da masu cutar SARS-CoV-2, sun tabbatar da tasiri.
Masu bincike da ke aiki a birnin Vò na Italiya, inda aka fara samun cutar COVID-19 a Italiya, sun ba da takardun bincike ga al'ummar da suka kamu da cutar ta 3,400 a cikin kwanaki 10.
Kusan rabin mutanen da aka gano sun kamu da cutar ba ta da lafiya, kuma duk waɗanda aka gano sun kamu da cutar sun tafi da su.
Kuma ba a iya yin tafiya a cikin birnin ba, wanda ya hana kamuwa da cutar.
Tare da dawo da marasa lafiya, hana zirga-zirgar jiragen sama ga masu shigowa, bincike, da kuma hana mutane shiga, annobar coronavirus ta duniya ta 2020 a Singapore ta kasance mafi muni a cikin ƙasashe masu haɗari, amma ba tare da wata matsala ba kamar rufe gidajen abinci da ƙarfi ko wuraren cin kasuwa.
An dakatar da ayyukan da yawa, kuma a Singapore an fara ganin jama'a a gida a ranar 28 ga Maris, amma makarantu sun buɗe a kan lokaci bayan ranar 23 ga Maris.
Yawancin ƙasashe sun magance matsalar ta duniya ta hanyar hana mutane da kuma haɗuwa da marasa lafiya, hana zirga-zirga, bincike, da kuma fitar da mutane, amma tare da tsarin zama na gida mai sauƙi kamar Iceland da Koriya.
Nazarin kididdiga ya nuna cewa ƙasashen da suka fi fama da cututtuka, dangane da yawan mutuwar, yawan mutuwar sun fi ƙasa, saboda ƙasashe suna da tsari sosai don magance cututtukan da ba su da kyau ko kuma ba su da kyau.
WHO ta ce kasashen da ba su da tsarin gwaji da kuma cibiyoyin gwaji na kasa da ba su da cikakken bayani game da COVID-19 sun gabatar da magunguna shida da aka ƙayyade a matsayin masu cutar COVID-19 da kuma magunguna goma da aka ƙayyade a matsayin marasa cutar COVID-19 a cikin ɗaya daga cikin cibiyoyin gwajin 16 na WHO a matsayin hujja don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje 16, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka da 1 a Australia.
A cikin tebur na gaba, ƙungiyar "Rashin yawan bincike" ta rinjayi manufofin bincike na ƙasa.
Kasashen da ke kula da marasa lafiya ne kawai ke da yawan cututtukan da suka fi na asarar kashi 100 na gwaje-gwajen da ake yi wa al'ummarsu, ko da kuwa suna nuna alamun cutar ko ba su nuna alamun cutar ba, wasu abubuwa sun kasance marasa kyau.
Yin wanka da hannu, ko kuma wanke hannu, yana nufin wanke hannu don kawar da ƙasa, tufafi, kaya, ko wasu abubuwa marasa amfani.
Yin amfani da sabulu a hannu "a kowane lokaci" yana haifar da yaduwar cututtuka masu yawa, kamar su ciwon daji da kuma cutar kwalara, wanda ke gudana ta hanyar shan taba a bakinka.
Mutane za su iya kamuwa da cututtukan numfashi kamar kumburi ko kumburi, idan sun yi wanka kafin su taɓa idanunsu, haƙoran su ko bakinsu (kamar yadda ake magana da dabba mai kumburi).
Lokaci bakwai a cikin yini da ake bukatar wanke hannu da sabulu yana da muhimmanci: kafin da bayan haihuwa, bayan wanke yarinyar ko kuma wanke ta, kafin a yi wanka da kuma bayan ka sha abinci ko ka taɓa kwaskwarima, kifi, ko wani abu dabam.
Amma idan ba a wanke hannuwanka da sabulu ko ruwa, to, kada ka yi ta wankewa.
Kafin cin abinci, da safe, da kuma bayan cin abinci.
Kafin da kuma bayan ka yi wa mai haƙuri wanka.
Bayan an yi wa jariri kaciya ko kuma an yi masa renon jariri.
Bayan ka yi wa shanu shinkafa, ka yi ciki ko kuma ka yi ciki.
Bayan ka taɓa dabba, ka ƙone shi ko kuma ka ƙone shi.
Yin wanke hannu yana nufin yin amfani da hanyoyin da ake amfani da su wajen kula da lafiyar jiki.
Yin amfani da hannayen hannu kafin a ba da magani ko kuma yin amfani da magani a kan mai haƙuri zai iya hana ko kuma hana yaduwar cutar.
Yin tsabtace hannu yana da muhimmanci domin yana tsabtace hannu ta hanyar kawar da ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko ƙwayoyin cuta masu cutarwa) da kuma wasu abubuwa da za su iya cutarwa ko cutarwa.
Yana da muhimmanci ga mutanen da ba su da abinci ko kuma waɗanda ke aiki a fannin kiwon lafiya, amma kuma yana da muhimmanci ga dukan al'umma.
Yin amfani da hannu yana da amfani mai yawa, kamar hana yaduwar cutar, coronavirus, da sauran cututtuka; hana kamuwa da cuta; rage cutar numfashi;
kuma rage yawan mutuwar yara a gida.
Wani bincike a shekara ta 2013 ya nuna cewa yin amfani da wanka da hannu zai iya haifar da sakamako mai kyau a cikin ciwon yara har zuwa shekara bakwai.
A ƙasashe masu tasowa, yawan mutuwar yara da ke tattare da cututtukan numfashi da kuma rashin lafiya za a iya ragewa ta hanyar shigar da canje-canje a halayyarsu, kamar wanke hannu da sabulu.
Wannan zai iya rage yawan mutuwar da ake samu daga cutar da kashi 50%.
Hanyar wanke hannu mai tsabta na iya rage yawan cututtuka ta kashi uku, wanda ba daidai ba ne da samar da ruwa mai tsabta a wuraren wankewa.
Kashi 48% na rage yawan cututtukan da ke tattare da wanke hannu da sabulu. Yin amfani da sabulu a hannu shine mafi inganci da kuma mafi ƙarancin hanyar magance cututtukan da ke tattare da cututtukan numfashi (ARI), irin su dabi'un da muke yi a gidaje, makarantu, da kuma al'ummomi a duniya.
Ciwon huhu, cutar ARI a cikin yara, ita ce babbar cuta da ke kashe yara a ƙarƙashin shekara bakwai, wadda ke kashe kusan yara miliyan 1.8 a kowace shekara.
Ciwon huhu da kuma ciwon huhu suna kashe yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin yin barci ko kuma a lokacin da muke yin aiki a cikin gida zai iya ceton rayuka da yawa daga allurar rigakafi ko magunguna da za mu iya ɗauka, da kuma mutuwar kamuwa da cuta da mutuwa daga rashin lafiya na numfashi.
Yin amfani da hannayen hannu yana da nasaba da wasu hanyoyin kiwon lafiya kamar su tsarin ruwa, tsabtace jiki da kuma tsabtace jiki (WASH).
Yin addu'a da hannuwanmu na iya zama da wuya saboda rashin lafiyar jiki.
Wataƙila, wanke hannuwanmu a kai a kai zai sa mu yi rashin lafiya domin muna da rauni.
Wani bincike na Danish a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya haifar da ciwon jiki mai tsanani kamar eczema ko dermatis na hannu, wanda ke da matukar damuwa ga ma'aikatan kiwon lafiya.
Rashin ƙwayar cuta yana kama da rashin lafiyar ƙwayar cuta (OCD).
Akwai lokatai guda bakwai da ake bukatar wanke hannu da sabulu don rage yaduwar cutar daga bakin: a lokacin da aka fara fita daga cikin gida (dukiya, shaye-shaye), bayan an yi wankewar jariri (sandakewa), kafin a yi wanka, kafin a yi wanka/bayan an yi wanka da abinci ko kuma bayan an taɓa kayan da ba a yi wanka ba, da kuma kayan da ba a yi wanka ba.
Wasu lokutan da yin wanka na hannu zai iya taimakawa wajen kawar da cututtukan da ke tattare da wasu cututtuka sun haɗa da kafin ko bayan wankewa a kan albasa; bayan wankewa, wankewa, ko wanke haƙori; bayan taɓa ƙusa ko taɓa dabba; da kuma bayan taɓa gida.
A ƙasashe da yawa, yawan mutanen da suke shan taba da sabulu yana raguwa.
Wani bincike a shekarar 2014 ya nuna cewa Saudiyya ta samu kashi 97% na yawan masu amfani da sabulu a hannu. Amurka ta samu kashi 77% a tsakiya; China ta samu kashi 23%. Ana samun ci gaba da yin amfani da sabulu a wasu lokutan da suka dace. Kungiyoyin da ke amfani da sabulu a lokacin makaranta suna da amfani da sabulu a matsayin hanyar da za a iya amfani da ita a ƙasashe masu iko don shigar da halaye masu kyau na sabulu a cikin haƙƙin yara.
Shirin Kula da Lafiya na Muhimmanci da Hukumar Ilimi ta Philippines ta kafa ya zama misali na tsarin da za a ba da daraja ga lafiyar jiki da kuma tunanin yara.
Yin amfani da sabulu sau biyu a shekara, da kuma yin amfani da fluoride a cikin kayan aiki, yana da muhimmanci a tsarin kasa.
An kuma yi amfani da shi sosai a Indonesia.
Ana iya cire ƙwayoyin cuta daga jiki ta hanyar ƙara sabulu ko ruwa mai tsabta.
Da farko, sabulu da ruwa masu tsabta suna taimakawa wajen rage yawan lalacewar tsarin, da kuma inganta yanayin barci.
Wasu ruwa mai dadi suna kama da ruwa mai laushi don ƙwayoyin cuta da furotin, abubuwa ne da suka samo asali daga ƙasa, ba za a iya cire su daga ruwa ba.
Amma dai sai a wanke shi da ruwa mai tsabta.
Sabulu mai tsabta, domin yana da amfani da shi, zai iya ƙunsar ƙwayoyin cuta da suka shiga ciki a lokacin da aka yi amfani da shi.
Ƙananan nazarin da suka yi nazarin yadda kwayoyin cuta suke rayuwa daga sabulu na dabba sun nuna cewa ba za su iya rayuwa ba saboda kwayoyin sun bar rayuwa.
CDC ta kuma ce "sabo na ruwa mai ruwan sama da aka yi amfani da shi a hannu ba zai iya shafar yaduwar cutar ba".
Ana ba da shawarar sabulu mai ƙonewa da ƙwayoyin cuta ga jama'a masu tunani game da lafiyarsu.
A halin yanzu, babu wata hujja da ta nuna cewa amfani da maganin kashe kwayoyin cuta ko magungunan kashe kwayoyin cuta yana sa a zabi kwayoyin da suka fi dacewa da maganin kashe kwayoyin cuta.
Duk da haka, samfurori masu ƙonewa suna da kayan kashe kwayoyin halitta kamar triclosan, wanda ke da ƙwayoyin cuta masu yawa.
Bugu da ƙari, ko da yake kwayoyin da ke da lahani a cikin maganin rigakafi za su iya yin amfani da sabulu wanda ba zai kashe ƙwayoyin cuta ba, ba za su iya zama masu ƙarfi kamar yadda aka nuna a cikin rashi ba.
Domin karawa da surfactant da kayan aikin tsaro, hada kayan aiki na iya samar da acid (acetic acid, ascorbic acid, lactic acid) kamar mai bada PH, benzoic acid wanda ke kashe kwayoyin cuta da kayan aikin rigakafi (aloe vera, bitamin, menthol, magani). Bincike daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu mara amfani yana da karfi daya da sabulu da aka nuna wa masu amfani da triclosan don hana cututtuka da kuma kawar da kwayoyin cuta.
Ruwan da ke cikin ruwa mai tsabta don wanke hannu zai iya taimakawa wajen kashe kwayoyin cuta.
Kwayoyin suna cin abinci da sauri tare da ƙarancin jiki (37 °C).
Amma, ruwan sabulu da ruwan sanyi suna da amfani sosai fiye da ruwan sanyi don kawar da ƙwayoyin cuta da ke tattare da kwayoyin cuta.
Ba kamar yadda mutane suke zato ba, nazarin masana sun nuna cewa wanke hannu da ruwa mai laushi yana da amfani ko kuma yana da amfani wajen rage yawan rashin lafiyar hannu.
Kayan wanke hannu ko maganin hana kamuwa da cutar hannu na iya zama kayan wanke hannu amma ba kamar ruwa ba.
A ƙarshen shekarun 1990 da farkon karni na 21, kayan aikin wanke hannu da giya da kuma kayan wanke hannu (wanda ake kira kayan wanke hannu da giya, kayan wanke hannu masu maganin sauro, ko kayan wanke hannu) sun fara bayyana sosai.
Yawanci suna dogara ne akan isopropyl alcohol ko ethanol wanda aka haɗa da kayan aiki na fasaha kamar Carbomer (polymer acrylic acid) a gel, ko kayan aiki na sanyaya kamar glycerin a cikin ruwa, ko kuma iska don samun aiki mai sauƙi da kuma rage yawan abin da giya ke motsawa.
Ƙara yawan hydrogen peroxide da ke shiga cikin jiki yana taimakawa wajen kashe ƙwayoyin cuta. Tsabtace hannu mai dauke da barasa daga 60 zuwa 95% yana da amfani sosai wajen kashe ƙwayoyin cuta.
Kayan wanke hannu da barasa suna kashe kwayoyin cuta, ƙwayoyin cuta masu tsanani (MRSA da VRE), cututtukan cuta, da sauran ƙwayoyin cuta (kamar HIV, herpes, RSV, ƙwayoyin cuta, allurar rigakafi, cutar sankara, da kuma fungi).
Kayan tsabtace hannu da giya mai dauke da kashi 70% na giya zai kashe kashi 99.97% (ƙimar log 3.5, a cikin rage na decibel 35) na kwayoyin cuta a cikin dakika 30 bayan shan su da kashi 99.99 zuwa 99.999% (ƙimar log 4 zuwa 5) na kwayoyin cuta a cikin minti 1 bayan shan su. Kayan tsabtace hannu suna da amfani ga kwayoyin cuta kuma suna da amfani ga wasu ƙwayoyin cuta.
Aikin wanke hannu da giya yana da matukar rauni saboda irin wannan cutar ta fata (ko Norwalk), wanda aka fi sani da cutar ta numfashi. Aikin wanke hannu da maganin kashe kwayoyin cuta ko kuma giya dole ne a yi amfani da shi don samun tsabtace hannu da kuma rufe hannuwan biyu.
Kafin da bayan da aka yi amfani da shi a cikin ruwa, a cikin ruwa ko a cikin gel, sai a shafe minti 30.
Dole ne a yi wa masu bi wanka sosai, ta hanyar yin musu wanka da hannu biyu. Hukumar Kula da Cututtuka ta Amurka ta ba da shawarar yin wanka da hannu a kan yin aikin wanke hannu, musamman idan hannu ya zama kamar yana da hannu.
Ƙarin haɗuwa da kayan aiki yana da wuya a yi amfani da shi kuma yana kashe ƙwayoyin cuta; duk da haka, ba zai iya zama kamar yadda za a yi amfani da shi don cire hannayen hannu ba tare da sabulu da ruwa ba.
Yin amfani da kayan wanke hannu da giya a kai a kai zai iya haifar da rashin lafiyar jiki idan kayan wankewa sun ƙaru a cikin haɗuwa.
Ana iya rage ko kuma dakatar da shan giya ta hanyar ƙara glycerin da/ko wasu abubuwa masu ƙonewa a cikin cakuda.
Binciken da aka yi a cikin dakin gwaje-gwaje ya nuna cewa kayan wanke hannu da ke dauke da kayan wanke hannu a ciki ba za su iya wanke hannu a kan sabulu ko kayan wanke ba.
Allergic contact dermatitis, cututtukan urticaria ko kuma rashin tausayi ga barasa ko kuma abubuwan da ke cikin kayan wanke hannu da barasa suna kaiwa ga rashin lafiya.
Ƙarƙashin ƙwayar cututtukan fata na irritant yana da kyau idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da ƙarfi, to, ba za su iya yin wanka da hannu ba, sai dai su yi wanka.
Domin wannan na'urar wanke hannu ba ta da ƙarfi kamar sabulu da ruwa don hana yaduwar cututtuka, saboda akwai cututtuka a hannu.
Ƙarfin kayan aikin wanke hannu ba tare da shan barasa ba ya dogara da abin da ke ciki, kuma tarihi ya nuna mana cewa zai iya zama mai ƙarfi ga kayan aikin wanke hannu da giya.
Daga baya, wani magani da ya ƙunshi benzalkonium chloride ya nuna cewa yana da ƙarfi sosai kuma yana da ƙarfi bayan amfani, ba kamar giya ba, wanda ke nuna cewa yana da ƙarancin ƙarfi bayan ci gaba da amfani da shi don amsa ga rashin lafiyar jiki.
Mutane da yawa a cikin al'ummomi masu talauci ba su da sabulu kuma suna aiki da rashin ƙarfi.
Ƙasa ko ƙasa za su iya zama kamar ruwa, amma za su iya zama kamar sabulu.
Wata matsala ita ce, ko kuma ko wani abu mai kama da daji ko ƙasa mai ƙarancin ƙwayoyi zai iya ƙara yaduwar cutar fiye da rage shi.
Kamar sabulu, duhu yana da amfani wajen kashe ƙura domin idan ya haɗu da ruwa, zai zama kamar ƙura.
WHO ta haramta yin amfani da sabulu ko kuma kayan lambu.
Tsarin wanke hannu na Hukumar Kula da Cututtuka da Cututtuka ta Amurka ya bada shawarar wadannan matakan:
Ka wanke hannuwanka da ruwa mai laushi ko kuma mai laushi.
Ana ba da shawarar ruwan da aka yi amfani da shi don mai riƙe da ruwa zai iya zama da rashin lafiya, kuma ruwan da aka yi amfani da shi ba zai iya canza wasu abubuwa ba.
Ka yi ta yin wanka da sabulu a hannunka, domin ya fito daga numfashi, daga ƙafafunka, daga tsakanin ƙafafunka, da kuma daga cikin ƙafarka.
Sabulu yana kawar da ƙwayoyin cuta a jikin mutum, kuma bincike ya nuna cewa mutane sun fi so su wanke hannayensu idan sabulu ya wanke su da ruwa mai dafa abinci.
Ka yi barci aƙalla na biyu na 20.
Wannan yana haɗa hannaye, yana cire ƙwayoyin cuta, kuma yana sa ƙwayoyin cuta da yawa su zama ƙwayoyin cuta.
Ku yi addu'a da ruwa mai zurfi.
Yin amfani da ita a cikin miya zai iya sa hannu ya sake yin amfani da ita.
Amma ku yi ado da tufafi masu tsabta ko kuma da iska.
Ƙarƙashin hannuwanka ma za su iya yin aiki a kan ƙafafunka. Ƙarƙashin hannuwanka da ƙuƙwalwar hannuwanka da ƙuƙwalwar ƙafafunka da ƙuƙwalwar ƙafafunka su ne wuraren da mutane suke yin aiki.
Ƙananan ƙwayoyin da aka yi amfani da su ko kuma waɗanda aka yi amfani da su a cikin yanayi mai wuya suna iya ƙunsar ƙwayoyin cuta.
Ana ba da shawarar yin amfani da maganin rigakafi don maganin rigakafi; kula da jiki na iya zama wani abu da zai iya rage yaduwar cutar.
Wasu hanyoyin da ba su da kyau za su iya taimakawa wajen wanke hannu a wuraren da ruwa ya yi sanyi da/ko sabulu ya yi sanyi, kamar su rufin ruwa a cikin kwanon rufi ko kuma a cikin matakala da/ko ɗaukar inuwa idan ya dace kamar a ƙasashe masu ruwa mai yawa. A lokacin da ruwa ya yi yawa (kamar a makarantu ko gidajen abinci a ƙasashe masu ruwa mai yawa), akwai hanyoyin da za a iya ajiye ruwa, kamar "tippy-taps" da sauran hanyoyin da ba su da kyau.
Tippy tap wani tsari ne na musamman wanda ke haifar da wani abu mai ban sha'awa game da kayan aiki da kuma wasu abubuwa da za su iya sauka daga ƙasa don samun ƙananan rufi a hannayen hannu da kuma sabulu.
Yin wanka da hannu yana da muhimmanci a matsayin hanya mai kyau don yin wanka da hannu, amma akwai wani zaɓi na yin wanka da hannu a cikin ɗakin jama'a.
Yawancin bincike na yanzu yana ba da shawarar cewa a ajiye takardar shaidar gida don a yi amfani da ita a cikin ɗakin jama'a.
A shekara ta 2008, wani bincike da aka gudanar a Jami'ar Westminster, London, tare da taimakon wani dakin gwaje-gwaje na Turai Tissue Symposium, ya gwada yadda za a yi amfani da kayan shafawa a cikin dakin, da kuma yadda za a yi amfani da iska don yin amfani da hannayen hannu.
Bayan wanke hannu da kuma yin amfani da hannayen hannu, dukkanin kwayoyin da aka gano sun ƙaru a cikin takalmin namiji da kashi 194% da kuma kashi 254%.
Yin amfani da kayan shafawa na iska ya nuna cewa akwai karuwar kwayoyin cuta a cikin fararen fata na maza da kashi 42% da kuma a cikin fata na 15%.
Bayan an yi amfani da takarda mai kyau, adadin kwayoyin cuta a cikin takarda na maza ya ragu da kashi 76% da kuma a hannun zuwa 77%. Masu bincike sun gudanar da gwaje-gwaje don sanin ko za a iya samun kamuwa da cutar daga takarda mai kyau zuwa takarda mai kyau da kuma takarda mai kyau kamar yadda a cikin binciken kowane hanya.
Tsarin iska mai iska, wanda ke busa iska da sauri na 180m/s (650 km/h; 400 mph), zai iya fitar da iska daga hannun jirgin kuma zai iya lalata mutanen da ke tafiya a kusa da ɗakin da kuma wani wuri mai nisa na 2 mita.
A cikin tsari na yin amfani da hannayen da aka yada a cikin mita 0.25 da kuma a cikin tsari na yin amfani da shi.
Wani takarda na gida zai nuna yadda ake rarraba kayan aiki. A shekara ta 2005, a wani binciken da TÜV Pordukt und Umwelt ta gudanar, an gano wasu hanyoyin da za a iya yin amfani da su wajen kawar da cutar.
Ka lura da sakamakon da aka samu a cikin adadin kwayoyin bayan an wanke hannayen:
Akwai masu yin aikin hannu dabam dabam, da kuma masu yin aikin hannu a kan ƙofar ɗakin.
Yin amfani da kayan wanke hannu da kuma wanke kayan wanke hannu na iya zama wani zaɓi a lokacin tafiya idan babu sabulu da ruwa.
Abubuwan da ke tsabtace jiki da barasa dole ne su ƙunshi aƙalla kashi 60 cikin ɗari na giya.
Maganin hannu ya zama dole domin likitan Hungary Ignaz Semmelweis ya gano cewa yana da amfani (a cikin 1846) don magance cutar a wani asibiti.
Akwai umarni da ke ba da shawara ga ma'aikatan asibiti su wanke hannayensu a lokacin da suka dawo.
Wasu bincike sun nuna cewa yawan cututtuka ya ragu idan aka yi amfani da shi.
Yin amfani da hannayen hannu zai ɗauki akalla 15 seconds, kuma sabulu kaɗan da ruwa ko gel za su iya yin numfashi da kuma wanke shi.
Ya kuma yi wa Yahuda da sauran karnuka magana mai kyau.
Idan akwai wani abu a cikin tufafi, ana iya amfani da bros don cire tufafi.
Don haka, kamar yadda yake da kyau a wanke hannayenmu, haka kuma a yi wanka da kyau da kuma yin ado da kyau.
Bayan ya shiga, dole ne ya ɗauki wani ƙaramin ƙofa don ya rufe ruwa (kuma ya buɗe ƙofar idan akwai).
Domin kada ka yi wa hannunka laifi.
Manufar wanke hannu a wurare masu lafiya na jiki shine don kawar da ƙwayoyin cuta ("ƙwayoyin cuta") da kuma hana su yadawa ga wasu.
The New England Journal of Medicine ta ce yin amfani da wanka na hannu a cikin jiki yana da kyau a yawancin wuraren kiwon lafiya, kuma likitoci da masu kula da marasa lafiya suna yin amfani da wanka na hannu kafin su taɓa marasa lafiya, wanda ke haifar da cutar ga wasu mutane.
Wani bincike ya nuna cewa wanke hannu da hannu da sauran sigogi na iya rage cututtukan da ke tattare da cututtukan jini da kashi 66%. Hukumar Lafiya ta Duniya ta ba da rahoton da ya nuna wanke hannu da kuma wanke hannu a wuraren kiwon lafiya.
Ana samun takardar shaidar tsabtace hannu a shafin yanar gizonmu don amfanin jama'a.
Wani bincike mai muhimmanci ya faru ne da Whitby et al.
Dokokin kasuwanci na iya gwadawa da kuma yarda da tsabtace jiki, idan akwai tabbaci na bin waɗannan dokoki.
Hukumar Lafiya ta Duniya tana da "Lokaci na Biyu" don wanke hannu:
bayan ya shafi jini/ji
kafin aikin kula da marasa lafiya, da
Ƙara kayan wanke hannu a sabulu (sabulu "kayan lafiya" ko "sanya kayan wanke") yana ƙara yawan kashewa a cikin kayan wanke hannu.
Irin wannan aikin kashewa zai iya zama da amfani kafin a kai ga mai haƙuri ko a wurin da akwai ƙwayoyin cuta masu cutarwa. Don 'sanin' hannu a wurin da ake kai ga mai haƙuri, yana da muhimmanci a sami ruwa mai tsabta wanda mutum zai iya buɗewa ko rufewa ba tare da taɓa shi ba, wanke shi da chlorhexidine ko iodine, da takalma da ba a taɓa amfani da su ba, da kuma goga mai tsabta da kayan wankewa don wanke ƙwayoyin cuta.
Sai ya kawar da dukan abin da yake a ciki.
Jirgin yana motsa hannuwansa daga ƙasa zuwa ƙasa, yawanci na minti 2-6.
Yin amfani da lokaci mai tsawo fiye da minti 10 ba shi da amfani.
Da rana ta yi, sai ruwa ya sake faɗuwa a hannunsu.
Bayan ya gama wanke hannuwansa, sai ya sa tufafi masu tsabta a hannunsa, ya sa tufafi masu tsabta a kansu.
Don rage yaduwar cututtuka, yana da muhimmanci a wanke hannuwanku ko kayan aikin wanke hannu kafin da bayan yin amfani da su a wurin marasa lafiya.
Domin maganin rashin lafiyar staphylococcus a asibitoci, an nuna cewa yawan riba a cikin tsabtace hannu ya kai kashi 20% na farkon cutar, kuma wannan karamin karuwa ya faru ne lokacin da yawan tsabtace hannu ya karu da kusan 35%.
Yin amfani da sabulu na yau da kullum ya nuna sau uku yawan kamuwa da kwayar cuta mai cutarwa da ke shiga cikin abinci bisa ga abinci da kuma wankewa da sabulu mai kashe kwayoyin cuta. Wani bincike na wanke hannu da sabulu mai kashe kwayoyin cuta a cikin dakika 30 daban-daban ya nuna cewa wanke hannu da aka yi da kayan da ke dauke da barasa ya rage yawan kamuwa da kwayoyin cuta da kashi 26% fiye da wanke hannu da sabulu mai kashe kwayoyin cuta.
Amma sabulu da ruwa sun fi dacewa da kayan tsabtace hannu masu amfani da giya don rage cutar cutar H1N1 A da Clostridium difficile spores a hannun. Hanyoyi don inganta tsabtace hannu a cikin wuraren kiwon lafiya na iya haɗawa da sanin ma'aikata game da tsabtace hannu, wanda ke hana shan kayan tsabtace hannu masu amfani da giya, da kuma amfani da rubutu da na bakuna ga ma'aikata.
Akwai bukatar ƙarin bincike don ganin cewa waɗannan hanyoyin suna da muhimmanci a wasu fannoni na kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu suna da kyau, suna da amfani ga lafiyar jiki, da kuma abinci mai gina jiki.
Ko da yake, wanka mai kyau ko ruwa mai kyau, sabulu ko kuma wuraren wanka na dogon lokaci a gidajen mutane, a makaranta da kuma a wurin aiki suna da wuya a san su a matsayin halaye masu kyau na wanke hannu.
Alal misali, a yawancin ƙasashen Afirka, yana da wuya a sami wuraren wanke hannu da ruwa mai kyau don rufe mutum ko al'umma, ko da yake akwai hanyoyin gina wuraren wanke hannu da suka dace.
Amma, ƙila yawan wankewar jiki zai iya raguwa domin ba su da sabulu ko ruwa.
Jin daɗi da kuma sha'awar yin amfani da sabulu na iya shafar siyasa, ya nuna amfanin yin amfani da sabulu na hannu kuma ya canza halin jama'a a nan gaba.
Domin wannan tsarin ya yi aiki da kyau, kula da bincike yana da muhimmanci.
Wani bincike na nazarin 70 ya nuna cewa yin amfani da kayan wanke hannu a cikin jama'a yana da muhimmanci wajen rage yawan wanke hannu a LMIC, wani lokaci kuma yana da tasiri ga jama'a don sayen kayan wanke hannu ga yara. Wani dalili kuma na cewa rashin amfani da wanke hannu a makarantu shine abin da ake kira "Mataki na Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakan da suka dace don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran hanyoyin tsabtace hannu.
Idan an samu tarurruka na farko, za a iya samun ci gaba daga kashi ɗaya zuwa uku.
Yin amfani da kayan wanke hannu na iya zama cikin hanyoyin da ake amfani da su wajen wanke hannu don rage cututtuka da mutuwar yara.
Ranar Duniya ta Cin Hanci da Sawu ta zama wani abin da ya nuna rashin amincewar da ake yi wa 'yancin jama'a da ke sa mutane su yi canje-canje a halayensu. Saboda annobar korona ta 2019-20, UNICEF ta kasa amincewa da batun cin hanci da sawu.
Kadan daga cikin binciken sun nuna cewa akwai kudin da za a iya amfani da shi don yin amfani da kayan shafa a ƙasashe masu tasowa kamar yadda DALY ta ruwaito.
Amma, akwai wasu bincike da suka nuna cewa yin wanka da sabulu a hannu ya fi dacewa da wasu hanyoyin ruwa ko magani.
Rashin wanke hannu a rayuwar mutum, mafi yawan al'ummomin da ke fama da wasu matsaloli kamar masu rauni ko kuma marasa lafiya da ke asibitoci, ya faru ne a tsakiyar 1900 ta hanyar masu fafutukar tsabtace jiki: Ignaz Semmelweis, wani masanin Hungary da ke aiki a Vienna, Austria da Florence Nightingale, "mahaifiyar likitancin" na Ingila.
A lokacin da mutane da yawa suka yi zaton cewa cutar ta samo asali ne daga cikin cututtukan da ba za a iya warkar da su ba.
A shekara ta 1980, cututtukan abinci da cututtukan lafiya sun sa Ma'aikatar Kula da Cututtuka da Cututtuka ta Amurka ta amince da tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cutar.
Kashewar cutar zazzabin cizon sauro a shekara ta 2009 da kuma barkewar cutar COVID-19 a shekara ta 2020 sun kara da cewa a ƙasashe da dama ana bukatar yin amfani da sabulu da wanke hannu don kare kai daga irin wannan cuta.
Alal misali, hotuna da "saƙon wanka na musamman" suna fitowa a wuraren wanke hannu a wasu gidajen jama'a da kuma wasu dakunan aiki da kuma tashar jiragen sama a Jamus.
Kalmar nan "sa hannuwansa ga" wasu abubuwa, tana nufin cewa ka nuna cewa ba za ka iya saka kanka cikin wani abu ko wani abu ba a matsayin mai taimako.
Ya fara ne daga littafin Matta inda Pontius Bilatus ya sa hannunsa a kan Yesu Kristi, amma yana da wani abu da ya shafi jama'ar Ingila.
A cikin Macbeth Shakespeare, Lady Macbeth ta fara da wanke hannayenta don neman yadda za ta gane wasu kurakurai a zuciyarta, wanda ya nuna laifinta ga kisan da ta yi wa mijinta a cikin shekaru.
An kuma ga mutane suna ƙyale abubuwa masu tsarki ko kuma su yi tunani a kansu, suna sa hannuwansu su zama mafi tsattsarkansu fiye da na wasu, ba sa girmama abubuwan da suke wanke hannu.
Amma, mutanen da suke da alhakin wanke hannuwansu bayan irin waɗannan abubuwa ba za su iya yin amfani da "tsabtace" a matsayin taimako ba.
Addinai suna ba da shawarar yin wanka a hannu don yin tsabta da kuma nuna alama. Wanke hannu, da ruwa ba tare da sabulu ba, yana cikin al'adun addinai da yawa, kamar Baha'i, Hindu, tevilah da netilat yadayim a Yahudanci, Lavabo a cikin Masallaci, da kuma Wuda a cikin Musulunci. Addinai kuma suna ba da shawarar yin wanka a hannu, musamman bayan al'amuran.
Hindu, Yahudanci da Musulunci sun yi watsi da yin watsi da gidajen.
Addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun bada shawarar wanke hannu kafin da kuma bayan kowane abinci.
Hanyoyin haɗari a wurin aiki don COVID-19
Kula da haɗarin aiki na COVID-19 shine tsarin da za a yi amfani da shi a cikin yanayin aiki da kuma kiwon lafiya don hana cutar coronavirus 2019 (COVID-19).
Manufofin tsaro a wurin aiki sun bambanta da wurin aiki da kuma irin aikin da ake yi, dangane da kimanta haɗarin zama, yadda ake kamuwa da cutar a cikin al'umma, da kuma abubuwan da ke sa ma'aikata su kamu da COVID-19.
Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OSHA) ta ce, irin wannan aikin ba shi da haɗari ga yin amfani da manyan motoci tare da jama'a ko ma'aikata, wanda ake ba da shawarar matakan rigakafin farko, kamar wanke hannu, hana wasu ma'aikata zama a gida idan sun kamu da cutar, kula da numfashi, da kuma tsabtace da kuma tsabtace wuraren aiki.
Ayyukan da ke da haɗarin kamuwa da cutar na iya kasancewa waɗanda suka rayu da waɗanda suka kamu da cutar ko kuma waɗanda suka kamu da cutar COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar hanyar ƙaurawar jama'a ko ta hanyar tafiya zuwa wata ƙasa.
Wannan ya shafi ma'aikata masu iya aiki da kuma jama'a kamar makaranta, wurin aiki da ke da yawan jama'a, da kuma wuraren da ake sayen kayayyaki masu yawa.
Abubuwan da ke cikin haɗarin wannan rukunin, ban da matakan rigakafin cutar na farko, sun haɗa da yin amfani da umarnin hana yaduwar kwayoyin cuta, yin amfani da tufafin da ke rufe jarirai, da kuma sanya tufafin kariya na sirri da ke samuwa idan kana tare da wani wanda ke da COVID-19.
OSHA ta lissafa ma'aikatan kiwon lafiya da ma'aikatan da suka mutu a matsayin wadanda suka tabbatar da cewa ko kuma wanda zai iya kamuwa da COVID-19 yana da haɗarin kamuwa da cutar, wanda ke kara haɗarin kamuwa da cutar idan ma'aikatan suka yi amfani da iska mai guba, ko suka yi amfani da, ko sun sha miyagun ƙwayoyi, ko kuma sun kamu da COVID-19.
Abubuwan da ke da muhimmanci ga irin wannan ma'aikata sun haɗa da matakan injiniya kamar su ɗakunan iska masu kyau, da kuma kayan rufewa da ke tattare da aikin.
Cutar COVID-19 na iya haifar da haɗari a wurin aiki.
Ma'aikata suna iya kasancewa a wurin aiki don sun kamu da cuta, don su so su yi wanka, ko kuma don tsoron kamuwa da cuta.
Alamar kasuwanci na iya bambanta, dangane da abin da suke so, da kuma yadda za a iya samun kayan (kamar sayen kayan a lokacin da kayan aiki ba su da yawa, ko kuma ta hanyar mutanen da ba su dawo da su gida ko a cikin motoci.
A ƙarshe, ana iya dakatar da cire kayan daga wuraren da COVID-19 ke da tasiri sosai. Tsarin shiri ko maganin cutar zai iya zama da amfani wajen kare ayyukan.
Shirye-shiryen suna rage haɗarin haɗari da ke tattare da duk wuraren aiki da irin waɗannan ayyukan, kamar su nuna kai, abubuwan da ke iya ƙara haɗarin gida a cikin al'umma, da abubuwan da ke iya ƙara haɗarin mutanen da ke amfani da su kamar rashin lafiya ko wata cuta mai zuwa.
Sun kuma kafa matakan hana irin wannan hatsarin, da kuma tsare-tsaren da za a yi don a hana su daga cutar.
Shirye-shiryen da kuma shirye-shiryen da za a yi don magance cutar za su iya shiga cikin jihohi ko jihohi.
Hanyoyin da za a iya magance cutar sun haɗa da kula da masu aiki, kula da mutane da ke fuskantar haɗarin kamuwa da wasu cututtuka, ci gaba da kasuwanci, da kuma rage wasu haɗarin a wani wuri a cikin aikin su.
Rashin lafiyar al'umma a cikin masana'antu yana shafar tsarin da aka tsara.
Tsarin tsaro na haɗari shine tsarin da ake amfani da shi a fannonin lafiya da kiwon lafiya don samar da tsaro ga ƙungiyoyi da kuma amfanin su.
A wani wuri da ba za a iya kawar da haɗarin COVID-19 ba, dole ne a yi amfani da matakan tsaro na injiniya, sannan a yi amfani da matakan tsaro, kuma a ƙarshe a yi amfani da kayan rufewa.
Gudanar da aikin injiniya ya ƙunshi hana ma'aikata haɗarin aiki ba tare da la'akari da halayyar ma'aikaci ba, kuma yana iya zama hanya mafi inganci.
Ayyukan ma'aikata sune canje-canje a cikin manufofin aiki ko tsarin da ke buƙatar haƙƙin ma'aikaci ko mai gudanarwa.
Kayan kare lafiyar mutum (PPE) ba su da ƙarfi ga aikin injiniya da aikin injiniya, amma suna iya zama masu amfani ga aikin tsaro a wasu wurare.
Kowane PPE dole ne a zaɓi shi bisa ga haɗarin mai amfani, wanda ya dace (kamar umarnin yin iska), ana iya sa shi da kyau kuma a iya gyara shi, bincika shi, tsabtace shi, kuma a canza shi idan ya dace a kan lokaci, cire shi da kyau, adana shi, adana shi ko kuma ya ba da shi don lalacewa.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Aiki ta Amurka (OSHA), aikin da ba shi da wata hujja ba zai iya zama da haɗari ga jama'a ko ma'aikata.
Abubuwan farko da ake ba da shawara a wuraren aiki sun hada da wanke hannuwan da aka yi amfani da su a kai a kai, hana ma'aikata kasancewa a gida yayin da suke da rashin lafiya, hana numfashi ta hanyar rufe su da jarirai, ba da takalma da kuma ba da tufafi, shirya don canja wurin gida ko gida idan ya cancanta, hana ma'aikata uku yin amfani da kayan aiki ko umarnin wasu, da kuma tsabtace da kuma kula da wurin aiki.
Yin hankali da kuma taimaka wa mutane da ke fama da cutar yana da muhimmanci wajen kare ma'aikata, abokan ciniki, masu ba da shawara, da sauransu a wurin aiki.
Hukumar Kula da Lafiya da Kiwon Lafiya ta Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na yau da kullum su kasance a gida sai dai idan sun sami rashin lafiya, rashin lafiya, ko wasu alamun sun sake bayyana bayan awanni 24 ba tare da shan magani ba, kuma cewa ba za a iya ba da izinin rashin lafiya ba, ba da lada ga ma'aikata da ke cikin gida don kula da mai kula da gida da ke cikin gida, kuma wanda ya san wannan manufofin.
A cikin OSHA, ayyukan da ke da haɗari na musamman sun haɗa da waɗanda suke so su yi tafiya a cikin ƙafafun mutum guda shida (1.8 m) wanda ya san ko zai iya kamuwa da COVID-19, amma zai iya kamuwa da cutar SARS-CoV-2 saboda yaduwar jama'a a cikin yankin kasuwanci, ko kuma don wani mutum na dogon lokaci wanda ya yi tafiya a waje da yaduwar COVID-19.
Wannan ya shafi ma'aikata da ke aiki da jama'a kamar makarantu, wuraren aiki da ke cike da mutane, da kuma wuraren sayayya da ke da yawan jama'a. Ayyukan injiniyoyi don ganowa da kuma kungiyoyin da ke da haɗarin kamuwa da cutar sun haɗa da samar da kayan aikin da ke hana iska, iska mai tsabta, samar da iska mai tsabta kamar su katako, da kuma samar da ƙofar mota. Ayyukan da ke aiki da kungiyoyin da ke da haɗari na ganowa sun haɗa da samar da kayan aiki da ke cikin gida, canja wurin masu amfani da iska da kuma amfani da kayan aiki na gwamnati, irin su tsarin kula da gida, inganta yanayin yanayin da ke cikin gida, inganta yanayin da ke cikin gida, inganta yanayin da ke cikin gida, samar da wasu ayyuka da ke buƙatar ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, ɗaukar hoto, da kuma ɗaukar hoto.
Ma'aikatan da ke cikin wannan rukunin suna bukatar umurni na yin iska.
Idan mutum ya kamu da cutar a cikin jirgin sama, matakan da ake bukata don kare ma'aikatan da sauran ma'aikatan jirgin sun haɗa da sanya mai haƙuri a cikin wani wuri, yin tafiya a ƙafafun 6, zaɓar wani daga cikinsu ya kula da mai haƙuri, kuma ya ba mai haƙuri takardar rufe fuska ko koya wa mai haƙuri ya rufe bakinsa da hancinsa da takardar lokacin da yake kwance ko kuma yana motsawa.
Ƙungiyoyin Kabin za su saka kayan rufe hannu da aka ba su bayan sun yi wa mai haƙuri da ke tafiya magani ko kuma sun taɓa jikin mutum ko kuma jikin mutum da zai iya kamuwa da cutar, idan hakan zai yiwu tare da wasu kayan kariya idan mai haƙuri yana da rashin lafiya, rashin lafiya ko kuma rashin numfashi.
Dole ne a ajiye kayan rufe hannu a cikin iska mai riƙe da irin wannan kayan, kuma dole ne a tsabtace da kuma tsabtace kayan da aka lalata. Ya ƙunshi lalata kayan aiki na kasuwanci, kamar lalata jiragen sama da sauran abubuwa masu cutarwa, rigakafin cutar ya ƙunshi lalata jirgin sama ga mai cutar, kasancewa a cikin tsari da kuma sanar da likitocin lafiya idan kun haɗu da su.
A wasu lokuta, ana yin amfani da wannan tsari a cikin ɗakin da aka yi amfani da shi. Game da makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don bincika ko kula da yanayin da wani mai cutar yake ciki a cikin ɗakin makaranta ba tare da la'akari da watsawa tsakanin jama'a ba.
Idan akwai ƙananan ƙuntatawa a cikin al'umma, tsarin ba da izini na iya zama da amfani kamar hana balaguron balaguro, haɗuwa, da kuma haɗuwa da abubuwa masu banƙyama kamar yin wasanni, yin wasa ko cin abinci, ƙara sanduna a cikin gidajen abinci, rage lokaci zuwa da tashi, hana ziyarar da ba ta dace ba, kula da asibitin yara da sauran waɗanda ke da alamun cutar.
Idan akwai wani abu na farko da zai faru a cikin al'umma, bayan an yi amfani da hanyoyin da za a yi wa jama'a, za a iya rage lokacin rufe makarantu. Game da rayayyun mutane da ke damuwa da abin da ke faruwa, CDC ta ɗauki haɗarin lafiya.
Mutanen da ke da dangantaka da mutanen da ke da ko kuma waɗanda za su iya kamuwa da COVID-19 suna da shawarar bin ƙa'idodin da ma'aikatan kiwon lafiya ke bi, kamar su saka kayan kariya.
Idan an yi taron a lokacin kama, ma'aikata za su yi wanka da kuma tsabtace kayan aikin su kafin su yi aiki da su kuma su yi amfani da kayan wanke gida ko kuma su yi aiki, kuma su bi dokokin da suka shafi tattara kayan PPE da kuma sakawa ko kuma saka tufafi.
OSHA tana daukar ma'aikatan kiwon lafiya da ma'aikatan da suka mutu a matsayin wadanda kungiyoyin da ke fama da hatsari ko kuma suka yi amfani da su suka yi.
Ayyukan da ke da haɗari sun haɗa da ma'aikatan kiwon lafiya na musamman, masu taimako, masu bincike, da kuma kula da lafiyar jiki da ke da alaƙa da marasa lafiya da ke da ko kuma waɗanda za su iya kamuwa da COVID-19.
Akwai haɗari mai yawa idan ma'aikata suka yi amfani da iska mai iska, ko kuma suka yi amfani da su ko suka taɓa kayan aiki, mutane da suka san ko kuma za su iya kamuwa da COVID-19.
Ayyukan aerosol sun haɗa da motsawa ta hanyar hanci, tashar tashar jiragen ruwa, bronchoscopes, wasu shirye-shirye da bincike, ko kuma yin amfani da kayan aiki.
Ayyukan masu kula da hadarin sun hada da tsare mutanen da suka kamu da cutar COVID-19 a lokacin mutuwarsu; wannan yana nufin cewa ana iya gano haɗarin da ke tattare da cutar yayin da ake neman su don gano ko ya mutu.
Hanyar da za a iya amfani da ita a wasu fannoni na kiwon lafiya da kuma kula da lafiyar jiki.
Dole ne a yi amfani da takardun tsaro na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa masu kamuwa da cutar dole ne su kasance a cikin wuraren da ake kira wuraren da ake da cutar COVID-19. Baya ga PPE, OSHA ta ba da shawarar yin izinin yin iska ga mutanen da ke aiki a cikin ƙafafun mutane shida da aka gano suna da, ko kuma waɗanda ake zaton suna da cutar SARS-CoV-2, da kuma waɗanda ke yin iska mai iska.
A Amurka, allurar rigakafin N95 da NIOSH ta amince da ita ko fiye dole ne ta yi aiki a matsayin mai amfani a cikin tsarin rigakafin numfashi, wanda aka rubuta a matsayin gwaji, bincike, da kuma gwaji.
Wasu umarnin tashi na iya ba da kariya mai yawa ga mai aiki. WHO ta ba da shawarar yin ado mai rufe jiki saboda COVID-19 shine cutar huhu ta hanyar tunani kamar yadda ake samu ta hanyar jiki.
Hukumar ta WHO ta ba da shawarar cewa ma'aikatan asibiti su yi amfani da allurar rigakafi a gaban masu binciken.
Ya shafi mutanen da ba sa shan numfashi, yin amfani da su, ko kuma ba sa yin magana game da cutar.
Idan an yi amfani da iska mai iska, an sauya fuskar mai binciken da aka yi amfani da ita ta hanyar N95 ko FFP2.
Domin samar da PPE a duniya, WHO ta ba da shawarar rage bukatar PPE ta hanyar gudanar da bincike na yau da kullum, kayan aiki kamar ƙofofi da ƙofofi, wanda ke ba da damar shiga cikin kayan aikin lafiya ga masu cutar COVID-19, amfani da kayan aikin PPE a lokacin da aikin ya kasance, amfani da umarnin da kuke da shi ba tare da cire shi ba a lokacin kula da marasa lafiya daban-daban da ke da irin wannan gwajin, kula da kare masu amfani da PPE, hana su.
GABATARWA: Katherine Maher, Shugaba na Gidauniyar Wikimedia
A nan: Dukkanin kungiyoyin Wikimedia Foundation
HALIN DA KARANTA: [Covid-19] Rashin kamuwa da cuta da kuma tsara tsarin ilimi
Lokaci da lokacin: 14 ga Maris, 2020, 00:24 UTC
LISANSI: CC0: Babu haƙƙoƙin da aka tanada
Mun sami kanmu cikin matsala a wannan watan.
COVID-19 wani abu ne da ke sa rayuwarmu ta zama mai sauƙi ko ba haka ba domin muna damuwa da abin da ke faruwa a yanzu.
Ba mu da tabbaci game da wannan, amma mun san cewa amsarmu ta musamman ga ƙin yarda da ƙin yarda, aiki, da kuma aiki a cikin al'umma shine ainihin abin da ke cikin wannan rayuwar.
Yin hulɗa da al'umma da muke sadarwa da juna ta hanyar imel, shawarwari, da kuma labarai aiki ne mai muhimmanci da ɗan adam yake da lokaci mai yawa da za mu yi amfani da shi.
Na gode muku ƙwarai da na aiko muku da ɗan'uwa.
A ranar da aka gicciye ni, sai wani ya bar ni, yana zarginmu da aikinmu.
Ya tunatar da ni game da muhimmancin duniya ta gyara ta hanyar Wikipedia a yau, kuma yana da matukar muhimmanci domin tsarin yana dogara ne akan ko wane ne kuma kowa zai iya samun shi.
Za a iya yin aiki mai sauƙi, ko da yake yana kula da shafukan da ba a samu ba ko kuma an biya ku kuɗi ko kuma al'ummomin da ke da lafiya.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da yadda ta saba.
Wannan lokaci ne da za mu yi ba kawai abin da za mu yi ba, amma kuma yadda za mu yi shi zai sa mu yi wa duniya ban mamaki.
Don mu san yadda za mu yi wannan aikin da kuma abin da za ku yi a ciki, za mu yi la'akari da shirinmu na yin hakan, tun daga mako mai zuwa.
Bayanai game da aikinmu da kuma jadawalinmu
Kamar yadda Robyn ta bayyana a takaice, c-team ya haɗu da Kenya don tsara tsarin da jadawalinmu na kwanaki da watanni masu zuwa.
A cikin waɗannan labaran, mun ɗauki abin da muke tsammanin zai zama amsa mai kyau ga abin da muke fuskanta yanzu da kuma hanya mafi kyau don yin magana da jama'a a wannan lokacin.
Saboda haka, muna so mu kawar da rashin ƙarfi da kuma rashin aikinmu.
Idan kana so ka koma, ka tafi.
Ga dukan waɗanda suke cikin ikilisiya, ga shugabanni, ga waɗanda suke aiki.
aikinmu wanda zamu iya yin duk abin da aka rubuta shi ne kwana 4 a rana, ko kwana 20 a mako a wasu bayanai.
Amma za mu tuna cewa idan kun yi aiki a kan wani abu da aka sani, za ku yi aiki a kan wani abu.
Amma, a wannan zamani, babu wanda ya san abin da zai faru a nan gaba, kuma ko kana bukatar ka dafa abinci, ka sayi kaya, ko ka je wurin likita, lafiyar jikinka ita ce aikinmu.
Don haka sai mu yi tambaya game da abin da kuka yi a lokacinku.
Idan kana rashin lafiya, ka yi aiki.
Ba mu da wani dalili na yin haka, amma muna yin haka.
Ba mu ba da ranar annoba ko ranar da za a yi taron ba, sai mai kula da ka ya sanar da kai kuma ya taimaka wa ƙungiyar ka ta tattauna shirye-shiryen don gano ko wuraren da ake bukata sun rufe.
(Idan an gwada ka da COVID-19, ka duba bayanan Bryau a cikin T&C Ops don tabbatar ko kana lafiya kuma kana da haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin).
Waɗanda suke aiki a cikin gonar nan za su sami albashin wata ɗaya.
Mun yi watsi da wannan, kuma mun yi wa masu ba mu aiki da kuma 'yan'uwanmu masu aiki wuya.
Mai aikin ya biya kuɗin wata ɗaya, kamar yadda yake a lokacin da ba a biya shi ba.
Ko da kana rashin lafiya ba za ka iya aiki ba.
Idan kana son ka yi aiki, za mu taimake ka.
Mutane da yawa suna ɗaukan aiki a matsayin hanyar da za su iya yin tunani a wannan duniyar.
Amma, muna iya yin amfani da wannan lokaci don mu biya bashinmu.
Wannan ya ƙunshi kula da kanka.
Muna roƙonku ku nemi waɗanda suke shugabanci a cikinku, domin a sami lokaci a kan tafiyarmu.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da za a ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma kungiyoyin kulawa da taimako (a tsakanin sauran) suna yin aiki mai muhimmanci wanda zai iya bukatar ƙarin taimako.
Mun fara wani gwagwarmaya da dukan kungiyoyi don magance matsalolinmu na yanzu da kuma mayar da aikinmu ga abubuwan da suka fi muhimmanci a rayuwarmu.
Akwai aiki mai yawa a gaban kowa, amma bari mu mai da hankali ga ayyukan da suka fi muhimmanci.
Rashin halin yanzu yana cutar da makaranta.
Muna fatan za mu "karɓi ku na lokaci biyu" bayan annoba ta duniya.
Ba ma bukatar mu ƙara yawan wahalar da muke sha don mu yi aiki tare da ku.
Mun san cewa abubuwa suna canjawa, kuma muna aiki don daidaita tsarinmu da tsarinmu a inda ya dace.
Menene ke faruwa da APP (Shirye-shiryen Hannuwa)?
Don mu iya daidaita aikinmu na yanzu da kuma yadda za mu iya yin aiki a yau, muna so mu daidaita lokacin da za mu gabatar da Shirinmu na Hadin Kai na 2020-2021.
Muna fatan za mu yi amfani da tsarin 2019-2020 wanda ke ba da lokaci mai yawa don tara kudade don ba da lada ga ma'aikatan da ke da aiki mai kyau, kula da kansu, da kuma kula da bukatunsu a wannan lokacin kuma za mu karɓi waɗanda suke son shiga ko kuma waɗanda ke son rage jadawalin su a cikin mako mai zuwa.
Wannan lokaci na gaggawa ya kawo gaggawa ga dukan al'umma.
Bari mu bayyana abin da muka faɗa wa shugabanmu a mako mai zuwa, kuma mu sanar da waɗanda suke cikin ikilisiya a ƙofar nan mai zuwa idan muka sami izini.
Muna godiya ga ƙungiyar APP don kare ku.
Kasancewa da daidaituwa, nunawa da kuma tsabta
A makon da ya gabata, na koyi cewa ɗaya daga cikin 'yan'uwanmu a SF, ya riga ya kamu da cutar COVID-19.
Duk da haka, a cikin haƙƙoƙinmu, mun ɗauki ƙungiyar da ke kula da tsabtace da kuma tsabtace duk wuraren da ke da ƙwayoyin cuta a cikin yankin San Francisco.
Ƙungiyar ta yi amfani da tsarin kashe ƙwayoyin cuta wanda dukan asibitoci ke amfani da shi don tsabtace ɗakin kwana, shigarwa, da kuma kayan aiki a cikin wani ɗakin.
Ginin yana amfani da tsarin tsabtace gida da kuma kayan da ke cutar da lafiyar wasu.
Don haka muna jiran aikin da za a shirya mana don hidimarmu.
Dakinmu na DC na cikin WeWork, wanda ke raba tsarin COVID-19 tare da mu da kuma wani mai kula da kungiyar DC.
A makon da ya gabata, ofishinmu na DC ya koma wani wuri mai zurfi wanda ke bin tsarin da aka raba da San Francisco.
Kamar 'yan'uwanmu da ke birnin NYC, mun san cewa muna da wani gidan da za mu yi haya a Brooklyn.
Wannan labarin ya ci gaba amma ba zai yiwu ba.
Wasu daga cikin 'yan'uwanmu sun yi aiki tun lokacin da aka haife su.
'Yan'uwanmu da suka ƙware a aikin sun san cewa za a iya gwada su, kuma suna so su ba ku wasu takardun shaida:
Kada ka ƙara taro ɗaya ko biyu.
Idan muna bukatar ƙarin taro, za mu iya yin taro na kwanaki da yawa.
Don haka, bari mu ba da labarin wannan taron, mu kuma aika da kayan aikin karatu a kan kari.
Ƙarƙashin bidiyo, da kuma kayan aiki kamar Google Docs da Zoom don inganta amfani da haɗin kai.
Masu sauraro suna da ikon yin taro, wani wanda zai iya yin magana don alamomi da kuma tattauna yawan masu magana, da kuma wani don taimakawa wajen rubuta abin da aka lissafa (ko amfani da rubutu).
Aika imel zuwa taimakon fasaha idan kana bukatar ingantaccen kayan aiki.
Ka dawo lafiya don cin abinci.
Ka raba tashar #remoties a Slack don tattaunawa da 'yan uwanka game da aikin da aka yi
Ƙungiyar HR tana gudanar da wani shiri na yanar gizo don tallafawa ayyukan da aka rarraba a cikin Foundation.
A makon da ya gabata mun gayyaci masu karɓar tallafi na jama'a su san ayyukan da Wikimedia ta ba da gudummawa, kamar su editingathons, a lokacin da WHO ta sanar da cewa annobar ta duniya.
Mun sanar da su cewa mun fahimci cewa mu na da tabbaci game da takunkumi da kuma takunkumi da za su iya sa su kasa kammala aikin da aka ba su kuma kada su yi wa kowa laifi don barci ko kuma yin canje-canje.
A cikin mako mai zuwa muna sa ran ci gaba da gabatar da Wikimania da kuma tattaunawa da al'ummomin sauran wurare.
Dukkanin al'ummomin kasar suna da ra'ayin cewa ba za a iya dakatar da su ba amma za a iya dakatar da su kuma su yi amfani da su don su kula da al'ummomin su, Wikimedia da sauransu.
CRT ta ci gaba da aiki don samar da labarai a kan Meta-Wiki don samar da damar jama'a su ci gaba da kasancewa da karfi da kuma ci gaba da kasancewa tare da su.
Kasancewa a cikin yanayin COVID-19.
Za mu aika da sanarwar zuwa ga alƙawari na ranar Talata, 14:00 UTC/07:00 PT don taron ƙungiyoyi na musamman.
Bari mu yi amfani da wannan lokaci don rarraba wasu gwaje-gwaje, amsa tambayoyinku kuma ku ɓata lokaci kaɗan don yin tambaya ko a'a.
Muna cikinta, muna kuma ba da kanmu ga kowa.
A wasu lokatai, za ka iya ci gaba da samun bayanai game da wannan imel da kuma wasu muhimman bayanai game da COVID-19, a kan Office Wiki.
CRT za ta yi amfani da dukkan bayanan da aka samu a cikin wani shafi.
Muna kuma aiki don samar da hanyoyin sadarwa da kungiyoyi a kasashen da abin ya shafa a yanzu.
Idan kana da wata damuwa game da tafiya, aiki, aiki mai muhimmanci, ko kuma damuwa game da dangantaka, ko kuma wasu abubuwa da za ka iya bukatar, ka yi tunani game da yin amfani da CRT.
Muna nan don taimaka wa mutane da kuma taimaka musu a lokacin da suke bukatar hakan.
Idan kana da wani abin dogara ko kuma wani abu mai muhimmanci, ka tuntuɓi Bryan Judan - mai kula da HR International Global Operations.
Babu wani daga cikin waɗannan canje -canje da zai iya zama kamar yadda muke da aikinmu ko ayyukanmu.
Amma, kamar dai a wannan lokacin, dole ne a gwada aikinmu da ayyukanmu bisa ga abin da muke yi.
Waɗannan su ne hanyoyin da muke tsammanin za su taimaka ko a'a don samun ci gaba da aiki, don taimakawa wajen ci gaba da aiki da bukatunmu, da kuma duniya da kuma ayyukan da suka dace.
Aikinmu da muka yi a dā zai kasance a cikinmu har lokacin da ya dace.
Yanzu, lokaci ne da za a taimaka ko kuma a samu damar yin aiki mai muhimmanci a yankin da kuma a cikin shekaru masu zuwa.
Don haka muna bukatar ku duka ku yi tafiya a kan hanya, don haka ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a kan hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi tafiya a hanya, ku yi ta hanyar da ta zuwa zuwa ta zuwa ga Allah.
Yanzu fa, ka wanke hannunka, ka taɓa fuskarka.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran Ƙungiyoyin Gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
B'Angiotensin-converting enzyme 2 (ACE2) wani abu ne mai tsawo wanda ke aiki a waje da rarraba (bincike) kwayoyin halitta a cikin huhu, hanyoyin jini, zuciya, jini, da kuma jini.
ACE2 yana hana aikin da ke tattare da ƙimar angiotensin (ACE) ta hanyar rage yawan angiotensin-II da kuma rage Ang(1-7) wanda ya sa ya zama magani mai amfani wajen magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin ƙofar shiga cikin ƙwayoyin cuta a wasu coronaviruses.
Ana yawan amfani da shi a matsayin hACE2.
Angiotensin mai canzawa na 2 shine wani ƙarfe mai dauke da zinc wanda yake a cikin endothelial da sauran ƙwayoyin halitta.
Protein ACE2 yana da N-terminal peptidase M2 domain da kuma C-terminal collectrin renal amino acid transporter domain.
ACE2 shine shigarwa guda ɗaya na furotin membrane na nau'in I, wanda ke da tasiri mai tasiri a kan kwayoyin halitta a cikin huhu da sauran kwayoyin halitta.
Yanayin ACE2 na waje na kwayar halitta yana haɗuwa da yankin transmembrane ta hanyar wani nau'i wanda ake kira sheddase, kuma furotin da ke cikin jini yana shiga cikin jini kuma a ƙarshe yana fita daga cikin jini.
ACE2 yana samuwa a yawancin tsarin barci: ACE2 yana haɗuwa da tsarin ƙwayoyin cuta na ƙwayoyin cuta na alveolar type II, ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin jini da ƙwayoyin endothelial da ƙwayoyin jijiyoyin jini masu laushi a yawancin tsarin jiki.
Ana kuma samun ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus, da kuma kwakwalwa.
Aikin farko na ACE2 shine daidaitawa akan ACE.
ACE tana juya angiotensin I zuwa hormone mai saurin ƙonewa na angiotensin II.
ACE2 kuma yana juya amino acid phenylalanine zuwa carboxyl-terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) zuwa vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya ƙayyade adadin wasu peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana hana a lura da mai karɓar amino acid SLC6A19 kuma yana da alama a cikin cutar Hartnup.
A matsayin furotin mai watsawa, ACE2 yana aiki a matsayin ƙofa ɗaya a cikin wasu ƙwayoyin cuta na coronavirus, kamar HCoV-NL63; SARS-CoV (ta hanyar cutar da ke haifar da SARS); da kuma SARS-CoV-2 (ta hanyar cutar da ke haifar da COVID-19).
Har ila yau, an gano cewa an haɗa ƙwayoyin S1 na SARS-CoV da SARS-CoV2 a cikin ƙwayoyin ACE2 na enzymatic domain don ƙwayoyin cuta na endocytosis da kuma translocation na waɗannan ƙwayoyin cuta biyu da kuma ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Wannan shigarwar ta hana samar da furotin S ta hanyar mai karɓar protease serine TMPRSS2, wanda ake bincike a kai a kai a matsayin magani. Saboda haka, mun yi imanin cewa rage matakan ACE2, a cikin kwayoyin halitta, zai iya zama da amfani wajen magance cutar.
Duk da haka, kungiyoyi da hukumomi masu yawa sun bada shawarar ci gaba da maganin ACE inhibitor da ARB.
Bincike da kuma nazarin binciken da aka yi a ranar 11 ga Yuni, 2012, ya gano cewa "sake amfani da masu hana ACE ya shafi rage yawan cutar huhu da kashi 34% idan aka kwatanta da rigakafi".
Bugu da ƙari, "sashin cutar ta huhu ya ragu a cikin marasa lafiya da ake bi da su da masu hana ACE wanda ke da haɗarin kamuwa da cutar ta huhu, musamman a cikin waɗanda ke fama da cutar hawan jini da kuma cututtukan zuciya.
Shan ACE inhibitors ya kuma rage yawan mutuwar da ake samu daga cutar huhu, ko da yake alamun cutar sun ragu a kan cutar pneumonia gaba ɗaya".
Recombinant ACE2 na mutum (rhACE2) wani sabon magani ne don amfani da shi a kan cutar huhu, kuma a sakamakon haka yana inganta jini a cikin huhu da kuma samar da iska ga yara da aka cire daga cutar huhu wanda ya shafi lipopolysaccharide.
Rayuwar rabin rai na rhACE2 a cikin mutum ta wuce kwanaki 10 kuma farkon aiki na tsawon minti 30 kuma yana da tsawo a cikin lokaci na tsawon kwanaki 24.
Yawancin bincike sun nuna cewa rhACE2 na iya zama magani mai mahimmanci ga mutanen da ba su yarda da masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ba ko kuma ga cututtukan da angiotensin II ke hana su. An gwada rhACE2 a cikin gwaji na asibiti don magance matsalolin numfashi.
Aikace-aikacen COVID-19 aikace-aikace ne da aka kirkira don taimakawa wajen gano mutane a cikin martani ga cutar coronavirus ta 2019-20, kamar su gano mutane ("masu karatu") da ke da alaƙa da wanda ya kamu da cutar.
Akwai aikace-aikace da yawa da suka taso ko kuma sun ɓace, tare da taimakon gwamnati da kansa a wasu yankuna da yankuna.
An samar da tsarin samar da aikace-aikacen sadarwa.
Matsalolin amincewa sun bayyana a cikin tsari, musamman dangane da hanyoyin da ake amfani da su wajen gano wani ɓangare na rayuwar mutanen da ke amfani da waɗannan aikace-aikacen.
Hanyoyi masu amfani da ke ƙasa don gano wani mutum suna amfani da siginar Bluetooth don rufe fuska da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar a lokaci guda cewa za su shigar da aikace-aikace don tallafawa irin wannan aikace-aikacen da Bluetooth a cikin tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, gami da Alipay, ta kirkiro wani aikace-aikacen da ke ba da ladabi ga jama'a don yin la'akari da yadda suke da dangantaka da mutanen da ke da cutar COVID-19.
Mutane suna amfani da shi a birane 200 na kasar Sin. A Singapore, akwai aikace-aikacen da za a iya amfani da su don samun TraceTogether.
Masu amfani da IT na al'umma sun kirkiro wannan aikace-aikacen, wanda ya bayyana a matsayin budewa ga kowa kuma zai ba da shi ga gwamnati. A Arewacin Macedonia akwai wani aikace-aikacen da ke aiki tare da Bluetoth wanda ke kiran "Dakatar da Corona!", don gano haɗarin da ke tattare da masu cutar da kuma ba da amsa ga hukumomin lafiya.
Aikace-aikacen ya fito ne ta hanyar aikin Hukumar Kula da Ilimin Kimiyya da Ilimin Kimiyya da Kiwon Lafiya.
A ranar 14 ga Afrilu, 2020, an ba da damar yin amfani da aikace-aikacen a cikin Google Play Store da Apple App Store.
A ranar 12 ga watan Afrilu, gwamnati ta sanar da cewa aikace-aikacen gano mutane a cikin yanayin cutar, za a yi amfani da su don rarraba a cikin ƙasashen Turai. An kammala aikace-aikacen irin wannan a Ireland, da Faransa ("StopCovid").
Australia da New Zealand suna nazarin aikace-aikacen da ke cikin TraceTogether Singapore da kuma tsarin BlueTrace. Rasha na fatan samar da aikace-aikacen da za su samar da wasu kayan aikin tsaro ga masu cutar COVID-19 da ke cikin Moscow, don tabbatar da cewa ba za su bar gida ba.
Ross Anderson, wani farfesa a jami'ar Cambridge, ya lissafa yadda matsaloli da aikace-aikace ke iya fuskanta, kamar gano wani a matsayin mai cutarwa amma ba gaskiya ba, zai zama da muhimmanci idan an yi la'akari da ƙananan al'umma.
Ta hanyar magance matsalolin da ake samu na bayyanar da aikace-aikacen "coronavirus" da ba su da gaskiya ko kuma ba daidai ba, Apple ya bayyana iyakancewar da kungiyoyi za su iya sanya aikace-aikacen da suka shafi coronavirus a cikin App Store, suna hana su daga "gwamnati" ko kuma kungiyoyi masu sanannun.
Google da Amazon sun kawo karshen irin wannan rikici.
Masu ba da shawara kan batun rashin amincewa sun nuna damuwa game da batun kare jama'a ta hanyar aikace-aikacen coronavirus, musamman game da ko tsarin rigakafin da aka bayyana don hana cutar coronavirus zai ƙare idan cutar ta barke.
Amnesty International da fiye da kungiyoyi 100 sun yi ta yin magana game da irin wannan kariya.
Wadannan kungiyoyin sun bayyana matsalolin da suke fuskanta game da ayyukan gwamnati:
iya zama "mai kyau, mai amfani da marar kyau";
yin amfani da kayan aiki da kuma kula da su bisa ga ka'idojin da aka kafa;
aiki da kuma bayani game da haɗarin da ake samu a kan COVID-19.
Tsaron bayanai da kuma rashin rubutun da za a yi a cikin wannan tsari zai kasance daidai da bayanan da aka samu;
kiyaye bayanai da za su kasance masu ƙin yarda da su da kuma ƙara su;
Kowane mutum da ya yi jayayya da wani, zai yi hukunci a kansa.
tsarin da za a kafa wa al'umma da kuma al'umma da za su iya yin amfani da shi;
Dole ne a koya wa kowa ya kasance cikin wannan tsarin ta hanyar "masu kula da tsaro", kamar yadda masu kula da lafiya da kungiyoyin da aka yi watsi da su suka yi. Ƙungiyar Kwamfuta ta Jamus (CCC) da 'Yan Jarida ba tare da iyaka ba (Reporter ohne Grenzen) (RSF) sun kuma samar da manufofi.
Shirin Google/Apple na nufin magance wannan matsalar ta hanyar kawar da tsarin gano inda wani ya kasance a cikin jerin sunayen su a baya idan ba su da amfani.
Wasu ƙasashe suna amfani da umarnin kulawa ba tare da aikace-aikace ba, wanda ke faruwa ba tare da yin amfani da wasu aikace-aikace ba tare da wani tsari da ba a bi ba.
A Isra'ila, an kafa tsarin kula da tsari.
Tsarin da ke ƙarƙashin kulawar yanki na iya haifar da rikice-rikice da kuma bayanan sirri na mutane.
Duk da haka, ba duk tsarin da kuma umarni na tsakiya suke buƙatar shiga cikin bayanan sirri ba; akwai tsarin tsare bayanan da ke gudana ta hanyar umarni na tsakiya don canza rayuwar mutum (watau ƙananan ƙungiyoyi).
A Koriya ta Kudu, akwai tsarin da ke da amfani wajen magance matsalar rashin lafiya.
Dangane da amfani da aikace-aikacen da aka bayar, wannan umarnin ya ba da bayanan bincike ta hanyoyi daban-daban kamar bayanan waya da bayanan katin kuɗi, kuma ya haɗa su duka don aika saƙonnin rubutu zuwa ga mutanen da ke da damar kamuwa da cutar.
Baya ga amfani da bayanan gano cutar, gwamnati ta samar da bayanan da za a bude wa jama'a, wanda ya shafi wasu canje-canje da kuma dokokin da ake bayarwa bayan annobar MERS a kasar.
Wannan bayanin yana buɗewa ga jama'a ta hanyar aikace-aikace da aikace-aikace. Kasashe kamar Jamus sun gabatar da tsarin haɗin kai na bayanai da na tsakiya.
A ranar 6 ga Afrilu, 2020, za a sake sarrafa bayanan a matsayin yanzu.
A ranar 7 ga Afrilu, 2020, fiye da masu sana'a goma sha biyu sun yi amfani da hanyoyin da za su iya sarrafa bayanai, kamar amfani da Bluetooth Low Energy (BLE) don bincika mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT wani nau'i ne na haɗin gwiwa wanda ya ƙunshi duka hanyoyin sadarwa na tsakiya da na watsawa, kuma ba za a iya samun daidaito ba. Hanyoyin watsawa sun haɗa da Tsarin Tsare Sirri na Tsare Sirri na Tsare-tsare (DP-PPT/DP-3T), Lambobin Sadarwa na Waya (TCN, fka Contact Event Numbers, CEN), Tsarin Sirri na Sirri da Tsarin Sadarwa na Sadarwa na Waya (PACT) da sauransu.
A cikin wannan tsarin, bayanan da za a iya samu ba za su fito daga cikin tsari ba, kuma duk haɗin yana wucewa ta hanyar tsari.
Ƙungiyar Tsaro a MIT Media Lab ta yi amfani da SafePaths, wani tsari na amfani da hanyoyin tsaro masu kyau yayin tattara bayanai da kuma amfani da bayanan gida da na gida don hana yaduwar COVID-19.
Wannan ya dogara ne da binciken da aka yi a cikin wani littafi mara amfani "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" wanda aka fitar a watan Maris 2020. Wani irin tsari ne wanda aka tsara ta SafeTrace ta hanyar Enigma MPC, wata ƙungiya da ke aiki a kan samar da hanyoyin gano bayanai da aka samo a MIT Media Lab.
SafeTrace yana amfani da fasaha mai kyau don kare ma'aikata daga yin amfani da bayanan sirri na gida da na kiwon lafiya ga mutane da kuma jami'an gwamnati, ba tare da lalata bayanan sirri ba.
A ranar 5 ga Afrilu, 2020, TCN Coalition ta kasance ta hanyar ƙungiyoyi da suka haɗu bayan da aka yi amfani da irin wannan tsarin da irin wannan matakan, wanda aka yi don rage yawan cutar, kuma ya tabbatar da cewa an hana yaduwar cutar ta hanyar aikace-aikacen da za a iya amfani da su a ƙarshen duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bayyana shirin BlueTrace ga jama'a ta hanyar aikace-aikacen da ta bayar ga gwamnatin ta.
A ranar 10 ga Afrilu, 2020, Google da Apple, ƙungiyoyin masu amfani da wayoyin hannu na Android da iOS, sun sanar da wani sabon tsarin sarrafa bayanai, wanda ake tsammanin zai iya ɓoye bayanan mutane, ta hanyar haɗa fasahar Bluetooth Low Energy da kuma bayanan da ke tattare da bayanan sirri.
Sun kuma kafa tsarin da ke cikin wannan tsarin.
A cewar Apple da Google, za a gabatar da wannan umarnin a cikin matakai uku:
samar da kayan aiki don samun gwamnati ta bayyana aikace-aikacen hana yaduwar cutar coronavirus na gwamnati da na yanzu.
shigar da aikace-aikacenka a cikin tsarin iOS da Android Google da Apple don samun amsoshin game da shigarwa da matsalolin tsaro ta hanyar rarraba shi a farkon yana da kyau a bincika yadda ake amfani da umarnin, sannan a cire shi kamar yadda aka fara lokacin da cutar ta ƙare.
Yin amfani da kwayoyi (wanda aka fi sani da sake duba magani, sake tsarawa, sake aiki ko kuma canja magani) shine yin amfani da magani na farko wanda ya ƙare saboda maganin wani magani ko kuma wani magani da za a yi a baya.
Ka lura da bincike na ilimi a cikin wata sanarwa mai zuwa don samar da magani mai lafiya da amfani don magance cutar COVID-19.
Wasu bincike sun shafi bayyanar cutar COVID-19 da kuma jini. SARS-CoV yana da sunadarai 66 da za su iya haɗuwa da magunguna, kowannensu yana da manyan haɗuwa.
Yin amfani da waɗannan magungunan yana da muhimmanci wajen samar da maganin kashe kwayar cutar da ke da amfani ga furotin COVID-19.
Daga cikin sunadarai mafi nisa na SARS-CoV-2 akwai protease mai kama da papain, RNA dependent RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein AA, et al. sun yi nazarin abubuwan da suka shafi gwajin da aka yi a cikin gwaji na asibiti, kuma sun gano wasu abubuwa da yawa da za su iya faruwa a lokacin da za a iya samun magani mai mahimmanci wanda ba zai iya kashe SARS-CoV-2 ba a cikin binciken da ya gabata don samun damar yin amfani da shi a cikin tsarin gwaji na asibiti.
Chloroquine magani ne na shuka wanda ya fi dacewa da wasu cututtuka.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine na iya kasancewa cikin magungunan da ke cikin gwajin gwaji a asibitin Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin New York State na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da umarnin karɓar hydroxychloroquine sulfate da chloroquine phosphate idan akwai izinin Amfani da Gaggawa (EUA).
Hukumar kula da asibiti ta FDA ta amince da wannan magani kuma ta amince da ba da izinin EUA a matsayin magani na gwaji ba sai dai idan akwai gaggawa da magani ga marasa lafiya da ke asibiti amma ba su da damar samun magani a gwajin asibiti.
Hukumar ta CDC ta ce "sanyawa, ba da, ko kuma jinkirta amfani da hydroxychloroquine don rigakafi ba magani ba ne ga cutar SARS-CoV-2".
Masu binciken sun ce suna ba da maganin ne kawai "ba tare da wata hanya ba".
Wata ƙungiyar bincike ta Turkiyya a Istanbul ta gudanar da wani bincike game da chloroquine da zinc, bitamin A, bitamin C da bitamin D.
Wasu bincike na musamman sun kasance a Duke University da kuma Jami'ar Oxford.
Makarantar likitancin NYU Langone tana gudanar da gwaji game da lafiyar da amfani da shan hydroxychloroquine a matsayin magani.
Gwaje-gwajen asibitoci a birnin Wuhan da Shenzhen na kasar Sin sun ce favipiravir yana da "amfani sosai".
Mutane 35 da ke Shenzhen sun kamu da cutar a cikin kwanaki 4, kuma an samu kamuwa da cutar a cikin kwanaki 11 daga cikin mutane 45 da za su kamu da cutar.
A wani binciken da aka yi a Wuhan a kan mutane 240 da ke fama da cutar huhu, rabin su sun sha favipiravir kuma rabin su sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta sanar da jama'a cewa za a iya samun sakamakon sakamakon gwajin a jarfa.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan saboda an yi ta halaka a can, kuma an yi amfani da su wajen ɓoye magunguna, kuma za a yi amfani da su wajen magance cutar COVID-19.
A cikin jaridar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump zargin cewa ta sayar da magunguna. Magunguna na iya zama marasa tasiri wajen magance cututtukan da ke tattare da cutar, kuma ana ganin cutar ta ƙare.
Kada ku yi haka ga mata masu ciki, ko waɗanda suke so su zubar da ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), wanda ya haɗa da lopinavir da ritonavir wanda ke kashe kwayar cutar, ya ce "ba a samu wani amfani ba".
Magungunan sun samo asali ne don kamuwa da cutar HIV ta hanyar shan abinci ta hanyar haɗuwa da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado ta yi niyyar canja magunguna don samun wani abu da zai iya danganta da SARS-CoV protease. Akwai wasu shawarwari a tsakanin masu bincike don yin amfani da kayan aikin da za a iya amfani da su wajen duba magunguna da aka samar don cutar HIV/AIDS.
WHO ta kawo kwayar cutar ta clinicavir/ritonavir a cikin gwajin Solidarity na kasa da kasa.
Gilead Sciences ta kuma gano cewa Remdesivir yana da aikin kashe ƙwayoyin cuta a cikin vitro akan ƙwayoyin cuta da yawa kamar su philo-, pneumonia-, paramyxo-, da corona.
Wani abin da ke damun maganin cutar shi ne tsawon lokaci ta hanyar juyin halitta, wanda zai iya zama mummunan abu ga cututtuka masu tsanani da kuma kamuwa da su.
Wasu bincike da aka fara kafin gwajin sun nuna cewa remdesivir na iya samun ciwon jini na dogon lokaci. Akwai gwaje-gwaje na asibiti da ke gudana a yanzu, kamar biyu da ake gudanarwa a asibitocin Jami'ar Cleveland; daya ga mutanen da ke da cutar ta jini da kuma wani ga waɗanda ke da cutar da ta fi tsanani.
Akwai gwaji na asibiti guda uku na Vitamin C a cikin jini a cikin mutanen da ke asibiti da ke da mummunan COVID-19; placebo a cikin mazauna biyu (China, Kanada) da kuma wanda ba a kula da shi ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) ta shirya gwajin asibiti na Teijin's Alvesco (ciclesonide), wani corticosteroid da ke haifar da cutar ƙwayoyin cuta, don magance marasa lafiya marasa alamun cutar da suka kamu da sabon coronavirus.
Wani nau'in angiotensin-converting enzyme 2, wani gwaji na Phase II wanda ya shafi kamuwa da cutar da aka zaɓa a cikin 200 daga cikin marasa lafiya masu cutar, an yi amfani da shi a asibitoci a Denmark, Jamus, da Austria don nazarin tasirin magani.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada suna nazarin aikin colchicine don rage amfani da cututtukan huhu a cikin marasa lafiya da ke da alamun cutar COVID-19.
Binciken, wanda ake kira COLCORONA, ya shafi mutane 6,000 da suka kai shekara 19 da haihuwa da suka kamu da COVID-19 kuma suna da alamun da ba su da bukatar zuwa asibiti.
Kada mata masu ciki, da mata masu renon ʼyaʼya, da mata masu ba da ciki, su yi aure.
Ana gwada maganin anticoagulants da yawa a Italiya.
Heparin mai ƙarancin ƙwayoyin cuta yana da mahimmanci a cikin maganin marasa lafiya, wanda shine dalilin da ya sa Hukumar Kula da Lafiya ta Italiya ta kirkiro takardun da za a yi amfani da shi.
Wani binciken da aka yi a kan 300 na marasa lafiya game da nazarin amfani da sodium enoxaparin a cikin prophylaxis da kuma tsarin rigakafi ya ruwaito a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 cutar ce, akwai damar da za a iya amfani da ita don bincika magungunan da ba su kashe ƙwayoyin cuta da suka faru kafin cututtuka kamar MERS, SARS, da West Nile virus.
Ribavirin: ribavirin an bada shawarar don maganin COVID-19 a matsayin adadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutuka.
Umfenovir: an bada shawarar umfenovir don maganin COVID-19 a matsayin adadi na asibitoci 7 na kasar Sin
Wasu kwayoyin cutar da aka sani da su za su iya amfani da su a matsayin maganin COVID-19:
Tocilizumab (Mai karɓar anti-IL-6): An amince da shi a kasar Sin.
Hakanan akwai gwaji a Italiya da China. da kuma duba Tocilizumab#COVID-19.
COVID-19 na iya zama irin wannan rigakafin da aka sani sosai don cutar coronavirus 2019 (COVID-19).
Ko da yake babu wani magani da ya kammala gwajin asibiti, akwai hanyoyi daban-daban da ake bi don samar da irin wannan magani.
A watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ana sa ran za a samu allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, a cikin shekaru 18.
Hanyoyi shida na gwaji sun dogara ne akan koyarwar zaman lafiya na Afrilu na I.
COVID-19 ya faru ne a watan Disamba na 2020.
Yaduwar cutar a duniya ta barke a shekarar 2020, wanda ya jawo kudade masu yawa kuma masu bincike sun yi bincike kan samar da maganin.
Ƙungiyoyi da yawa suna amfani da kwayoyin halittar mutum don samar da allurar rigakafin cutar SARS-CoV-2.
An fitar da shi a watan Afrilu, kuma abubuwan da ke cikin shirin CEPI na samar da allurar rigakafi sune gaggawa, tsari na halitta, amfani da al'umma, da kuma samun damar yin amfani da shi.
A watan Afrilu, jami'an CEPI sun sanar da cewa, za a gudanar da bincike da kuma gabatar da wasu matakai guda 10 a farkon shekarar 2020 don samar da allurar rigakafi mai amfani da COVID-19.
Babban rabo na koyarwar zaman lafiya na farko ya ƙunshi:
nucleic acid (DNA da RNA) (mai amfani da nau'in I da kuma maganin gwaji: Moderna, mRNA-1273)
cutar cutar (mai amfani da allurar rigakafi na Nau'in I: CanSino Biologics, adenovirus nau'i na 5 vector)
Kamar yadda jami'an CEPI suka ruwaito a watan Afrilu, alluran gwaji 115 sun kasance a shirye, 78 na su na aiki ne (79, a cewar Cibiyar Milken), kuma 37 na su na gaba, amma tare da bayanan jama'a (wanda zai shiga cikin shirin ko kuma ya zaɓa).
Gwajin I-II ya kasance farkon gwajin lafiya da rigakafi, kamar magani, magani da placebo, kuma a lokuta da dama, a matsayin gano cutar da kyau.
Gwaje-gwajen Phase III sun sa al'umma da yawa, da kuma kungiyoyin tsaro, su yi la'akari da amfanin yin allurar rigakafi don hana cutar, da kuma hana haɗarin da ke tattare da ita.
Daga cikin alluran rigakafin da aka yi a cikin gwaji 79 (wanda aka gano a farkon watan Afrilu na 2020), 74 za su shiga gwajin mutum (a halin yanzu a cikin binciken "kwararrun asibiti").
A ranar 24 ga watan Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana bincike kan kwayoyin da za su iya samar da maganin rigakafi wanda zai iya canza furotin na kwayar cutar don samun kwayar cutar.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa za a fara aikin allurar rigakafi, wanda ke da niyyar kawo karshen gwajin mutum a shekara ta 2021.
An ba da rahoton aikin samar da allurar rigakafi ga Ofishin Kula da Cututtuka na kasar Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ke da alhakin shi, ta sanar da cewa ta fara amfani da allurar rigakafi.
Janssen tana aiki a kan maganin baki tare da matarsa, Vaxart.
A ranar 18 ga watan Maris, Emmergent BioSolution ta sanar da yin amfani da Vaxart wajen samar da maganin.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya fitar da wani rahoto game da tsarin samar da allurar rigakafi da kuma irin fasahar da allurar neoantigen na maganin ke yadawa.
A ranar 25 ga watan Maris, ƙungiyar bincike ta sanar da cewa sun kammala gwajin rigakafin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin mallakar Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna fara aikin bincike kan allurar rigakafi don gano maganin li-Key peptide don cutar COVID-19.
Suna son su samar da allurar rigakafi da za mu iya yi wa mutane magana a "kwana 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga watan Maris, shugaban cibiyar bincike ta rundunar sojin Amurka a Fort Detrick da kuma cibiyar bincike ta Walter Reed a Silver Spring, duka biyu a yammacin Marvland, sun sanar da cewa suna aiki don samar da maganin.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta yi aiki tare da Novavax Inc.
don samar da maganin rigakafi.
Masu bincike sun bayyana cewa za a ba da izinin gwajin gwaji kafin a yi maganin da kuma gwajin asibiti na Nau'in I a watan Yuni na 2020.
A ranar 12 ga Maris, 2020, Hukumar Lafiya ta Indiya ta ba da sanarwar cewa ana aiki da alluran rigakafi 11, kuma ko da yake yana iya ɗaukar shekaru da rabi ko shekaru biyu don samar da allurar.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a birnin Quebec, Quebec, ya sanar da wani shiri na samar da wasu kayan aikin da suka dace da cutar korona wanda cibiyar bincike ta Kanada ta bayar da tallafi.
Ana gudanar da gwajin a cikin dakin gwaje-gwaje, kuma ana gudanar da gwajin mutum don Zwiiye ko Uut 2020.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac "damar samar da allurar COVID-19 mai yawa", wanda gwamnatin Jamus za ta amince da shi.
A ranar 17 ga Maris, 2020, kamfanin farmasutik na Amurka Pfizer ya sanar da cewa zai yi aiki tare da kamfanin BioNTech na Jamus don samar da allurar mRNA.
A halin yanzu ana gwada gwajin mRNA BNT162, wanda ya riga ya fara gwajin magani da kuma gwajin da za a yi a farkon watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin ta Tarayyar Turai ta Takis Biotech ya sanar da cewa za a yi wa asibitin gwajin gwaji a watan Afrilu na 2020 kuma za a fara gwajin gwaji na karshe na allurar riga-kafi kafin karshen wannan shekara.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta ba da sanarwar bayar da dala miliyan 4.9 don bincike kan allurar COVID-19 tare da kungiyoyi kamar Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya haɗa da kudaden CEPI don samar da allurar COVID-19 zuwa dala miliyan 29.
Wasu wuraren da CEPI ke aiki tare don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, gwamnatin Rasha ta sanar da cewa masu bincike sun fara gwajin kwayoyi da alluran rigakafi guda shida.
Masu binciken Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa za su yi shirin samar da allurar rigakafin NRA mai amfani da COVID-19.
Ana iya amfani da allurar a cikin kwanaki 14 daga lokacin da aka karɓi samfurin a China.
A karshen watan Maris, gwamnatin Kanada ta ba da sanarwar bayar da dala miliyan 275 a matsayin tallafin bincike na 96 don tsarin kiwon lafiya na COVID-19, da kuma gwaji na alluran rigakafi a kungiyoyin da jami'o'in kiwon lafiya na Kanada kamar su Medicago da Jami'ar Saskatchewan.
A wannan lokacin, gwamnatin Kanada ta ba da sanarwar kashe C$192 miliyan don samar da allurar COVID-19, da kuma shirin gina "tushen allurar rigakafi" don sababbin alluran rigakafi da za su iya amfani da su a lokacin da wani sabon kamuwa da cutar coronavirus ya faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun sanar da cewa PittCoVacc, rigakafin COVID-19 a cikin yara, ta hanyar bayyana cewa "MNA ta samar da wani rukuni na allurar SARS-CoV-2 S1 wanda ke tattare da kwayoyin halitta masu ƙarancin antigens [a cikin jarirai] na farkon makonni 2 bayan rigakafi".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da wani bincike na DNA na wata allurar da za ta iya zama maganin shan magani a cikin al'ada.
Tare da kwayoyin cuta, DNA yana da amfani don yin amfani da kwayoyin halitta na mutum don samar da kwayoyin cuta masu kama da kwayar cutar, wanda zai iya zama kamar tsarin rigakafin jiki don samar da kwayoyin cuta na SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da kuma hukumomi sun haɗa kai don shiga cikin ayyukan da IBM ta yi, ciki har da ayyukan da suka shafi Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu jiragen ruwa suna da haɗari, kuma za mu iya lura da haɗarin da ke faruwa.
Wannan yana nufin cewa za su iya samun sakamako mai kyau a kan wani abu mai tsanani.
Wani gwaji a Ostiraliya yana neman shigar da ma'aikatan kiwon lafiya 4,170.
Hakanan, allurar rigakafi na iya zama marasa lafiya ko kuma marasa amfani.
Binciken farko na magance amfani da allurar rigakafi ta hanyar hana irin COVID-19 da ke faruwa a dabbobi kamar kwayar ACE2-transgenic, wasu kwayoyin gwaji, da kuma kwayoyin da ke shiga cikin jikin mutum, ya nuna bukatar matakan kiyaye lafiyar jiki na 3 don hana kamuwa da cutar da ke faruwa, da kuma kare lafiyar duniya don tabbatar da ingantattun hanyoyin lafiya.
Ana nazarin cututtukan SARS da MERS a cikin kwayoyin halitta.
A shekarar 2020, babu magani ko rigakafin cutar SARS da aka tabbatar da cewa yana da lafiya da amfani ga mutane.
A cewar rahoton bincike na 2005 da 2006, ganowa da kuma bayyana sabbin kwayoyi da magungunan maganin SARS shine babban abin da gwamnatoci da kungiyoyin kiwon lafiya na kasa suka yi tunani a kai.
A lokacin da cutar ta MERS ta bayyana, mutane sun yi imanin cewa binciken SARS zai iya zama wata hanya ta samar da allurar rigakafi ko magani don cutar MERS-CoV.
A ranar 20 ga Maris, 2020, an samu samfurin rigakafin MERS (wanda ya danganci DNA) wanda ya kammala gwajin gwaji na asibiti na I, tare da wasu uku, dukansu rigakafin cutar, adenovirus, (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-vectored (MVA-MERS-S) guda ɗaya.
Bayanan labarai a cikin kafofin watsa labarun sun ba da labari mai ban mamaki game da cewa kwayar cutar da ta kasance bayan COVID-19 ta kasance sananne kuma an kammala allurar rigakafi.
Bayanan da aka lissafa a kan rarraba al'umma sun koma ga bayanan da suka gabata game da kwayar halittar kwayoyin halitta don wasu cututtukan coronaviruses kamar SARS.
Cutar korona ta 2019 (COVID-19) cuta ce mai saurin kamuwa da cutar huhu da ta samo asali daga cutar korona ta 2 (SARS-CoV-2).
Abubuwan da suka fi faruwa sun haɗa da rashin ƙarfi, rashin ƙarfi, da numfashi.
Wasu alamun sun haɗa da rashin ƙarfi, ciwo, ciwo, ciwo da kuma ciwo, shan taba, ciwo, ciwo a ciki.
Lokaci daga kamuwa da cuta zuwa bayyanar cututtuka na farko yana da kwanaki shida amma zai iya zuwa daga kwana biyu zuwa goma sha huɗu.
Yawancin marasa lafiya suna da alamun cututtuka masu tsanani, amma wasu na iya kaiwa ga cutar huhu da kuma cututtukan ciki.
A ranar 17 ga Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a cikin kasashe da yankuna 210, kuma fiye da mutane 153,000 sun mutu.
Mutane fiye da 568,000 ne suka ci abinci. Kwayar ta bazu cikin al'umma a karo na farko ta hanyar haɗuwa, galibi ta hanyar ƙwayoyin cuta da ke tattare da ƙwayoyin cuta, ƙwayoyin cuta, ko kuma mutuwa.
Sa'ad da aka yi ruwan sama, sai su yi addu'a a ƙasa ko a kan tudu don kada iska ta shafe su.
Mutane za su iya kamuwa da cutar ta wurin taɓa wani abu marar tsabta, amma daga baya su taɓa idanunsu ko bakinsu.
Wannan kwayar cutar za ta iya wucewa tsawon kwanaki 72.
Cutar tana da yawa a cikin kwanaki uku na farko na kamuwa da cutar, ko da yake ana iya samun yaduwar kafin bayyanar cututtuka da kuma bayan kamuwa da cutar. Mafi yawan hanyoyin da aka saba amfani da su a gwajin su shine nazarin polymerase chain reaction (rRT-PCR) ta hanyar hanci ko hanci.
Kasancewa da rigar fuska yana da matukar damuwa ga mutanen da suke da tabbacin cewa suna da cutar da kuma wadanda ke yin amfani da su.
Kasancewar mutane suna rufe fuskokinsu da bambanci, kuma wasu shugabannin suna son su sa su, wasu kuma suna ba da shawara su sa su, wasu kuma suna son su sa su.
A halin yanzu, babu wani magani ko magani na cutar da aka sani don COVID-19.
An samu rahoton yawan kamuwa da cutar a cikin al'umma a kusan dukkanin ƙasashen WHO.
Waɗanda suka kamu da cutar za su iya nuna alamun cutar ko kuma su nuna alamun rashin lafiya kamar su saurin ji, jin zafi, rashin ƙarfi, da kuma numfashi.
Alamun farko sun hada da rashin numfashi, ciwo ko ciwon zuciya na dogon lokaci, haushi, rashin jin daɗi, rashin fuska da kuma rashin magana; idan alamun sun faru, ya kamata ka je wurin likita.
A wasu lokatai, ana iya samun cututtukan numfashi kamar zubar da ciki, zubar da ciki ko kuma zubar da ciki.
Alamomin ciki ko shan giya kamar fitsari, zubar da ciki da kuma zubar da ciki suna da bambancin yawan ciki.
Wasu cututtuka a kasar Sin sun nuna cewa suna da ciwon zuciya da kuma rashin lafiya.
A wasu, cutar tana iya zama sakamakon ciwon huhu, wanda ke haifar da rashin lafiyar ciki.
Ba za a yi wannan ba a lokacin da aka yi wa Yahudawa shari'a.
Lokacin tunawa da COVID-19 yana daga kwana shida zuwa shida amma zai iya kasancewa tsakanin kwana biyu zuwa 14.
Kashi 97.5% na mutanen da ke da alamun cutar za su yi hakan a cikin kwanaki 11.5 na cutar. Rahotanni na bincike sun nuna cewa ba kowa ba ne ke da alamun cutar.
Aikin irin waɗannan masu cutar a cikin kwayoyin halitta ba a sani ba; duk da haka, alamun farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ana bukatar a duba yawan mutanen da ke da wannan rigakafin amma ba su nuna alamun cutar ba, domin Hukumar Kula da Cututtuka da Cututtuka (KCDC) ta ce kashi 20 cikin 100 na mutanen da ke da rigakafin za su nuna alamun cutar a lokacin da suke cikin asibiti.
Hukumar Lafiya ta kasar Sin ta fara tattara marasa lafiya marasa alamun cutar a cikin marasa lafiya na yau da kullum a ranar 1 ga Afrilu; daga cikin marasa lafiya 166 a wannan rana, 130 (78%) ba su nuna alamun cutar ba a lokacin gwajin.
Kowane irin ƙwaya da ƙwaya za su iya sa ƙwaya ta lalace.
Magana da ƙarfi tana da yawa fiye da magana da ƙarfi.
Wani bincike a Singapore ya gano cewa jirgin sama mai zurfi zai iya yin tsalle-tsalle kuma zai kai tsawon mita 4.5 (ƙafa).
Ko da yake ƙwayoyin cuta suna iya kamuwa da iska, National Academy of Science ta nuna cewa watsawa ta iska na iya faruwa, kuma masu ɗaukar iska a ƙofar ƙwayoyin cuta suna kama da ƙwayoyin cuta masu ƙwayoyin RNA.
Wasu hanyoyin kiwon lafiya kamar su shigar da abubuwa ta cikin ciki da kuma motsa jiki da numfashi (CPR) na iya nuna rashin numfashi wanda zai iya fita daga numfashi kuma ya zama iska mai yaduwa.
Idan akwai matsaloli game da sanin ko cutar za ta iya kamuwa da cutar, haɗarin zai ragu; idan cutar ta kamuwa da cutar kafin bayyanar cututtuka, haɗarin zai ragu.
Hukumar Kula da Cututtuka da Cututtuka (ECDC) ta ce ko da yake babu wata sanarwa game da yadda cutar za ta iya yaduwa da cutar, mutum ɗaya zai iya kamuwa da mutane biyu ko uku. Kwayar cutar za ta iya kamuwa da cututtuka a cikin kwayoyin halitta a kowace rana.
An gano cewa kwayar cutar tana iya tabbatar da ita a rana ɗaya a kan takarda, saboda a cikin kwana uku akan takarda (polypylene) da nama mai ƙonawa (AISI 304), kuma a cikin 99% na ƙarfe.
Amma, ba za a iya yin hakan ba.
Sabulu kuma yana da amfani wajen ɗauke shi da kyau. Sabulu yana sa waɗanda suke shan safa su yi amfani da shi wajen cire su, kuma su sa su yi aiki a jikin su da sauran gabobin jiki.
Wasu abubuwa kamar benzalkonium chloride da chlorhexidine gluconate (abin da ke sa mutum ya zama mai tsabta), ba su da ƙarfi sosai. Wani bincike a Hong Kong ya nuna cewa shan taba yana ɗaukar kwanaki biyu bayan da aka fara asibiti.
Daga cikin mutane hudu da suka kamu da cutar, gwajin farko ya nuna cewa akwai ƙwayoyin cuta da yawa, kuma mutum shida da ɗaya sun nuna ƙwayoyin cuta da yawa a rana ta biyu ta gwajin.
Cutar coronavirus ta 2 (SARS-CoV-2) wadda ke haifar da cutar huhu ita ce sabuwar cuta ta huhu, wadda aka fara ganowa a cikin mutane uku da ke fama da cutar huhu da ke tattare da cutar huhu a birnin Wuhan.
Alamu na sabon SARS-CoV suna kama da na coronavirus.
A waje da jikin mutum, sabulu na gida yana kashe kwayar, wanda ke hana cutar ta kamuwa da cutar. SARS-CoV-2 ya yi kama da SARS-CoV na farko.
Fuffu yana da matukar tasiri a kan COVID-19 saboda kwayar cutar ta shiga cikin ƙwayoyin mai karɓa ta hanyar samar da enzyme 2 mai canza angiotensin (ACE2), wanda ya fi dacewa da nau'in II na ƙwayoyin alveolar fuka.
Wannan kwayar cutar tana daukar wani nau'in glycoprotein da aka samo daga wani "peplomer" don shiga cikin ACE2 kuma ya shiga cikin kwayar mai karɓa.
An gano karamin aiki a cikin zuciya a cikin kashi 12% na marasa lafiya da kuma asibitoci a Wuhan, China, kuma wannan shine mafi yawan cututtuka.
Lissafin alamun cututtukan zuciya ba su da iyaka, saboda amsawar da ke tattare da maganin hanawa da kuma rigakafi a lokacin cutar, amma amfani da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta zai iya hana mai karɓar ACE2 a cikin ƙwayar ƙwayar ƙwayar.
Ana samun ACE2 a cikin kwakwalwa kuma yana taimakawa wajen aikin kwakwalwa.
An gano cewa akwai wasu abubuwa da ke faruwa a cikin jini (31%) kuma an gano wani abu mai kama da thromboembolism (25%) a cikin marasa lafiya na ICU da ke da cutar COVID-19 kuma za mu iya yin watsi da shi. Binciken jiki na marasa lafiya na COVID-19 da suka mutu ya nuna cutar numfashi (DAD), kuma ruwan jini da ke dauke da cutar yana cikin numfashi.
Ko da yake SARS-COV-2 yana da tropism don ƙwayoyin epithelial na numfashi na ACE2-expressing, marasa lafiya da COVID-19 masu cutar suna da alamun ci gaba da wannan aikin.
A cewarsa, kwayoyin GM-CSF suna lalata T-cell kamar yadda suke faruwa tare da shigar da IL-6 mai kumburi wanda ke haifar da monocytes da alamun kumburi masu cutarwa ga marasa lafiya na COVID-19.
An kuma ruwaito cewa cutar lymphocytosis ta mutu.
WHO ta bayyana hanyoyin da za a iya gano cutar.
Wani sanannen tsarin bincike shi ne ainihin lokacin rikitarwa na polymerase transcription chain reaction (rRT-PCR).
Ana yin wannan gwajin ne a kan numfashi na shanu ko na shanu; amma, ana iya yin gwajin ne a kan naman shanu ko na shanu.
Sau da yawa, ana samun saɓo a cikin 'yan kwanaki ko kwana biyu.
Gwajin jini zai iya zama da amfani, amma ana buƙatar ɗaukar gwaje-gwaje biyu da aka ɗauka na mako biyu tare da bayyanar cututtuka.
Masana kimiyya na kasar Sin sun yi kokarin gano wasu kwayoyin cutar korona kuma sun gano cewa, wata hanyar samar da kwayoyin halitta da aka samu a cikin dakunan gwaje-gwaje a duniya na iya samar da gwajin polymerase chain reaction (PCR) don gano cutar.
A watan Afrilu na shekarar 2020, gwajin likita (wanda zai iya gano cutar da kuma idan mutum ya kamu da cutar) yana kan hanya, amma ba a riga an yi amfani da shi ba.
Wani bincike da bincike na kasar Sin ya nuna cewa yawan rashin lafiyar mutum ya kai kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko na likita a ranar 21 ga Maris, 2020 don amfani a ƙarshen watan. Tsarin gwaji da aka gabatar a asibitin Zhongnan na Jami'ar Wuhan ya bayyana alamun ganewar asali ta hanyar alamun cutar da kuma yiwuwar kamuwa da cutar.
Ana samun ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Ƙarƙashin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Babu bayanai da yawa game da amfani da man fetur da kuma yadda COVID-19 ke gudana a jiki.
Alamomin farko na bayyanar cututtuka a gwajin mutuwa sune:
Maganin gani: pleurisy, pericarditis, cututtukan numfashi da kuma zubar da jini
Cutar huhu ta cutar ta nuna alamun matsaloli hudu:
cututtukan huhu masu mutuwa: ciwon huhu, hyperplasia na pneumocytes, ciwon huhu, aiki na interstitial da kuma cutar lymphocyte da kuma ciwon kwayoyin halitta masu girma da yawa
cututtukan huhu masu tsanani: cututtukan alveolar diffuse (DAD) da kuma cututtukan alveolar diffuse.
DAD shine dalilin cututtukan cututtukan numfashi (ARDS) da kuma rashin ƙarfi mai tsanani.
cututtukan huhu: haɗuwa da exudate a cikin rami na alveolar da kuma pulmonary interstitial fibrosis
A cikin nono: ɓarnar intravascular (DIC); maganin leukoerythroblastic
Hanyoyin rigakafi don rage yawan lokaci na kamuwa da cuta sun hada da kasancewa a gida, hana tarurruka na jama'a, wanke hannuwanka da sabulu da ruwa a kowane lokaci na akalla dakika 20, kula da numfashi da kuma kula da idanu, hanci ko baki da kuma hannayen da suka lalace.
CDC ta bada shawarar rufe bakinka da hancinka idan kana shan wahala ko kuma kana shan wahala kuma tana bada shawara a rufe hannunka idan ba a yi maganin ba.
Ba a ba da shawarar yin addu'a da hannuwa ba bayan an haifi jariri ko jariri.
CDC ta hana yin amfani da sutura a wuraren da jama'a ke da shi, don rage kamuwa da cutar ta hanyar mutanen da ba su da alamun cutar. Tsarin kula da jama'a da kuma jama'a na nufin rage rayuwa tare da mutanen da ke da cutar a wuraren da jama'a ke zaune ta hanyar rufe makarantu da wuraren aiki, rage zirga-zirga da kuma hana jama'a yin bukukuwa.
Tsarin yin hakan ya ƙunshi kasancewa aƙalla mita 6 (1.8) tare da wani.
Babu wani magani da aka sani da za a iya amfani da shi don hana cutar COVID-19. Tun da ba za a samu allurar rigakafi ba kafin 2021 aƙalla, hanyar da za a iya hana COVID-19 ita ce rage yaduwar cutar, wanda aka sani da "tsayawa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kowane lokaci na akalla dakika 20, musamman idan sun yi tafiya a hankali ko kuma idan hannayensu sun kasance a rufe, kafin su yi wanka da kuma bayan sun yi wanka, su yi wanka ko su yi wanka.
Ya kuma bada shawarar yin amfani da kayan wanke hannu da ke dauke da giya aƙalla kashi 60 cikin dari, amma ka sha idan sabulu da ruwa ba su wanke ba. A wuraren da babu sayen kayan wanke hannu, WHO ta ba ka izinin yin hakan da kanka.
A cikin waɗannan yankuna, aikin kashe kwayoyin halitta ya faru ne ta hanyar ethanol ko isopropanol.
Hydrogen peroxide yana da amfani wajen shigar da kwayoyin a cikin giya; yana da "abin da ake amfani da shi wajen wanke hannu".
Glycerol ya ƙaru a matsayin kayan taimako.
Za a ba mutane abinci don rigakafi, wanda zai iya haɗa da magani da shan giya, taimako da iska, da kuma wasu abubuwan da suka dace.
Hukumar ta CDC ta ba da shawarar cewa mutanen da suke da tabbacin cewa suna da cutar su sa abin rufe fuska.
Oxygenation membrane extracorporeal (ECMO) yana da amfani sosai wajen magance cutar numfashi, amma amfaninta yana kan gwaji a yanzu.
Ana ba da shawarar yin tsabtace jiki da kuma abinci mai gina jiki don inganta rigakafi.
Ana iya amfani da taimakon taimako don gano cutar a farkon annobar. WHO da Hukumar Lafiya ta Kasa ta kasar Sin sun bayyana cewa akwai bukatar a kula da mutanen da ke asibiti da ke dauke da COVID-19.
Ma'aikatan gaggawa ko masu kula da gaggawa a Amurka sun yi wa wata kungiya mai ba da taimako, IBCC, ba'a ba da rahoto ba.
A watan Afrilu 2020, an ba da shawarar yin maganin COVID-19 na musamman.
Bisa ga rahotanni, masu aikin kiwon lafiya sun ba da shawarar paracetamol (acetaminophen) a kan ibuprofen ga marasa lafiya.
Ana yin aiki da kyau don rage haɗarin kamuwa da cutar, musamman a cikin yanayin rashin lafiya yayin yin matakan da za su iya haifar da numfashi, kamar shigar da abubuwa a cikin ciki ko numfashi da hannu.
Ga ma'aikatan da ke neman lafiyar jama'a da COVID-19, CDC ta ba da shawarar a saka wani a cikin dakin keɓewar kamuwa da cutar ta iska (AIIR) don ƙarin aiki da haƙƙin mallaka. CDC ta bayyana matakan kare kai (PPE) a lokacin annobar duniya.
Abubuwan da za a iya amfani da su: kayan PPE, kayan shafawa ko rufe fuska, kayan shafawa, da kuma kayan shafawa. Idan akwai, kayan shafawa (tare da rufe fuska) sun fi dacewa.
Dokokin samar da N95 sun yi watsi da amfani da su a masana'antun masana'antu amma FDA ta hana amfani da su a cikin dokar ta baci ta amfani da izini (EUA).
Ayyukan su na kare kansu daga abubuwa masu zafi kamar iska mai iska amma suna da amfani saboda ƙwayoyin da ba su da tasiri ba za su iya amsawa da kyau.
Idan babu abin rufe fuska, CDC ta ba da shawarar yin amfani da kayan kariya na fuska ko, a matsayin zaɓi na ƙarshe, sanya abin rufe fuska a gida.
Mutane da ke fama da COVID-19 sukan sha iska ta hanyar iska ko kuma ta wani hanya, NS
Irin taimakon numfashi ga mutanen da ke fama da COVID-19 da kuma matsalolin numfashi ya dogara ne akan nazarin da aka yi wa asibitoci, wanda ya nuna cewa zai iya hana shigar da abubuwa masu kumburi a cikin ciki da kuma cikin jini na shan inna da kuma matsalolin numfashi.
Idan dukansu biyu sun yi amfani da duk fa'idodin da ke amfani da masu cutar ba su da masaniya.
Wasu masana sun yi watsi da amfani da iska mai iska da kuma iska mai iska domin wannan tsarin yana rage yawan abubuwan da iska ke haifar idan aka kwatanta da shanun shanu masu cutarwa. Wannan cuta ta fi muni a cikin tsofaffi (mutanen da suka wuce shekaru 60, galibi waɗanda suka wuce shekaru 80).
Kasashen da ke da wadataccen ilimi ba su da cikakkiyar hanyar yin magani, wanda ke sa ba za a iya samun magani ga kowa ba idan adadin mutanen da ke da cutar COVID-19 da ke bukatar shiga asibiti ya ragu.
Wani bincike a kasar Sin ya nuna cewa kashi 5% na mutanen da ke fama da ciwon sukari sun kamu da cutar, kashi 2.3% na mutanen da ke fama da cutar sun kamu da cutar iska ta hanyar iska, kuma kashi 1.4% sun mutu.
A kasar Sin, kusan kashi 30 cikin 100 na mutanen da ke asibiti da COVID-19 za a yi musu asibiti a ICU.
Yin amfani da umarnin na iya zama mai sauƙi don sarrafawa idan an fara cutar huhu (ARDS) a cikin COVID-19 da kuma iska mai sauƙi don sarrafawa.
Umurnin yin iska mai kyau da kuma PEEP mai kyau zai taimaka wajen rage iska yayin da ake rage haɗarin amfani da iska da kuma pneumomothorax don yin iska mai kyau.
PEEP na iya samuwa a cikin tsarin numfashi na farko.
Bincike na yiwuwar magani ya fara ne a watan Janairun 2020 kuma ana gudanar da gwaji na asibiti na magungunan kashe ƙwayoyin cuta masu yawa.
Remsivir yana da kyau sosai.
Ko da yake ana iya samun sabon magani a shekara ta 2021 kafin a fito, yawancin kwayoyi suna kan gwaji kuma ana ba su izini don wani aiki ko kuma suna kan gwaji da aka kammala.
Ana iya gwada maganin kashe kwayar cutar a cikin mutane masu cutar.
WHO ta bukaci masu gwaji su kasance a cikin gwajin inganci da amincin magani da za a iya amfani da su. FDA ta ba da izini da kuma lokaci don yin amfani da jini a matsayin magani na gwaji ga marasa lafiya masu tsanani.
Za mu yi nazarin asibitoci da suka dace don tabbatar da cewa akwai amfanin cutar.
A watan Fabrairun 2020, kasar Sin ta fitar da wani aikace-aikacen da zai hana yaduwar cutar.
An ba da umarnin a rubuta wa masu aiki da kuma masu aiki a cikin littafin.
Wannan aikace-aikacen zai iya gano "ƙwarewar da ke kusa" ta hanyar amfani da bayanan kulawa da kuma haɗarin kamuwa da cuta.
Kowane ma'aikaci da mai aiki zai iya yin la'akari da cewa akwai wasu mutane uku da ke aiki.
Idan an gano wani haɗari, wannan aikace-aikacen zai ba ka shawara ka kasance mai tsaro, amma kuma ka sanar da ma'aikatan kiwon lafiya na yankin. Bayanai masu yawa na bincike game da bayanan waya, tsarin ganowa a gaba, bin diddigin wuri da kuma fahimtar tsari za su taimaka wajen gano masu cutar da kuma mutanen da suka sadu da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da umarnin ga kungiyoyin tsaro na bin diddigin alamun wayar salula na mutane na kamuwa da cutar coronavirus.
An tsara wannan tsarin ne don hana yin zaman lafiya da kuma kare waɗanda za su iya yin hulɗa da mutanen da ke da cutar.
Har zuwa watan Maris na 2020, Deutsche Telekon ta rarraba bayanan da ke nuna cewa cibiyoyin sadarwa na sadarwa suna aiki tare da ƙungiyar gwamnatin Jamus, Cibiyar Robert Koch, don ganowa da hana yaduwar cutar.
Rasha ta gabatar da wata hanyar da za ta iya yin rajistar mutanen da ba sa son zama a cikin ƙasa.
Jami'in kiwon lafiya na Italiya, Giulio Gallera, ya ce jami'an wayar tarho sun gaya masa cewa "kashi 40% na mutane suna ci gaba da yin amfani da wayar tarho".
Gwamnatin Jamus ta yi amfani da ilimin kimiyya ta hanyar canja wurin bayanai zuwa ga makarantu da mutane 42,000.
Duk da haka, Gwamnan Estonia, Kersti Kaljulaid, ya gayyaci mutane da yawa don yin amfani da hanyoyin da jama'a ke da su wajen sanar da cewa cutar ta yadu.
Mutane za su iya fuskantar matsaloli saboda rashin tsaro, haɗarin tafiya, haɗarin magani, da kuma tsoron cutar.
BBC ta yi sharhi a kan Rory O'Connor ta ce, "Rashin nuna bambanci, rashin daidaito, rashin lafiya, rashin ƙarfi da kuma rashin lafiyar dabbobi suna da tasiri a kan kare lafiyar ɗan adam da lafiyar ɗan adam".
Wannan zai iya faruwa ne a cikin jiki tare da ƙananan alamomi ko kuma bayyanar cututtuka, irin su cututtukan numfashi da ke kama da rashin ƙarfi.
Marasa lafiya da ke da ciwon daji kawai sukan ci abinci na tsawon makonni biyu, waɗanda ke da ciwon daji ko kuma mafi tsanani za su iya cin abinci na tsawon makonni uku zuwa shida da ɗaya.
Mata masu ciki suna iya fuskantar haɗarin kamuwa da COVID-19 fiye da alamun bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
A cikin waɗanda suka kamu da cutar, COVID-19 na iya haifar da cututtukan numfashi na yau da kullum (ARDS) wanda ke haifar da rashin lafiya a cikin numfashi, numfashi ko kuma wasu cututtukan jiki.
Abubuwan da ke tattare da COVID-19 sun haɗa da rauni na jiki, barci ko rauni na jiki, na jiki da na numfashi.
Rashin jini, da kuma karuwar lokaci na prothrombin, an nuna su a cikin kashi 6% na waɗanda aka yi asibiti da COVID-19, da kuma kashi 4% na waɗanda suka yi aiki daidai a cikin rukuni.
Kusan kashi 20-30 cikin dari na mutanen da ke da cutar COVID-19 suna nuna rashin lafiyar jiki.
A cewar wannan rahoton, lokacin da ake nuna alamun cutar a cikin jiki yana da kwanaki goma, kuma yana da kwanaki goma a asibiti.
Amma, marasa lafiya da aka aika zuwa ICU suna da kwanaki takwas da suka wuce tsakanin rashin lafiya da mutuwa.
A cikin binciken farko na marasa lafiya, lokacin da aka fara bayyanar cututtuka zuwa mutuwa ya kai kwanaki 14, kuma kwanakin sun tashi daga bakwai zuwa goma sha ɗaya zuwa 41.
A cewar wani binciken da hukumar lafiya ta kasar Sin ta gudanar, maza suna da kashi 2.8% na mutuwar mata kuma kashi 1.7%.
Binciken da aka yi na cutar a cikin jikin mutum ya nuna lalacewar alveolar da ke ɓoye da kuma ɓarkewar fibromyxoid a cikin jikin mutum.
An gano ƙwayoyin cuta a cikin ƙwayoyin cuta a cikin ƙwayoyin cuta.
Hotunan numfashi suna kama da cututtukan numfashi (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta bayar, an bayar da rahoton cewa an sami cututtukan zuciya da yawan maganin tropinin ko kuma rashin lafiyar zuciya.
A cewar wani rahoto na watan Maris a Amurka, kashi 89 cikin dari na marasa lafiya na asibiti suna fama da wasu matsaloli.
Yawan mutuwar da ke tattare da cutar ya bambanta saboda bambancin kwayoyin halitta, amma kuma saboda matsalolin da ke tattare da cutar.
Yawan marasa lafiya da ba su da tsanani zai iya rage yawan mutuwar.
Amma, yawan mutuwar da aka samu daga marasa lafiya da suka kamu da cutar na iya nuna cewa yawan mutuwar yanzu ya ragu.
Masu bincike sun ce irin wannan cutar tana nuna alamun cutar COVID-19 sau 1.4 da kusan sau 2.4 wanda ya fi dacewa da wasu cututtuka ko magani idan aka kwatanta da wadanda ba a gwada su ba. Akwai damuwa game da yadda cutar za ta bar bayan an warkar da ita.
Hukumar asibitocin Hong Kong ta gano raguwar kashi 20 zuwa 30% a cikin ƙarfin numfashi a cikin mutanen da suka kamu da cutar, kuma gwajin numfashi ya nuna cewa akwai samfurori.
Wannan zai iya zama mummunan sakamako ga rashin lafiyar jiki bayan cin abinci.
A watan Maris na shekarar 2020, mutane sun yi ta lura da yadda cutar ta kamuwa da cutar ta kare lafiyar mutanen da aka warkar.
Halin zai kasance mai yiwuwa, dangane da halaye na wasu cututtukan coronavirus, amma marasa lafiya da suka kamu da COVID-19 za su ci gaba da gwajin da ke nuna cewa suna da cutar.
Irin wannan magani ana ganin shi ne wani rashin lafiya na yau da kullum da ake samu daga sabon kamuwa da cuta.
Wannan kwayar cutar tana da alama ta fito ne daga dabbobi a cikin daji, saboda cutar ta ƙare.
Mun lura da yadda cutar ta bayyana, amma a watan Disamba na 2019 cutar ta yadu sosai, ko a'a.
Wani bincike na farko na mutane 41 da aka gano suna dauke da COVID-19, wanda aka buga a watan Janairun 2020 a cikin Lancet, ya nuna cewa lokutan da alamun cutar suka fi bayyana a hankali a ranar 1 ga Disamba, 2019.
Bayanan WHO sun nuna farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Akwai hanyoyi da yawa da za su iya taimakawa wajen ƙididdige mutuwar.
Wadannan kididdigar suna canzawa daga lokaci zuwa lokaci kuma ana rinjayar su ta hanyar gwaji, darajar tsarin kiwon lafiya, zaɓin magani, lokaci daga farkon bayyanar cutar da kuma halaye na al'umma kamar shekaru, bambanci da lafiyar gaba ɗaya.
A karshen shekarar 2019, WHO ta ba da lambar cutar ICD-10 U07.1 don mutuwar daga gano cutar SARS-CoV-2 a cikin dakin gwaje-gwaje da U07.1 don mutuwar da aka gano a asibiti ko sakamakon cutar COVID-19 ba tare da SARS-CoV-2 ta shiga asibiti ba.
Bisa ga binciken da aka samu daga Jami'ar Johns Hopkins, yawan kamuwa da cutar ya kai kashi 6.9% (153,822/2,240,191) daga ranar 17 ga Afrilu, 2020.
Wasu sun hada da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da ke kamuwa da cutar da mutuwa, da kuma yawan kamuwa da cutar (IFR), wanda ke nuna yawan mutanen da (ba a manta da su ba) suka mutu saboda wani cuta.
Wadannan alamun suna da wuya a lokaci kuma suna biye da wasu mutane don cutar ta hanyar magani.
Ko da yake ba kowa ba ne zai iya yin amfani da rigakafin jiki, kasancewa da su zai iya ba da labari game da yadda mutane da yawa suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin gari ne da ke da mazaunan 4,600, kuma kashi 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ta hanyar bikin Carnival, ta shafi al'ummar da ke cikin gida, kuma yawan mutuwar da aka samu daga COVID-19 ya ragu sosai.
Amma, tsarin kiwon lafiya na Jamus zai kasance da kyau.
A Netherlands, kusan kashi 3 cikin 100 na mutanen da ke da cutar sun kamu da cutar, kamar yadda ake ganin masu ba da jini.
69 (0.004% na yawan jama'a) sun kamu da cutar COVID-19.
Rashin kamuwa da cuta da kuma yawan mutuwa sun bambanta tsakanin maza da mata.
Yawan mutuwar da aka samu a maza sun fi girma a cikin binciken da aka yi a kasar Sin da Italiya.
Dalilin da ya fi sa mutane su kai shekaru 50 a duniya, kuma bambancin tsakanin maza da mata ya fi shekaru 90.
A kasar Sin, yawan mutuwar mata ya kai kashi 2.8 cikin 100 na maza da kuma kashi 1.7 cikin 100 na maza.
Hakika, akwai wasu abubuwa da za su iya sa mutum ya bambanta da mata, amma akwai wasu abubuwa da za su iya sa mutum ya bambanta da mata.
Rashin daidaito na rigakafi tsakanin maza da mata, ƙididdiga da gwaji a cikin mata da maza waɗanda ke nuna haɗarin cututtuka kamar jini da kuma karɓar ƙarfi daga mata na iya rage yawan mutuwar maza.
A Turai, maza ne ke da kashi 57 cikin 100 na mutanen da suka kamu da cutar da kuma kashi 72 cikin 100 na mutanen da suka mutu saboda COVID-19 maza ne.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ta duba bayanan da ke nuna cewa akwai cutar COVID-19.
Bincike ya nuna cewa cututtukan cututtuka irin su Ebola, HIV, zazzabin cizon sauro da SARS suna shafar maza da mata da kuma wasu.
Akwai wasu ma'aikatan kiwon lafiya da likitoci da mata da kuma waɗanda ba su da lokaci don yin magana da ƙwayoyin cuta.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa za a yi amfani da sunan cutar "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin ya bayyana Coronavirus, VI na nufin cutar, D na cutar, da 19 na farkon bayyanar cutar: 31 ga Disamba, 2019.
Za a iya zaɓar sunan don ya haɗa da sunan wani yanki (kamar China), asalin dabba ko rukuni.
WHO ta kuma ƙara " cutar COVID-19 " da " cutar da ke haifar da COVID-19 " a rayuwar al'ummarta.
Ana kiran cutar da kwayar cutar "coronavirus".
A farkon annobar a Wuhan, China, an gano cutar da cutar a matsayin "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta bayyana cutar huhu mai dauke da 2019-nCov da 2019-nCoV a matsayin sunayen da suka gabata na cutar da kuma sunayen da suka dace na 2015 don tabbatar da yankin da cutar ta kamu da cutar.
An fitar da tabbacin COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin tsarin samar da kayayyaki, masana'antun kayayyaki suna samar da kayayyaki masu mahimmanci kamar su kayan shafawa da kuma tsarin numfashi.
A wani misali, a lokacin da wata asibiti a Italiya ta yi watsi da kayan aikin iska na gaggawa, mai sayarwa bai bayyana su ba a cikin lokaci mai tsawo, wani mai sayarwa a wani wuri da ba a san shi ba ya duba kayan aikin kuma ya fitar da 100 a daren.
Bayan farkon annobar COVID-19, an samu bayanai masu yawa, da kuma bayanan da aka samu ko kuma an yi watsi da su saboda abubuwan da suka shafi bayyanar, ci gaba, rigakafi, magani da alamun cutar.
Mutane suna iya yada kwayar cutar zuwa wasu dabbobi.
Wannan binciken zai nuna cewa kwayoyin sun lalace a cikin kwayoyin halitta, kwayoyin halitta, da kuma wasu kwayoyin halitta.
Babu magani ko magani da zai iya warkar da cutar.
Binciken duniya game da alluran rigakafi da magunguna don COVID-19 yana gwagwarmaya don samar da shi ta hanyar ƙungiyoyi, ƙungiyoyin kiwon lafiya da masu karɓar magani.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Taliban Solidarity" don magance haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin ƙwayoyi huɗu da ke nuna amfani da yawa.
Babu allurar rigakafi, amma kungiyoyi da dama suna aiki a kan alluran gwaji da ƙarfi.
SARS-Cov yana da amfani ga SARS-CoV BE sars cOv-2 duka suna aiki tare da ACE2 don shiga cikin jikin mutum.
Akwai maganin da ake gwadawa a yanzu.
Da farko, masu bincike suna son su gano inda cutar take.
Yin amfani da wannan nau'in kwayar cutar, ko tana aiki ko ta mutu, yana nufin neman maganin rigakafin jikin mutum ga sabon kamuwa da COVID-19.
Hanya ta biyu, wato, masu yin allurar rigakafi, tana nufin samar da allurar rigakafi ga wasu ƙwayoyin cuta.
A cikin binciken SARS-CoV-2, irin wannan binciken ya shafi furotin S-spike wanda ke taimakawa kwayar cutar shiga cikin tsarin ACE2.
Hanyar ta uku ita ce ta ƙwayoyin cuta na nucleic acid (DNA ko RNA, sabon tsarin bayyana ƙwayoyin cuta).
Dole ne a yi la'akari da gwajin gwaji a tsakanin waɗannan hanyoyin don aminci da amfani. A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar tare da masu gwaji huɗu.
Maganin yana dauke da wani kwayar halitta mai cutarwa wanda ba shi da cutar da ke haifar da cutar. An bada shawarar likitoci a matsayin maganin da zai iya magance SARS-CoV-2, amma wasu masu bincike ba za su yarda da shi ba.
Akwai gwaji na asibiti sama da 300 da aka gudanar da bincike tun daga watan Afrilu 2020.
Gwaje-gwaje guda shida sun yi la'akari da maganin da ake amfani da shi a maganin shuka, da kuma nazarin hudu na hydroxychloroquine ko chloroquine.
Magungunan kashe kwayar cuta da aka yi amfani da su a yau sun kasance babban abin bincike a kasar Sin, tare da gwajin Phase III na remdesivir a ƙasashe da yawa don gwaji a ƙarshen Afrilu.
An fara yin amfani da allurar rigakafi da magungunan COVID-19 a watan Afrilu na 2020.
Ana sa ran samun sakamako mai kyau na amfani da remdesivir, a watan Maris na 2020.
An samu ci gaba a gwajin asibiti a cikin marasa lafiya da ke shan remdesivir da kyau.
Gwaje-gwaje na asibiti na Nau'in III da aka yi a Amurka, China da Italiya. Chloroquine, wanda a baya aka yi amfani da shi wajen magance zazzabin cizon sauro, an gwada shi a China a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, akwai wasu bayanai game da binciken.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar rage yawan chloroquine.
Duk da haka, Cibiyar Kwayar cutar Wuhan, ta ce shan magani na gram daya a rana yana da haɗari sosai kuma yana da haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da umarnin gaggawa na amfani da hydroxychloroquine da chloroquine ba tare da sanarwa ga likitoci da ke kula da maganin COVID-19 ba. Rahoton bincike na 7 ya haɗa da interferon, ribavirin ko umifenovir don magance COVID-19.
Bayanai na farko sun nuna cewa ribavirin yana da amfani ga maganin SARS-CoV-2 a cikin vitro.
An ba da shawarar yin nazarin nitzoxanide a cikin vivo bayan an gano cewa ƙwayar cutar SARS-CoV-2 tana raguwa. Nazarin ya nuna cewa gano farkon furotin mai ƙyama ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci ga SARS-CoV-2 ta hanyar aiki tare da mai karɓar ACE2.
Bincike game da chloroquine da hydroxychloroquine da ko ba tare da azithromycin ba ya hana masu amfani da magunguna su karɓa ba tare da ƙarin bincike ba. Oseltamivir yana hana SARS-CoV-2 a cikin vitro kuma yana da muhimmiyar rawa wajen magance COVID-19.
Cytokine zai iya zama haɗari a wasu cututtukan COVID-19 masu cutarwa.
Akwai kuma tabbacin cewa hydroxychloroquine na iya samun damar gano tsarin cytokine. Tocilizumab an shigar da shi cikin tsarin magani ta Hukumar Lafiya ta Kasa ta kasar Sin bayan kammala wani karamin bincike.
An gudanar da wani bincike na biyu na rashin zabe a kasar Italiya domin gano cutar a cikin mutane da kuma kamuwa da cutar.
Tare da gwajin jini na jini don gano wani cytokine, aikin shi ne hana irin wannan ci gaba, wanda zai iya zama sanadin mutuwa ga wasu mutane da ke fama da cutar.
Maganin interleukin-6 antagonist mai karɓa ya yi watsi da FDA bisa ga binciken da aka yi na maganin cytokine mai karɓa na steroid wanda ya samo asali daga maganin CAR T cell, a shekara ta 2017.
Amma, ko kuma wani irin wannan bincike, da aka yi a kan batun ya nuna cewa tocilizumab yana da muhimmanci wajen magance CRS.
Bayyana magungunan da ke da tsabta da kuma haɗuwa da magungunan da ke cikin mutanen da ake bi da su don COVID-19 ga mutanen da ke da bukata ya dogara da gwaji a matsayin hanyar kariya ta rashin sani.
Wannan tsarin zai kasance ne don SARS amma zai samar da yara.
Ana amfani da kwayar cutar a matsayin hanyar aiki ta hanyar maganin kwayoyin cuta wanda zai iya nuna kariya ga SARS-CoV-2.
Wasu dalilai, kamar ƙwayoyin cytotoxity da/ko cin abinci, na iya zama.
Irin wannan magani ta hanyar likitan da ya san shi, alal misali, ta hanyar likitan da ke da kafa ɗaya, yana tafiya.
Bayyana jini ga wani mai jinya, wanda shine ruwan jini da aka kawo ga marasa lafiya da suka ci kuma suna da ƙwayoyin cuta, zai iya zama da wuya ga amsawa da kuma rashin lafiya.
Cutar korona, wata ƙungiya ta cututtuka
Li Wenliang, likita a asibitin Wuhan na tsakiya, wanda ya kamu da COVID-19 kuma ya mutu bayan ya yi kira ga jama'a su yi hankali da yaduwar cutar.
